0001493152-23-041025.txt : 20231114 0001493152-23-041025.hdr.sgml : 20231114 20231114160054 ACCESSION NUMBER: 0001493152-23-041025 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEA Industries Inc. CENTRAL INDEX KEY: 0001482541 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] IRS NUMBER: 273911608 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41266 FILM NUMBER: 231405576 BUSINESS ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-993-5271 MAIL ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Surna Inc. DATE OF NAME CHANGE: 20100128 10-Q 1 form10-q.htm
false --12-31 Q3 0001482541 Yes Yes 0001482541 2023-01-01 2023-09-30 0001482541 CEAD:CommonStock0.00001ParValueMember 2023-01-01 2023-09-30 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-09-30 0001482541 2023-11-14 0001482541 2023-09-30 0001482541 2022-12-31 0001482541 2023-07-01 2023-09-30 0001482541 2022-07-01 2022-09-30 0001482541 2022-01-01 2022-09-30 0001482541 us-gaap:CommonStockMember 2023-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001482541 us-gaap:RetainedEarningsMember 2023-06-30 0001482541 2023-06-30 0001482541 us-gaap:CommonStockMember 2022-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001482541 us-gaap:RetainedEarningsMember 2022-12-31 0001482541 us-gaap:CommonStockMember 2022-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001482541 us-gaap:RetainedEarningsMember 2022-06-30 0001482541 2022-06-30 0001482541 us-gaap:CommonStockMember 2021-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001482541 us-gaap:RetainedEarningsMember 2021-12-31 0001482541 2021-12-31 0001482541 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001482541 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001482541 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001482541 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001482541 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001482541 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001482541 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001482541 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001482541 us-gaap:CommonStockMember 2023-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001482541 us-gaap:RetainedEarningsMember 2023-09-30 0001482541 us-gaap:CommonStockMember 2022-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001482541 us-gaap:RetainedEarningsMember 2022-09-30 0001482541 2022-09-30 0001482541 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-09-30 0001482541 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-09-30 0001482541 CEAD:DirectorAndStaffMember 2023-01-01 2023-09-30 0001482541 CEAD:DirectorAndStaffMember 2022-01-01 2022-09-30 0001482541 2022-01-01 2022-06-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember CEAD:BookedSalesOrdersFromThreeCustomersMember 2023-09-30 0001482541 CEAD:OneCustomerMember 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2023-07-01 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2023-07-01 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerThreeMember 2023-07-01 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerFourMember 2023-07-01 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2023-01-01 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2023-01-01 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerThreeMember 2023-01-01 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2022-07-01 2022-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2022-07-01 2022-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2022-01-01 2022-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2022-01-01 2022-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerThreeMember 2022-01-01 2022-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2023-01-01 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2023-01-01 2023-09-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2022-01-01 2022-12-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2022-01-01 2022-12-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-07-01 2023-09-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-07-01 2022-09-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-01-01 2023-09-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-01-01 2022-09-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-07-01 2023-09-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-07-01 2022-09-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-01-01 2023-09-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-01-01 2022-09-30 0001482541 us-gaap:ShippingAndHandlingMember 2023-07-01 2023-09-30 0001482541 us-gaap:ShippingAndHandlingMember 2022-07-01 2022-09-30 0001482541 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-09-30 0001482541 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-09-30 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2023-07-01 2023-09-30 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2022-07-01 2022-09-30 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2023-01-01 2023-09-30 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2022-01-01 2022-09-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember 2023-09-30 0001482541 CEAD:TwoThousandAndTwentyFourMember 2023-09-30 0001482541 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001482541 us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001482541 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001482541 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-07-01 2023-09-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-07-01 2022-09-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-01-01 2023-09-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-01-01 2022-09-30 0001482541 CEAD:ProductDevelopmentCostsMember 2023-07-01 2023-09-30 0001482541 CEAD:ProductDevelopmentCostsMember 2022-07-01 2022-09-30 0001482541 CEAD:ProductDevelopmentCostsMember 2023-01-01 2023-09-30 0001482541 CEAD:ProductDevelopmentCostsMember 2022-01-01 2022-09-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2022-09-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-24 2021-07-28 0001482541 2021-07-28 0001482541 2022-01-01 2022-12-31 0001482541 us-gaap:FurnitureAndFixturesMember 2023-09-30 0001482541 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001482541 us-gaap:VehiclesMember 2023-09-30 0001482541 us-gaap:VehiclesMember 2022-12-31 0001482541 us-gaap:PropertyPlantAndEquipmentMember us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001482541 us-gaap:PropertyPlantAndEquipmentMember CEAD:InventoryMember 2023-01-01 2023-09-30 0001482541 us-gaap:SubsequentEventMember CEAD:EngineeringAgreementMember 2023-10-20 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:JanuarySeventeernTwoThousandTwentyTwoMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:JanuarySeventeernTwoThousandTwentyThreeMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:JanuarySeventeernTwoThousandTwentyTwoMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:JanuarySeventeernTwoThousandTwentyTwoMember CEAD:TwoNewDirectorsMember 2023-01-12 2023-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-03 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-02 2023-01-03 0001482541 srt:DirectorMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember 2023-01-01 2023-09-30 0001482541 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 CEAD:AuditCommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 CEAD:CommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 2022-01-12 2022-01-17 0001482541 2021-12-30 0001482541 srt:BoardOfDirectorsChairmanMember 2023-09-30 0001482541 2022-02-14 2022-02-15 0001482541 us-gaap:CommonStockMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-15 0001482541 us-gaap:WarrantMember CEAD:UnderwritersMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember CEAD:UnderwritersMember 2022-02-15 0001482541 2022-06-20 2022-06-21 0001482541 2022-06-21 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:NonQualifiedStockOptionMember 2023-09-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2021-03-22 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:FiveEmployeesMember 2023-01-01 2023-09-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:NonQualifiedStockOptionMember 2023-01-01 2023-09-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-09-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:NonQualifiedStockOptionMember 2023-09-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:IncentiveStockOptionMember 2023-09-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-09-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-09-30 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-09-30 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-09-30 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-16 2023-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:EmployeesDirectorsandConsultantsMember 2023-01-01 2023-09-30 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:EmployeesDirectorsandConsultantsMember 2022-01-01 2022-09-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:DirectorsMember 2023-01-01 2023-09-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-09-30 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-09-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-09-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-09-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001482541 CEAD:WarrantsRangeMember 2023-09-30 0001482541 CEAD:WarrantsRangeMember 2023-01-01 2023-09-30 0001482541 CEAD:WarrantsRangeOneMember 2023-09-30 0001482541 CEAD:WarrantsRangeOneMember 2023-01-01 2023-09-30 0001482541 CEAD:WarrantsRangeTwoMember 2023-09-30 0001482541 CEAD:WarrantsRangeTwoMember 2023-01-01 2023-09-30 0001482541 CEAD:WarrantsRangeThreeMember 2023-09-30 0001482541 CEAD:WarrantsRangeThreeMember 2023-01-01 2023-09-30 0001482541 CEAD:OwnershipMember 2023-09-30 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2022-10-12 2022-10-13 0001482541 CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember 2022-01-01 2022-12-31 0001482541 CEAD:ConsultingAgreementMember 2022-12-19 2022-12-20 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2023-01-01 2023-03-31 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2023-01-01 2023-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft CEAD:integer CEAD:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-41266

 

CEA INDUSTRIES INC.

 

(Exact name of registrant as specified in its charter)

 

Nevada   27-3911608

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

385 South Pierce Avenue, Suite C

Louisville, Colorado 80027

  80027
(Address of principal executive offices)   (Zip code)

 

(303) 993-5271

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.00001 par value   CEAD   Nasdaq Capital Markets
Warrants to purchase common stock   CEADW   Nasdaq Capital Markets

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer Accelerated Filer
Non-accelerated Filer Smaller Reporting Company
    Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO

 

As of November 14, 2023, the number of outstanding shares of common stock of the registrant was 8,076,372.

 

 

 

 
 

 

CEA Industries Inc.

Quarterly Report on Form 10-Q

For the Quarterly Period Ended September 30, 2023

 

Table of Contents

 

  Page
Cautionary Statement ii
   
PART I — FINANCIAL INFORMATION  
   
Item 1. Financial Statements (Unaudited)  
   
Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 1
   
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and September 30, 2022 2
   
Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Three and Nine Months Ended September 30, 2023 and September 30, 2022 3
   
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and September 30, 2022 4
   
Notes to the Condensed Consolidated Financial Statements 5
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 24
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk 33
   
Item 4. Controls and Procedures 33
   
PART II — OTHER INFORMATION  
   
Item 1. Legal Proceedings 34
   
Item 1A. Risk Factors 34
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 34
   
Item 3. Defaults Upon Senior Securities 34
   
Item 4. Mine Safety Disclosures 34
   
Item 5. Other Information 35
   
Item 6. Exhibits 35
   
SIGNATURES 36
   
EXHIBIT INDEX 37

 

i
 

 

In this Quarterly Report on Form 10-Q, unless otherwise indicated, the “Company”, “we”, “us” or “our” refer to CEA Industries Inc. and, where appropriate, its wholly owned subsidiary.

 

CAUTIONARY STATEMENT

 

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical fact but are based on current management expectations that involve substantial risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance. We generally identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other similar words. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements including, but not limited to, any projections of revenue, gross profit, earnings or loss, tax provisions, cash flows or other financial items; any statements of the plans, strategies or objectives of management for future operations; any statements regarding current or future macroeconomic or industry-specific trends or events and the impact of those trends and events on us or our financial performance; any statements regarding pending investigations, legal claims or tax disputes; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing.

 

These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. These forward-looking statements are based on assumptions regarding our present and future business strategies and the environment in which we operate. Important factors that could cause those differences include, but are not limited to:

 

  our business prospects and the prospects of our existing and prospective customers;
     
  our overall financial condition, including the impact of higher interest rates and inflation, business disruption due to the COVID-19 pandemic, the Ukraine war, Israeli conflict, and the supply chains on which we depend;
     
  the impact on our business from our restructuring and cost containment actions taken in the first quarter of 2023 and continuing thereafter;
     
  the inherent uncertainty of product development and product selection to meet client requirements;
     
  regulatory, legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;
     
  increasing competitive pressures in the CEA (Controlled Environment Agriculture) industry and our engineering service and product supply position within the industry;
     
  the ability to effectively operate our business, including servicing our existing customers and obtaining new business;
     
  our relationships with our customers and suppliers;
     
  the continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance payments from our customers;
     
  general economic conditions, our customers’ operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, adversely affecting demand for the products and services offered by us in the markets in which we operate;

 

ii
 

 

  the business disruptions that are happening in the CEA industry, including bankruptcies and shifting market demands, that are having an adverse impact on the demand for our engineering services and construction solutions and, consequently, our revenues;
     
  the supply of products from our suppliers and our ability to complete contracts, some of which depend on other actors for a comprehensive project completion;
     
  changes in our business strategy and development plans, and in our plans for seeking strategic alternatives;
     
  our ability to attract and retain qualified personnel;
     
  our ability to raise equity and debt capital, as needed from time to time, to fund our operations and business strategy, including possible strategic alternatives and acquisitions;
     
   our ability to identify, complete and integrate potential strategic alternatives and acquisitions;
     
  future revenue being lower than expected;
     
  The substantial changes in the amount and current size of our backlog and our ability to convert backlog into revenue in a timely manner, or at all; and
     
  our intention not to pay dividends.

 

These factors should not be construed as exhaustive and should be read with the other cautionary statements in this report.

 

Although we believe that we use reasonable assumptions for these forward-looking statements, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, as updated from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”). You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q. The forward-looking statements and projections contained in this Quarterly Report on Form 10-Q are intended to be within the meaning of “forward-looking statements” in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”).

 

iii
 

 

PART I — FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

CEA Industries Inc.

Condensed Consolidated Balance Sheets

(in US Dollars except share numbers)

 

   September 30,   December 31, 
   2023   2022 
   (Unaudited)     
ASSETS          
Current Assets          
Cash and cash equivalents  $13,342,805   $18,637,114 
Accounts receivable, net   272,547    2,649 
Inventory, net   315,096    348,411 
Prepaid expenses and other   323,751    1,489,921 
Total Current Assets   14,254,199    20,478,095 
Noncurrent Assets          
Property and equipment, net   45,737    68,513 
Intangible assets, net   1,830    1,830 
Deposits   14,747    14,747 
Operating lease right-of-use asset   383,169    462,874 
Total Noncurrent Assets   445,483    547,964 
           
TOTAL ASSETS  $14,699,682   $21,026,059 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
           
LIABILITIES          
Current Liabilities          
Accounts payable and accrued liabilities  $571,885   $1,207,258 
Deferred revenue   474,888    4,338,570 
Accrued equity compensation   -    89,970 
Current portion of operating lease liability   124,319    118,235 
Total Current Liabilities   1,171,092    5,754,033 
           
Noncurrent Liabilities          
Operating lease liability, net of current portion   290,051    376,851 
Total Noncurrent Liabilities   290,051    376,851 
           
TOTAL LIABILITIES   1,461,143    6,130,884 
           
Commitments and Contingencies (Note 6)   -    - 
           
SHAREHOLDERS’ EQUITY          
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding   -    - 
Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively   81    80 
Additional paid in capital   49,441,231    49,173,836 
Accumulated deficit   (36,202,773)   (34,278,741)
Total Shareholders’ Equity   13,238,539    14,895,175 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $14,699,682   $21,026,059 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

1
 

 

CEA Industries Inc.

Condensed Consolidated Statements of Operations

(in US Dollars except share numbers)

(Unaudited)

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Revenue, net  $913,571   $5,063,079   $6,659,858   $9,822,391 
                     
Cost of revenue   1,017,634    4,465,888    5,831,953    8,828,453 
                     
Gross profit (loss)   (104,063)   597,191    827,905    993,938 
                     
Operating expenses:                    
Advertising and marketing expenses   21,551    304,600    256,965    865,305 
Product development costs   -    58,978    76,487    254,473 
Selling, general and administrative expenses   681,448    1,292,746    2,452,305    3,684,617 
Goodwill impairment charges   -    -    -    631,064 
Total operating expenses   702,999    1,656,324    2,785,757    5,435,459 
                     
Operating loss   (807,062)   (1,059,133)   (1,957,852)   (4,441,521)
                     
Other income (expense):                    
Other income (expense), net   -    6,358    7,778    191,358 
Interest income (expense), net   8,043    10,725    26,042    24,585 
Total other income (expense)   8,043    17,083    33,820    215,943 
                     
Loss before provision for income taxes   (799,019)   (1,042,050)   (1,924,032)   (4,225,578)
                     
Income taxes   -    -    -    - 
                     
Net loss  $(799,019)  $(1,042,050)  $(1,924,032)  $(4,225,578)
                     
Convertible preferred series B stock dividends   -    -    -    (35,984)
Deemed dividend on convertible preferred series B stock on down round   -    -    -    (439,999)
                     
Net loss available to common shareholders  $(799,019)  $(1,042,050)  $(1,924,032)  $(4,701,561)
                     
Loss per common share – basic and diluted  $(0.10)  $(0.13)  $(0.24)  $(0.69)
                     
Weighted average number of common shares outstanding, basic and diluted   8,076,372    7,953,974    8,074,842    6,804,741 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

2
 

 

CEA Industries Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity

For the Three and Nine Months Ended September 30, 2023 and September 30, 2022

(in US Dollars except share numbers)

(Unaudited)

 

   Number of Shares   Amount  

Additional

Paid in Capital

   Accumulated Deficit   Shareholders’ Equity 
   Common Stock            
   Number of Shares   Amount  

Additional

Paid in Capital

   Accumulated Deficit   Shareholders’ Equity 
Balance June 30, 2023   8,076,372   $81   $49,426,065   $(35,403,754)  $14,022,392 
Fair value of vested stock options granted to employees   -    -    15,166    -    15,166 
Net loss   -    -    -    (799,019)   (799,019)
Balance September 30, 2023   8,076,372   $81   $49,441,231   $(36,202,773)  $13,238,539 

 

   Common Stock            
   Number of Shares   Amount  

Additional

Paid in Capital

   Accumulated Deficit   Shareholders’ Equity 
Balance December 31, 2022   7,953,974   $80   $49,173,836   $(34,278,741)  $14,895,175 
Fair value of vested stock options granted to employees   -    -    166,080    -    166,080 
Common shares issued in settlement of restricted stock units issued to directors   122,398    1    (1)   -    - 
Fair value of restricted stock units issued to directors   -    -    101,316    -    101,316 
Net loss   -    -    -    (1,924,032)   (1,924,032)
Balance September 30, 2023   8,076,372   $81   $49,441,231   $(36,202,773)  $13,238,539 

 

   Common Stock            
   Number of Shares   Amount   Additional Paid in Capital   Accumulated Deficit   Shareholders’ Equity (Deficit) 
Balance June 30, 2022   7,953,974   $   80   $49,091,496   $(31,965,094)  $17,126,482 
Fair value of vested stock options granted to employees   -    -    49,099    -    49,099 
Fair value of restricted stock units issued to directors   -    -    6,245    -    6,245 
Cashless exercise of prefunded warrants   -    -    -    -    - 
Net loss   -    -    -    (1,042,050)   (1,042,050)
Balance September 30, 2022   7,953,974   $80   $49,146,840   $(33,007,144)  $16,139,776 

 

   Common Stock            
   Number of Shares   Amount  

Additional Paid in Capital

   Accumulated Deficit   Shareholders’ Equity (Deficit) 
Balance December 31, 2021   1,600,835   $   16   $25,211,017   $(28,781,566)  $(3,570,533)
Fair value of vested stock options granted to employees   -    -    208,672    -    208,672 
Fair value of vested stock options granted to directors   -    -    29,656    -    29,656 
Common shares issued in settlement of restricted stock units issued to directors   3,367    -    24,994    -    24,994 
Fair value of restricted stock units issued to directors   -    -    17,418    -    17,418 
Issuance of common shares to round up partial shares following reverse split   6,798    -    -         - 
Common shares and warrants issued for cash   5,811,138    58    21,711,073    -    21,711,131 
Common shares and warrants issued on conversion of series B preferred stock   362,306    4    1,979,996    -    1,980,000 
Dividends on series B preferred stock   -    -    (35,984)   -    (35,984)
Cashless exercise of prefunded warrants   169,530    2    (2)   -    - 
Net loss   -    -    -    (4,225,578)   (4,225,578)
Balance September 30, 2022   7,953,974   $80   $49,146,840   $(33,007,144)  $16,139,776 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3
 

 

CEA Industries Inc.

Condensed Consolidated Statements of Cash Flows

(in US Dollars except share numbers)

(Unaudited)

 

   2023   2022 
  

For the Nine Months Ended

September 30,

 
   2023   2022 
Cash Flows From Operating Activities:          
Net loss  $(1,924,032)  $(4,225,578)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation and intangible asset amortization expense   22,476    24,731 
Share-based compensation   177,427    280,739 
Provision for doubtful accounts   (2,056)   93,500 
Provision for excess and obsolete inventory   111,123    (5,332)
Loss on disposal of assets   100    4,489 
Amortization of operating lease ROU asset   79,705    76,917 
Goodwill impairment charges   -    631,064 
           
Changes in operating assets and liabilities:          
Accounts receivable   (267,842)   8,801 
Inventory   (77,808)   (230,966)
Prepaid expenses and other   1,166,170    171,582 
Accounts payable and accrued liabilities   (635,373)   910,523 
Deferred revenue   (3,863,683)   1,595,644 
Operating lease liability, net   (80,716)   (65,157)
Accrued equity compensation   -    (14,065)
Net cash provided by (used in) operating activities   (5,294,509)   (743,108)
           
Cash Flows From Investing Activities          
Purchases of property and equipment   -    (30,348)
Proceeds from the sale of property and equipment   200    2,250 
Net cash provided by (used in) investing activities   200    (28,098)
           
Cash Flows From Financing Activities          
Payment of dividends on series B preferred stock   -    (35,984)
Redemption of series B preferred stock   -    (1,980,000)
Net cash proceeds on sale of common stock and warrants, net of expenses   -    21,711,131 
Net cash provided by financing activities   -    19,695,147 
           
Net change in cash and cash equivalents   (5,294,309)   18,923,941 
Cash and cash equivalents, beginning of period   18,637,114    2,159,608 
Cash and cash equivalents, end of period  $13,342,805   $21,083,549 
           
Supplemental cash flow information:          
Interest paid  $-   $- 
Income taxes paid  $-   $- 
           
Non-cash investing and financing activities:          
           
Conversion of series B preferred stock   -   $1,980,000 
Deemed dividend on series B preferred stock arising on down round   -   $439,999 
Cashless exercise of prefunded warrants       $2 
Options issued for accrued equity compensation liability  $89,970   $78,938 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Note 1 – Nature of Operations and Significant Accounting Policies

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.

 

Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

5
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

6
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of September 30, 2023, the balance in the Company’s accounts was approximately $13,343,000, consequently approximately $13,093,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

As of September 30, 2023 and 2022, there were respectively, 7,992,829 and 7,881,160, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 related to warrants outstanding at both September 30, 2023 and 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining 369,057 and 257,388 potentially dilutive equity instruments outstanding as of September 30, 2023 and 2022, respectively, related to options and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.

 

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

 

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

7
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Revenue Recognition

 

The following table sets forth the Company’s revenue by source:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Equipment and systems sales  $647,870   $4,941,380   $5,944,445   $9,375,093 
Engineering and other services   235,301    104,434    462,943    382,559 
Shipping and handling   1,000    17,265    18,335    64,739 
Forfeited non-refundable customer deposits   29,400    -    234,135    - 
Total revenue  $913,571   $5,063,079   $6,659,858   $9,822,391 

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

8
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

9
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of September 30, 2023 and December 31, 2022, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of September 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $474,888 and $4,338,570, respectively.

 

For the three and nine months ended September 30, 2023, the Company recognized revenue of $12,461 and $3,911,083, respectively, related to the deferred revenue at January 1, 2023 For the three and nine months ended September 30, 2022, the Company recognized revenue of $125,731 and $2,318,935, respectively, related to the deferred revenue at January 1, 2022.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of September 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $548,000. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at September 30, 2023, includes booked sales orders of $353,000 from four customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $65,000 (12% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.

 

10
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

  

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   195,000    353,000    548,000 
Total remaining performance obligations  $195,000   $353,000   $548,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of September 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $194,031 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the nine months ended September 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

 

11
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and September 30, 2022:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Share-based compensation expense included in:                    
Cost of revenue  $-   $3,956   $4,898   $9,851 
Advertising and marketing expenses   -    2,457    1,113    9,299 
Product development costs   -    2,481    3,570    7,442 
Selling, general and administrative expenses   15,166    69,637    167,846    240,083 
Total share-based compensation expense included in consolidated statement of operations  $15,166   $78,531   $177,427   $266,675 

 

Included in the expense for the three and nine months ended September 30, 2022, is an accrual for $23,187 and $69,561, respectively, for the 2022 Annual Employee Incentive Compensation Plan. No accrual is being recorded in 2023.

 

Concentrations

 

Four customers accounted for 29%, 19%, 16%, and 12% of the Company’s revenue for the three months ended September 30, 2023. Three customers accounted for 38%, 20% and 12% of the Company’s revenue for the nine months ended September 30, 2023. Two customers accounted for 53% and 24% of the Company’s revenue for the three months ended September 30, 2022 and three customers accounted for 28%, 25%, and 13% of the Company’s revenue for the nine months ended September 30, 2022.

 

Two customers accounted for 78%, and 12% of the Company’s accounts receivable as of September 30, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

 

Recently Issued Accounting Pronouncements

 

In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

12
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on the Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

Note 2 – Leases

 

In February 2016 the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.

 

The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

13
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

The lease cost, cash flows and other information related to the New Facility Lease were as follows:

 

  

As of

September 30, 2023

 
Operating lease right-of-use asset  $383,169 
Operating lease liability, current  $124,319 
Operating lease liability, long-term  $290,051 
      
Remaining lease term   3.6 years 
Discount rate   3.63%

 

  

For the Nine

Months Ended

September 30, 2023

 
Operating cash outflow from operating lease  $93,206 

 

14
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Future annual minimum lease payments on the New Facility Lease as of September 30, 2023 are as follows:

 

As of September 30, 2023    
     
Years ended December 31,    
2023 (excluding the nine months ended September 30, 2023)  $31,690 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   440,963 
Less imputed interest   (26,593)
Present value of minimum lease payments  $414,370 

 

Note 3 – Inventory

 

Inventory consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
Finished goods  $371,689   $270,555 
Work in progress   -    155 
Raw materials   125,437    148,608 
Allowance for excess & obsolete inventory   (182,030)   (70,907)
Inventory, net  $315,096   $348,411 

 

Overhead expenses of $15,145 and $12,770 were included in the inventory balance as of September 30, 2023, and December 31, 2022, respectively.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $36,000 and $1,176,000 in advance payments for inventory as of September 30, 2023, and December 31, 2022, respectively.

 

15
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
Furniture and equipment  $275,994   $278,389 
Vehicles   15,000    15,000 
Property and equipment, gross   290,994    293,389 
Accumulated depreciation   (245,257)   (224,876)
Property and equipment, net  $45,737   $68,513 

 

Depreciation expense was $22,476 for the nine months ended September 30, 2023. For the nine months ended September 30, 2023, $2,284 was allocated to cost of sales, $571 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
Accounts payable  $164,041   $311,162 
Sales commissions payable   4,018    25,951 
Accrued payroll liabilities   146,376    465,094 
Product warranty accrual   194,031    180,457 
Other accrued expenses   63,419    224,594 
Total  $571,885   $1,207,258 

 

Note 6 – Commitments and Contingencies

 

Litigation

 

On October 20, 2023, Green Ice, LLC and Sweet Cut Grow, LLC (“Claimants”) filed an Arbitration Petition in Denver, Colorado against the Company. The Claimants allege a breach by the Company of two contracts – an Engineering Agreement with Green Ice, dated January 14, 2021 (“Engineering Agreement”), and an Equipment Agreement with Sweet Cut Grow, dated March 29, 2021 (“Equipment Agreement”).

 

The Arbitration Petition alleges causes of action for breach of the Engineering Agreement, Breach of the Equipment Agreement, Breach of the Warranties under the Equipment Agreement, and Unjust Enrichment in the amount of moneys paid by Claimant to CEA to date under the contracts, of $1,049,280.

 

Given the Arbitration Petition’s current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.

 

Regardless, we intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer.

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

16
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

Note 7 – Stockholders’ Equity

 

As of September 30, 2023, the Company had 200,000,000 shares of common stock and 25,000,000 shares of preferred stock authorized at a $0.00001 par value.

 

As of September 30, 2023, 8,076,372 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

 

Directors Remuneration

 

On January 3, 2022, the Company issued 3,125 non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $4.80, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.

 

On January 17, 2022, the Company issued an RSU grant of 3,367 shares of common stock under the 2021 Equity Incentive Plan to each of two new directors, 1,684 shares of common stock vested immediately on grant date and the remaining 1,683 shares of common stock vested on January 17, 2023. 1,684 shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further 1,683 shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.

 

On January 3, 2023, the Company issued an RSU grant of 29,758 shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 119,032 shares of the Company’s common stock were issued in settlement of the RSUs.

 

Revised Compensation Plan for Directors

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The plan was effective retroactively for the then current independent directors and for independent directors elected or appointed after the Effective Date.

 

The plan is divided into two phases: from the Effective Date of the plan until February 9, 2022, the day prior to the listing of the Company securities on Nasdaq. (“Pre-uplist”) and from February 10, 2022, the uplist date forward (“Post-uplist”).

 

In the Pre-uplist phase, the Company paid its independent directors an annual cash fee of $15,000, which for the Post-uplist phase was increased to $25,000. The fee is payable quarterly in advance on the first business day of each quarter, as consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of the Board, the Chairman of the Company’s Audit Committee, and the Committee Chairman).

 

17
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.

 

In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.

 

The Company pays the Audit Committee Chairman an additional annual fee of $10,000, payable quarterly in advance, for services as the Audit Committee Chairman.

 

The Company pays the Chairmen of any other committees of the Board an additional annual fee of $5,000, payable quarterly in advance, for services as a Committee Chairman.

 

Directors who are also executive officers of the Company do not receive separate compensation for their Board service.

 

Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options. Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.

 

The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.

 

All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the plan.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

An additional 6,798 shares of common stock were issued to round up partial shares following the reverse split.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from 240,125,224 to 1,600,835. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

Change in Authorized Share Capital

 

In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to 200,000,000 shares of common stock and 25,000,000 shares of preferred stock.

 

18
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Equity Raise

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $22 million for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

Warrant Exercise

 

On June 21, 2022, the Company issued 169,530 shares of its common stock in connection with the cashless exercise of 170,382 prefunded conversion warrants.

 

Note 8 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

During the nine months ended September 30, 2023, no shares or options were issued and 1,665 options were cancelled under the 2017 Plan.

 

As of September 30, 2023, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards relating to 145,512 options remain outstanding, and 24,129 shares remain available for future equity awards.

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

During the nine months ended September 30, 2023:

 

-The Company issued 122,398 shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.

 

-138,489 non-qualified stock options were issued to five employees and three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of 10 years and an exercise price of $0.8955. An expense of $89,970 in respect of this issuance had been accrued in 2022. An additional expense of $32,376 was recognized in 2023 upon management and board finalization and approval of the awards.

 

-16,631 non-qualified stock options were cancelled and 333 non-qualified stock options were forfeited that had previously been issued under the 2021 Equity Incentive Plan.

 

19
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

As of September 30, 2023, of the 666,667 shares authorized under the 2021 Equity Plan, 132,568 shares have been issued in settlement of restricted stock units, awards relating to 182,728 non-qualified stock options, and 40,816 incentive stock options remain outstanding, and 310,555 shares remain available for future equity awards.

 

There was $15,586 in unrecognized compensation expense for unvested non-qualified and incentive stock options as of September 30, 2023 which will be recognized over approximately the next 18 months.

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the nine months ended September 30, 2023, are presented in the table below:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $        - 
Granted   138,489   $0.90    6.4   $- 
Exercised   -   $-    -   $- 
Forfeited   (18,629)  $2.63    9.2   $- 
Expired   -   $-    -   $- 
Outstanding, September 30, 2023   311,933   $5.74    6.6   $- 
Exercisable, September 30, 2023   286,843   $5.78    6.5   $- 

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the nine months ended September 30, 2023, are presented in the table below:

 

  Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2022   28,756   $4.73   $-   $136,016 
Granted   138,489   $0.88   $-   $121,870 
Vested   (141,822)  $0.92   $-   $(130,476)
Forfeited   (333)  $6.67   $-   $(2,222)
Expired   -   $-   $-   $- 
Nonvested, September 30, 2023   25,090   $4.98   $-   $124,948 

 

20
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

For the nine months ended September 30, 2023 and September 30, 2022, the Company recorded $76,110 and $129,733 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the nine months ended September 30, 2023, are presented in the table below:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value ($000) 
                 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $        - 
Granted   -    -    -   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, September 30, 2023   57,122   $9.44    5.3   $- 
Exercisable, September 30, 2023   57,122   $9.44    5.3   $- 

 

There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the nine months ended September 30, 2023.

 

During the nine months ended September 30, 2023 and September 30, 2022, the Company incurred $0 and $29,656 respectively, as compensation expense related to 0 and 6,250 fully vested options issued to directors, respectively.

 

Restricted Stock Units

 

Effective January 3, 2023, the Company issued a total of 119,032 restricted stock units (RSUs) under the 2021 Equity Plan to its four independent directors. These RSUs vested upon grant.

 

Effective January 17, 2023, the Company settled 3,366 RSUs that had been issued on January 17, 2022 to two new directors and that vested after 12 months by the issuance of shares of common stock

 

During the nine months ended September 30, 2023 and September 30, 2022, the Company recorded $101,316 and $42,413, respectively, as compensation expense related to vested RSUs issued to directors.

 

21
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

  Number of Units   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value 
            
Outstanding, December 31, 2022   3,366   $7.42   $      - 
Granted   119,032   $0.84   $- 
Vested and settled with share issuance   (122,398)  $1.02   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, September 30, 2023   -   $-   $- 

 

Note 9 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September 30, 2023:

 

              Weighted     
           Weighted   Average    
   Warrants  

Average

Exercise

   Remaining Life  

Aggregate

Intrinsic

 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2022   7,623,772    7,623,772   $5.14    49        - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at September 30, 2023   7,623,772    7,623,772   $5.14    40    - 

 

The following table summarizes information about warrants outstanding at September 30, 2023:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
$9.45    192,982    192,982    12 
                  
$10.40    34,737    34,737    13 
                  
$5.00    7,105,496    7,105,496    41 
                  
$5.16    290,557    290,557    41 
                  
      7,623,772    7,623,772    40 

 

22
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Note 10 – Income Taxes

 

As of September 30, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $27,873,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of September 30, 2023 and December 31, 2022. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

Note 11 – Related Party Transactions

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, one of our independent directors, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the nine months ended September 30, 2023 and September 30, 2022, the Company paid $18,273 and $9,884, respectively, in commissions under this agreement.

 

On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The balance due under this agreement totaled $2,500 with $1,250 received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $10,900. We entered into positive change orders in March 2023 of $3,577 increasing the total of the second sales order to $14,477. Revenue of $16,977 was recorded in the nine months ended September 30, 2023 in respect of these agreements. During the nine months ended September 30, 2023, the Company received $14,035 in cash payments for these contracts. A receivable of $1,692 remained outstanding as of September 30, 2023 which was subsequently paid in October.

 

Note 12 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No material subsequent events occurred after September 30, 2023, other than as set out below:

 

On October 20, 2023, Green Ice, LLC and Sweet Cut Grow, LLC (“Claimants”) filed an Arbitration Petition against the Company in Denver, Colorado. The Claimants allege a breach by the Company of two contracts – an Engineering Agreement with Green Ice, dated January 14, 2021 (“Engineering Agreement”), and an Equipment Agreement with Sweet Cut Grow, dated March 29, 2021 (“Equipment Agreement”).

 

The Arbitration Petition alleges causes of action for breach of the Engineering Agreement, Breach of the Equipment Agreement, Breach of the Warranties under the Equipment Agreement, and Unjust Enrichment in the amount of moneys paid by Claimant to CEA to date under the contracts, of $1,049,280.

 

Given the Arbitration Petition’s current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.

 

Regardless, we intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer.

 

23
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report, which include additional information about our accounting policies, practices, and the transactions underlying our financial results, as well as with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Cautionary Statements” appearing elsewhere herein and the risks and uncertainties described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, as updated from time to time in the Company’s filings with the SEC, and Part II, Item 1A of this Quarterly Report entitled “Risk Factors.”

 

Non-GAAP Financial Measures

 

To supplement our financial results on U.S. generally accepted accounting principles (“GAAP”) basis, we use non-GAAP measures including net bookings, backlog, as well as adjusted net income (loss) which reflects adjustments for certain non-cash expenses such as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures are helpful in understanding our past performance and are intended to aid in evaluating our potential future results. The presentation of these non-GAAP measures should be considered in addition to our GAAP results and are not intended to be considered in isolation or as a substitute for financial information prepared or presented in accordance with GAAP. We believe these non-GAAP financial measures reflect an additional way to view aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. For purposes of this Quarterly Report, (i) “adjusted net income (loss)” and “adjusted operating income (loss)” mean GAAP net income (loss) and operating income (loss), respectively, after adjustment for non-cash equity compensation expense, debt-related items and depreciation expense, and (ii) “net bookings” means new sales contracts executed during the quarter for which we received an initial deposit, net of any adjustments including cancellations and change orders during the quarter.

 

Our backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in the backlog or remaining performance obligations will actually generate revenues or when the actual revenues will be generated.

 

Overview

 

CEA Industries, through our subsidiary, Surna Cultivation Technologies LLC, is a company focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture (“CEA”) industry. The CEA industry aims to optimize the use of horticultural resources such as water, energy, space, capital, and labor, to create an agriculture business that is more efficient and more productive than those that use traditional farming methods. Typically, the CEA industry is focused on indoor agriculture and vertical farming.

 

Headquartered in Colorado, we leverage our experience in the CEA industry to bring our customers a variety of value-added technology solutions that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. We do this by offering our customers a variety of principal service and product offerings that include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting and climate control, and (viii) preventative maintenance services, through our partnership with a certified service contractor network, for CEA facilities.

 

24
 

 

Our revenue stream is currently derived primarily from supplying our products, services and technologies to licensed commercial indoor facilities operating in the cannabis industry. Our customers include state and provincial-regulated CEA growers located primarily in the U.S., Canada. We recently have developed customers in the non-cannabis CEA market to expand our market reach. Customers use our services for building new CEA facilities and expanding or retrofitting existing CEA facilities.

 

CEA growers currently face a challenging business environment that includes high energy costs, water usage and conservation issues, continuously evolving waste removal regulations, inflationary pressures, and labor shortages. In addition to these issues, our cannabis growing customers face increasingly rigorous quality standards and declining cannabis prices in a growing industry whose standards are constantly evolving. The part of the CEA industry focused on food related crops is also facing disruption from evolving market demand, competition, and reorganization, including the lack of growth capital and several noteworthy bankruptcies.

 

We support our clients by providing integrated mechanical, electrical, and plumbing (“MEP”) engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. Over our 16 years in business, we have served hundreds of commercial indoor CEA facilities.

 

We believe our customers partner with us because we have the reputation and experience to help them make cost-conscious and effective decisions on the design and engineering of their indoor cultivation facilities. CEA facilities are resource intensive, and a growing list of states have implemented building code changes that limit energy consumption in cultivation facilities. Energy and resource efficiency is a high priority to us as engineers, and the senior engineers on our team hold the Leadership in Energy and Environmental Design (“LEED”) credential. We believe this sustainability-focused technical experience is crucial in the value we provide to our customers.

 

We have three core assets that we believe will support us as we pursue our business strategy. First, we enjoy strong relationships with relevant stakeholders in the CEA industry. Largely focused in the cannabis segment, our partnerships include relationships with new and existing growers, capital providers, consultants, independent contractors, and numerous other providers in the segment. These partnerships include agreements reached in 2022 with Merida Capital and Hydrobuilder Holdings LLC. In June 2022 we announced a marketing arrangement with Merida Capital, a cannabis-focused private equity firm, whereby Merida will use CEA Industries Inc. as its sole provider of certain products and services for its indoor cultivation facilities. This relationship resulted in a new contract in October 2022 with one of Merida’s Connecticut based clients.

 

Second, our experience in this industry over time has built up specialized engineering know-how and experience. We have been serving indoor cultivators since 2006 and designing CEA cultivation facilities since 2016. Since then, we have tested and solidified best practices from designing environmental control systems for CEA cultivation facilities.

 

Third, we have a line of proprietary environmental control products that support the specific growing environments that our customers want. We believe these products offer significant benefits to our customers.

 

Shares of our common stock and warrants currently are traded on the Nasdaq Capital Markets under the ticker symbols “CEAD” and “CEADW”, respectively.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to have adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital. Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

25
 

 

Impact of Ukrainian Conflict

 

We believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending for the Ukraine and funding of our country’s response. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

Our Bookings, Backlog and Revenue

 

During the three months ended September 30, 2023, we executed new sales contracts with a total contract value of $644,000. During this same period, we had cancellations of $279,000. After adjustments for these cancellations, our net bookings in the three months ended September 30, 2023 were $365,000, representing an increase of $160,000 (or 78%) from net bookings of $205,000 in the second quarter of 2023.

 

Our backlog at September 30, 2023 was $548,000, a decrease of $518,000, or 49%, from June 30, 2023. The decrease in backlog is the result of lower bookings in the fourth quarter of 2022 and the first nine months of 2023. Our backlog at September 30, 2023 includes booked sales orders of $353,000 (64% of the total backlog) from four customers that we do not expect to be realized until 2024, if at all. Included in the projected revenue is one booked sales order of $65,000 (12% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. We believe the sales orders in these portions of our backlog have an elevated level of risk and may, ultimately, be delayed or cancelled by our customers. Therefore, investors should not view backlog as earned revenue.

 

Our backlog has declined for several quarters. The primary reason for the decline has been fewer new order bookings and contract cancellations.

 

The following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we have received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the period for which we received an initial deposit, net of any adjustments including cancellations and change orders during the period), (iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings, less recognized revenue). Based on the current economic climate and our cost cutting measures, there is no assurance that we will be able to continue to obtain the level of bookings that we have had in the past and or fulfill our current backlog, and we may experience contract cancellations, project scope reductions and project delays.

 

Our recognized revenue for the quarters ended March 31, 2023, June 30, 2023, and September 30, 2023 in the table below, excludes $148,776, $55,959, and $29,400, respectively, in revenue arising from the forfeiture of non-refundable deposits from former customers on previously cancelled contracts. The contracts were removed from the backlog at the time of cancellation.

 

26
 

 

   For the quarter ended 
  

September 30,
2022

  

December 31,
2022

  

March 31,
2023

  

June 30,
2023

  

September 30,
2023

 
Backlog, beginning balance  $9,698,000   $6,832,000   $5,577,000   $1,869,000   $1,066,000 
Net bookings, current period   2,197,000    206,000    826,000    205,000    366,000 
Recognized revenue, current period   5,063,000    1,461,000    4,534,000    1,008,000    884,000 
Backlog, ending balance  $6,832,000   $5,577,000   $1,869,000   $1,066,000   $548,000 

 

The completion of a customer’s new build facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for these customers to complete a new build project, which corresponds to when we are able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation systems; (vii) the availability of power; and (viii) delays that are typical in completing any construction project.

 

As has historically been the case for the Company at each quarter-end, there remains significant uncertainty regarding the timing of revenue recognition of our backlog as of September 30, 2023.

 

We have provided an estimate in our condensed consolidated financial statements for when we expect to recognize revenue on our remaining performance obligations (i.e., our Q3 2023 backlog), using separate time bands, with respect to engineering only paid contracts and partial equipment paid contracts. There continues to be significant uncertainty regarding the timing of our recognition of revenue on our Q3 2023 backlog. Refer to the Revenue Recognition section of Note 1 in our condensed consolidated financial statements, included as part of this Quarterly Report for additional information on our estimate of future revenue recognition on our remaining performance obligations.

 

Our backlog, remaining performance obligations, and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining performance obligations will generate revenues or when the revenues will be generated. Net bookings and backlog are considered non-GAAP financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures for recognized revenue, deferred revenue, and remaining performance obligations. Further, we can provide no assurance as to the profitability of our contracts reflected in remaining performance obligations, backlog and net bookings.

 

Results of Operations

 

Comparison of Three Months Ended September 30, 2023 and September 30, 2022

 

Revenues and Cost of Goods Sold

 

Revenue for the three months ended September 30, 2023 was $914,000, compared to $5,063,000 for the three months ended September 30 2022, representing a decrease of $4,149,000, or 82%. The decrease was primarily due to a decrease in bookings in the last 12 months. We believe the lower bookings are due to the suppression of capital expenditures in the cannabis market environment as a result of the prolonged effects of pricing and inflationary pressure, in addition to a reduced sales effort.

 

27
 

 

Cost of revenue decreased by $3,448,000, or 77%, from $4,466,000 for the three months ended September 30, 2022 to $1,018,000 for the three months ended September 30, 2023. The decrease was primarily due to a decrease in revenue and a decrease in variable costs, offset by higher fixed costs as a percentage of revenue, as discussed below.

 

During the three months ended September 30, 2023 we recognized a gross loss of $104,000 compared to a gross profit of $597,000 for the three months ended September 30, 2022, a decrease of 117%. Our gross profit margin decreased by 23.2 percentage points from a gross profit margin of 11.8% for the three months ended September 30, 2022 to a gross loss margin of 11.4% for the three months ended September 30, 2023 primarily due to lower revenue and an increase in fixed costs as a percentage of revenue, as described below. Additionally, total revenue in the three months ended September 30, 2023 includes $29,000 from forfeited, non-refundable deposits from former customers on previously cancelled contracts.

 

Our fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead) totaled $292,000, or 32% of total revenue, for the three months ended September 30, 2023 as compared to $373,000, or 7% of total revenue, for the three months ended September 30, 2022. The decrease of $81,000 was primarily due to a decrease in salaries and benefits (including stock-based compensation) of $78,000 and a decrease in fixed overhead of $3,000.

 

Our variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled $726,000, or 80% of total revenue, during the three months ended September 30, 2023, as compared to $4,093,000, or 81% of total revenue, in the three months ended September 30, 2022. The decrease in variable costs was primarily due to: (i) a decrease in equipment costs of $3,139,000 driven by lower revenue, partially offset by lower equipment margins, (ii) a decrease in warranty of $215,000, (iii) a decrease in other overhead of $48,000, (iv) a decrease in travel of $32,000, (v) a decrease in shipping and handling expense of $12,000, offset by (i) an increase in outside engineering costs of $58,000, and (ii) an increase in excess and obsolete inventory costs of $21,000.

 

We continue to focus on gross margin improvement through a combination of efforts, including more disciplined pricing, better absorption of our fixed costs as we convert our bookings into revenue, and the implementation over time of lower-cost supplier alternatives.

 

Operating Expenses

 

Operating expenses decreased to $703,000 for the three months ended September 30, 2023, from $1,656,000 for the three months ended September 30, 2022, a decrease of $953,000, or 58%. The operating expense decrease consisted of: (i) a decrease in selling, general and administrative expenses (“SG&A expenses”) of $611,000, (ii) a decrease in advertising and marketing expenses of $283,000, and (iii) a decrease in product development of $59,000. These decreases are the result of recent cost-cutting measures.

 

Our decrease in SG&A expenses for the three months ended September 30, 2023 compared to the three months ended September 30, 2022, was primarily due to: (i) a decrease of $299,000 in salaries and benefits (including stock-based compensation) and other employee related costs, (ii) a decrease in accounting and other professional fees of $145,000, (iii) a decrease in bad debt expense of $107,000, (iv) a decrease in commissions and other sales related expense of $47,000, (v) a decrease of $33,000 for facility and office expenses, (vi) a decrease in travel of $22,000, offset by (i) an increase in investor relations expense of $24,000, and (ii) an increase in business taxes and licenses of $19,000.

 

The decrease in advertising and marketing expenses was primarily due to (i) a decrease in salaries and benefits (including stock compensation of $124,000, (ii) a decrease in advertising and promotion of $77,000, (iii) a decrease in trade show related expenses of $65,000, and (iv) a reduction in outside services and other marketing expenses of $17,000.

 

The decrease in product development costs was due to (i) a decrease in salaries and benefits (including stock-based compensation) of $55,000, and (ii) a decrease in travel of $4,000.

 

28
 

 

Operating Income (Loss)

 

We recognized an operating loss of $807,000 for the three months ended September 30, 2023, as compared to an operating loss of $1,059,000 for the three months ended September 30, 2022, a decrease of $252,000 or 24%. The operating loss for the three months ended September 30, 2023 included $15,000 of non-cash, stock-based compensation, and $7,000 of depreciation expense, compared to $79,000 of non-cash, stock-based compensation, and $7,000 of depreciation expense for the three months ended September 30, 2022. Excluding these non-cash items, our operating loss decreased by $189,000.

 

Other Income (Expense)

 

We recognized other income (net) of $8,000 for the three months ended September 30, 2023, compared to other income (net) of $17,000 for the three months ended September 30, 2022. Other income for both the three months ended September 30, 2023 and the three months ended September 30, 2022 primarily consisted of interest income on a money market account.

 

Net Income (Loss)

 

Overall, we recognized a net loss of $799,000 for the three months ended September 30, 2023, as compared to a net loss of $1,042,000 for the three months ended September 30, 2022, a decrease of $243,000 or 23%. The net loss for the three months ended September 30, 2023 included $15,000 of non-cash, stock-based compensation, and $7,000 of depreciation expense, compared to $79,000 of non-cash, stock-based compensation, $7,000 of depreciation expense for the three months ended September 30, 2022. Excluding these non-cash items, our net loss decreased by $180,000.

 

Comparison of Nine Months Ended September 30, 2023 and September 30, 2022

 

Revenues and Cost of Goods Sold

 

Revenue for the nine months ended September 30, 2023 was $6,660,000, compared to $9,822,000 for the nine months ended September 30 2022, representing a decrease of $3,162,000, or 32%. The decrease was primarily due to a decrease in bookings over the past 12 months. We believe the lower bookings are due to the suppression of capital expenditures in the cannabis market environment as a result of the prolonged effects of pricing and inflationary pressure, in addition to a reduced sales effort.

 

Cost of revenue decreased by $2,996,000, or 34%, from $8,828,000 for the nine months ended September 30, 2022 to $5,832,000 for the nine months ended September 30, 2023. The increase was primarily due to a decrease in revenue and a decrease in variable costs as a percentage of revenue, offset by an increase in fixed costs as a percentage of revenue.

 

Our gross profit for the nine months ended September 30, 2023 was $828,000 compared to $994,000 for the nine months ended September 30, 2022, a decrease of 17%. Gross profit margin increased by 2.3 percentage points from 10.1% for the nine months ended September 30, 2022 to 12.4% for the nine months ended September 30, 2023 primarily due to a decrease in variable costs as a percentage of revenue, offset by an increase in fixed costs as a percentage of revenue, as described below. Additionally, total revenue in the nine months ended September 30, 2023 includes $234,000 from forfeited, non-refundable deposits from former customers on previously cancelled contracts.

 

Our fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead) totaled $1,002,000, or 15% of total revenue, for the nine months ended September 30, 2023 as compared to $1,181,000, or 12% of total revenue, for the nine months ended September 30, 2022. The decrease of $179,000 was primarily due to a decrease in salaries and benefits (including stock-based compensation) of $145,000 and a decrease in fixed overhead of $34,000.

 

Our variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled $4,830,000, or 73% of total revenue, during the nine months ended September 30, 2023, as compared to $7,647,000, or 78% of total revenue, in the nine months ended September 30, 2022. The decrease in variable costs was primarily due to: (i) a decrease in equipment costs of $2,497,000 driven by lower revenue, (ii) a decrease in warranty expense of $197,000, (iii) a decrease in travel of $84,000, (iv) a decrease in other overhead of $42,000, (v) a decrease in outside engineering costs of $30,000, (vi) a decrease in shipping and handling expense of $20,000, offset by an increase in excess and obsolete inventory of $52,000.

 

29
 

 

We continue to focus on gross margin improvement through a combination of efforts, including more disciplined pricing, better absorption of our fixed costs as we convert our bookings into revenue, and the implementation over time of lower-cost supplier alternatives.

 

Operating Expenses

 

Operating expenses decreased to $2,786,000 for the nine months ended September 30, 2023, from $5,435,000 for the nine months ended September 30, 2022, a decrease of $2,649,000, or 49%. The operating expense decrease consisted of: (i) a decrease of $1,232,000 in selling, general and administrative (“SG&A expenses”) (ii) a decrease of $631,000 for goodwill impairment charges, (iii) a decrease in advertising and marketing expenses of $608,000, and (iv) a decrease in product development of $178,000. The decreases are a result of cost-cutting measures implemented this year.

 

Our decrease in SG&A expenses for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022, was primarily due to: (i) a decrease of $671,000 in salaries and benefits (including stock-based compensation) and employee recruitment costs, (ii) a decrease in accounting and other professional fees of $315,000, (iii) a decrease in bad debt expense of $96,000, (iv) a decrease for commissions and other sales related expenses of $76,000, (v) a decrease in travel of $75,000, and (vi) a decrease of $68,000 for facility and office expenses, offset by (i) an increase in costs related to investor relations of $40,000, (ii) an increase in business taxes and licenses expense of $21,000, and (iii) an increase in board fees of $10,000.

 

The decrease in advertising and marketing expenses was primarily due to (i) a decrease in salaries and benefits (including stock compensation) of $230,000, (ii) a decrease in advertising and promotion of $165,000, (iii) a reduction in trade show related expenses of $107,000, (iv) a decrease in outside services and other marketing expenses of $106,000.

 

The decrease in product development costs was due to (i) a decrease in salaries and benefits (including stock-based compensation) of $143,000, (ii) a decrease in R&D consulting and materials expense of $21,000, and (iii) a decrease in travel of $14,000.

 

Operating Income (Loss)

 

We recognized an operating loss of $1,958,000 for the nine months ended September 30, 2023, as compared to an operating loss of $4,442,000 for the nine months ended September 30, 2022, a decrease of $2,484,000 or 56%. The operating loss for the nine months ended September 30, 2023 included $177,000 of non-cash, stock-based compensation, and $20,000 of depreciation expense, compared to $267,000 of non-cash, stock-based compensation, $20,000 of depreciation expense, and $631,000 for a goodwill impairment charge for the nine months ended September 30, 2022. Excluding these non-cash items, our operating loss decreased by $1,763,000.

 

Other Income (Expense)

 

We recognized other income (net) of $34,000 for the nine months ended September 30, 2023, compared to other income (net) of $216,000 for the nine months ended September 30, 2022. Other income for the nine months ended September 30, 2023 consisted of interest income on a money market account of $26,000 and $8,000 for adjustments to our ERC credit and unclaimed property liability. Other income for the nine months ended September 30, 2022 primarily consisted of $185,000 for an insurance settlement, and interest income on a money market account.

 

Net Income (Loss)

 

Overall, we recognized a net loss of $1,924,000 for the nine months ended September 30, 2023, as compared to a net loss of $4,226,000 for the nine months ended September 30, 2022, a decrease of $2,302,000 or 54%. The net loss for the nine months ended September 30, 2023 included $177,000 of non-cash, stock-based compensation, and $20,000 of depreciation expense, compared to $267,000 of non-cash, stock-based compensation, $20,000 of depreciation expense, and $631,000 for a goodwill impairment charge for the nine months ended September 30, 2022. Excluding these non-cash items, our net loss decreased by $1,581,000.

 

30
 

 

Financial Condition, Liquidity and Capital Resources

 

Cash, Cash Equivalents

 

As of September 30, 2023, we had cash and cash equivalents of $13,343,000, compared to cash and cash equivalents of $18,637,000 as of December 31, 2022. The $5,294,000 decrease in cash and cash equivalents during the nine months ended September 30, 2023, was the result of cash used in operations. Our cash is held in bank depository accounts in a financial institution. During the nine months ended September 30, 2023, we held deposits in this financial institution that exceeded the federally insured amount.

 

As of September 30, 2023, we had accounts receivable (net of allowance for doubtful accounts) of $273,000, inventory (net of excess and obsolete allowance) of $315,000, and prepaid expenses and other assets of $324,000 (including $36,000 in advance payments on inventory purchases). While we typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers are funded on an as-needed basis to complete facility construction.

 

As of September 30, 2023, we had total accounts payable and accrued expenses of $572,000, deferred revenue of $475,000, and the current portion of operating lease liability of $124,000. As of September 30, 2023, we had working capital of $13,083,000, compared to working capital of $14,724,000 as of December 31, 2022. The decrease in our working capital was primarily related to (i) a decrease in cash of $5,294,000, (ii) a decrease in deferred revenue of $3,864,000, (iii) a decrease in prepaid and other expenses of $1,166,000, (iv) a decrease in accounts payable and accrued liabilities of $635,000, and (v) an increase in accounts receivable (net) of $270,000.

 

We currently intend to retain all available funds and any future earnings for use in the operation of our business. We have never declared or paid any cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future.

 

Because of the post-pandemic macro-economic and CEA industry economy that has developed during 2021 and 2022, and is continuing into 2023, we cannot predict the continuing level of working capital that we will have in the future. Additionally, we cannot predict that our future financial position will not deteriorate due to cancelled or delayed contract fulfillment, reduced sales and our ability to perform our contracts. As mentioned elsewhere, we have taken steps to conserve our cash resources by reducing staff and taking other cost-cutting measures.

 

Summary of Cash Flows

 

The following summarizes our approximate cash flows for the nine months ended September 30, 2023 and September 30, 2022:

 

  

For the Nine Months Ended

September 30,

 
   2023   2022 
Net cash used in operating activities  $(5,294,000)  $(743,000)
Net cash used in investing activities   -    (28,000)
Net cash provided by financing activities   -    19,695,000 
Net increase (decrease) in cash  $(5,294,000)  $18,924,000 

 

31
 

 

Operating Activities

 

We incurred a net loss for the nine months ended September 30, 2023 of $1,924,000 and have an accumulated deficit of $36,203,000 as of September 30, 2023.

 

Cash used in operations for the nine months ended September 30, 2023 was $5,294,000 compared to cash used in operating activities of $743,000 for the nine months ended September 30, 2022, an increase in cash usage of $4,551,000.

 

The increase in cash used in operating activities during the nine months ended September 30, 2023 as compared to the nine months ended September 30, 2022, was primarily attributable to: (i) an increase in cash used to fund working capital of $6,136,000, (ii) a decrease in net loss of $2,302,000, and (iii) a decrease in non-cash operating charges of $717,000.

 

The decrease in our working capital was primarily related to (i) a decrease in cash of $5,294,000, (ii) a decrease in deferred revenue of $3,864,000, (iii) a decrease in prepaid and other expense of $1,166,000, (iv) a decrease in accounts payable and accrued liabilities of $635,000, and (v) an increase in accounts receivable of $270,000.

 

The decrease in non-cash operating charges was primarily due to (i) a decrease in goodwill impairment charges of $631,000, (ii) a decrease in share-based compensation of $103,000, and (iii) a decrease in the provision for doubtful accounts of $96,000, offset by an increase in the provision for excess and obsolete inventory of $116,000.

 

Investing Activities

 

Cash used in investing activities during the nine months ended September 30, 2023 was $0. Cash used in investing activities during the nine months ended September 30, 2022 of $28,000 was primarily related to the purchase of property and equipment.

 

Financing Activities

 

There were no cash flows from financing activities during the nine months ended September 30, 2023.

 

Cash flows from financing activities during the nine months ended September 30, 2022, was the result of cash proceeds from the sale of common stock and warrants (net of issuance costs) of $21,711,000, offset by a cash payment of $2,016,000 for the redemption of series B preferred stock, including related dividends.

 

Common Stock Equity Offering

 

On February 15, 2022, the Company completed a public offering of shares of common stock and warrants. The Company received net proceeds of approximately $21,711,000 for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00, expiring February 10, 2027. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.16, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

The net proceeds from the offering will be used for the Company’s operations, to pursue select acquisitions or strategic alternatives, and for general corporate and working capital purposes. In connection with the offering, we received approval to list our common stock on the Nasdaq Capital Market under the symbol “CEAD” and our warrants under the symbol “CEADW”. Effective February 10, 2022, trading of both shares of the Company’s common stock and certain of the Company’s warrants commenced on the Nasdaq. See Item 5 below for discussion of the notice received from Nasdaq concerning a potential delisting.

 

Inflation

 

Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases in the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

32
 

 

Contractual Payment Obligations

 

As of September 30, 2023, our contractual payment obligations consisted of a building lease. Refer to Note 2Leases of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of our building lease.

 

Commitments and Contingencies

 

Refer to Note 6 – Commitments and Contingencies of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of commitments and contingencies.

 

Off-Balance Sheet Arrangements

 

We are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. As of September 30, 2023, we had no off-balance sheet arrangements. During the nine months ended September 30, 2023, we did not engage in any off-balance sheet financing activities other than those included in the “Contractual Payment Obligations” discussed above and those reflected in Note 6 of our condensed consolidated financial statements.

 

Critical Accounting Estimates

 

This discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting policies are particularly important to the understanding of our financial position and results of operations and require the application of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, management uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, observance of trends in the industry, information provided by our customers, and information available from other outside sources, as appropriate. Actual results could materially differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, therefore are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and our Principal Financial and Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Principal Financial and Accounting Officer concluded that as a result of material weaknesses in our internal control over financial reporting as described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC, our disclosure controls and procedures were not effective as of September 30, 2023.

 

33
 

 

We did not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements, (ii) there is inadequate segregation of duties due to our limited number of accounting personnel, and (iii) we have insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets that we use for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant reliance on, for our financial reporting.

 

We intend to take appropriate and reasonable steps to make the necessary improvements to remediate these deficiencies. We are committed to continuing to improve our financial organization including, without limitation, expanding our accounting staff and improving our systems and controls to reduce our reliance on the manual nature of our existing systems. However, due to our size and our financial resources, remediating the several identified weaknesses has not been possible and may not be economically feasible now or in the future.

 

Changes in Internal Control over Financial Reporting

 

There were no changes identified in connection with our internal control over financial reporting during the three months ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On October 20, 2023, Sweet Cut Grow, LLC and Green Ice, LLC (collectively, “Claimant”) a client of the Company with which it had an equipment contract and engineering contract, filed a demand for arbitration asserting claims for breach of contract, breach of warranty, and unjust enrichment, and demand for $1,049,280 in damages, plus interest (“Claims”). The Company’s equipment contract with Claimant requires the parties to arbitrate their disputes under the rules of the American Arbitration Association (“AAA”). The arbitration will be heard in Denver, Colorado. There are no scheduled hearing dates currently. The parties will pay their own legal fees and expenses.

 

Item 1A. Risk Factors

 

In addition to the information set forth in this Form 10-Q, you should also carefully review and consider the risk factors contained in our other reports and periodic filings with the SEC, including, without limitation, the risk factors and uncertainties contained under the caption “Item 1A—Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, that could materially and adversely affect our business, financial condition, and results of operations. The risk factors discussed in that Form 10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not known to us or that we currently consider to be immaterial to our operations.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

34
 

 

Item 5. Other Information

 

Nasdaq Notice Regarding Minimum Bid Price

 

On April 10, 2023, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until October 9, 2023 (the “Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A) that could be extended upon application. On October 11, 2023, after Company application, Nasdaq formally determined to grant the Company a second 180-day Compliance Period. The Company now has until April 7, 2024, to satisfy the Listing Rule 5550(a)(2) deficiency.

 

In order to regain compliance with Nasdaq’s minimum bid price requirement, the Company’s common stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during the second Compliance Period. In the event the Company does not regain compliance by the end of the second Compliance Period, the Company will be delisted from The Nasdaq Capital Market.

 

The letter has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on The Nasdaq Capital Market, subject to the Company’s compliance with the other listing requirements of The Nasdaq Capital Market.

 

Initiation of Strategic Alternatives Review

 

On May 24, 2023, the Company’s Board of Directors hired Roth Capital Partners to assist in its review of strategic alternatives. While the Company is hopeful that this process increases the slate of opportunities available to create shareholder value, there can be no assurance regarding the results or outcome of this review.

 

Item 6. Exhibits

 

The documents listed in the Exhibit Index of this Form 10-Q are incorporated by reference or are filed with this Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

 

35
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CEA INDUSTRIES INC.
  (the “Registrant”)
     
Dated: November 14, 2023 By: /s/ Anthony K. McDonald
    Anthony K. McDonald
    Chief Executive Officer and President
    (Principal Executive Officer)
     
Dated: November 14, 2023 By: /s/ Ian K. Patel
    Ian K. Patel
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

36
 

 

EXHIBIT INDEX

 

Exhibit    
Number   Description of Exhibit
     
31.1 *   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2 *   Certification of Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1**   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2**   Certification of Principal Financial and Accounting, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
 101.INS*   Inline XBRL Instance Document
     
101.SCH*   Inline XBRL Taxonomy Schema
     
101.CAL*   Inline XBRL Taxonomy Calculation Linkbase
     
101.DEF*   Inline XBRL Taxonomy Definition Linkbase
     
101.LAB*   Inline XBRL Taxonomy Label Linkbase
     
101.PRE*   Inline XBRL Taxonomy Presentation Linkbase
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.
** Furnished herewith.

 

37

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Anthony K. McDonald, the Chief Executive Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended September 30, 2023;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated November 14, 2023.

 

By: /s/ Anthony K. McDonald  
 

Anthony K. McDonald

 
  Chief Executive Officer  

 

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Ian K. Patel, the Principal Financial and Accounting Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended September 30, 2023;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated November 14, 2023.

 

By: /s/ Ian K. Patel  
 

Ian K. Patel

 
  Chief Financial Officer  

 

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Anthony K. McDonald
  Name: Anthony K. McDonald,
    Chief Executive Officer
  Date: November 14, 2023

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Ian K. Patel, the Principal Financial and Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Ian K. Patel
  Name: Ian K. Patel,
    Chief Financial Officer
  Date: November 14, 2023

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

 

EX-101.SCH 6 cead-20230930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of Operations and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Equity Incentive Plans link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Equity Incentive Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Schedule of Revenue by Source (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Inventory (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Summary of Non-Vested qualified Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Schedule of Restricted Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Equity Incentive Plans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of Outstanding Warrants to purchase Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cead-20230930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cead-20230930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cead-20230930_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.00001 par value Warrants To Purchase Common Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Series B Preferred Stock [Member] Title of Individual [Axis] Director And Staff [Member] Award Date [Axis] 2023 [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Booked Sales Orders From Three Customers [Member] One Customer [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer [Axis] Customer One [Member] Customer Two [Member] Customer Three [Member] Customer Four [Member] Accounts Receivable [Member] Product and Service [Axis] Equipment And Systems Sales [Member] Engineering And Other Services [Member] Shipping and Handling [Member] Forfeited Non Refundable Customer Deposits [Member] 2024 [Member] Income Statement Location [Axis] Cost of Sales [Member] Advertising And Marketing Expenses [Member] Product Development Costs [Member] Selling, General and Administrative Expenses [Member] New Facility Lease [Member] Long-Lived Tangible Asset [Axis] Furniture and Fixtures [Member] Vehicles [Member] Property, Plant and Equipment [Member] Inventory [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Engineering Agreement [Member] Award Type [Axis] Non-Qualified Stock Options [Member] Plan Name [Axis] 2021 Equity Incentive Plan [Member] Restricted Stock Units (RSUs) [Member] January 17, 2022 [Member] January 17, 2023 [Member] Two New Directors [Member] Directors [Member] 2021 Equity Plan [Member] Director [Member] Audit Committee Chairman [Member] Committee Chairman [Member] Board of Directors Chairman [Member] Warrant [Member] Underwriters [Member] 2017 Equity Incentive Plan [Member] Restricted Stock [Member] Derivative Instrument [Axis] Non Qualified Stock Option [Member] Five Employees [Member] Incentive Stock Option [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Related Party, Type [Axis] Employees And Consultants [Member] Employees, Directors and Consultants [Member] Exercise Price Range [Axis] Warrants Range [Member] Warrants Range One [Member] Warrants Range Two [Member] Warrants Range Three [Member] Investment, Name [Axis] Ownership [Member] Consulting Agreement [Member] Legal Entity [Axis] Lone Star Bioscience Inc [Member] Chief Executive Officer [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Accounts receivable, net Inventory, net Prepaid expenses and other Total Current Assets Noncurrent Assets Property and equipment, net Intangible assets, net Deposits Operating lease right-of-use asset Total Noncurrent Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY LIABILITIES Current Liabilities Accounts payable and accrued liabilities Deferred revenue Accrued equity compensation Current portion of operating lease liability Total Current Liabilities Noncurrent Liabilities Operating lease liability, net of current portion Total Noncurrent Liabilities TOTAL LIABILITIES Commitments and Contingencies (Note 6) SHAREHOLDERS’ EQUITY Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively Additional paid in capital Accumulated deficit Total Shareholders’ Equity TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Preferred stock, par or stated value per share Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par or stated value per share Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue, net Cost of revenue Gross profit (loss) Operating expenses: Advertising and marketing expenses Product development costs Selling, general and administrative expenses Goodwill impairment charges Total operating expenses Operating loss Other income (expense): Other income (expense), net Interest income (expense), net Total other income (expense) Loss before provision for income taxes Income taxes Net loss Convertible preferred series B stock dividends Deemed dividend on convertible preferred series B stock on down round Net loss available to common shareholders Loss per common share - basic Loss per common share - diluted Weighted average number of common shares outstanding, basic Weighted average number of common shares outstanding, diluted Beginning balance value Balance, shares Fair value of vested stock options granted to employees Net loss Common shares issued in settlement of restricted stock units issued to directors Common shares issued in settlement of restricted stock units issued to directors, shares Fair value of restricted stock units issued to directors Cashless exercise of prefunded warrants Fair value of vested stock options granted to directors Issuance of common shares to round up partial shares following reverse split Issuance of common shares to round up partial shares following reverse split, shares Common shares and warrants issued for cash Common shares and warrants issued for cash, shares Common shares and warrants issued on conversion of series B preferred stock Common shares issued and warrants on conversion of series B preferred stock, shares Dividends on series B preferred stock Cashless exercise of prefunded warrants, shares Ending balance value Balance, shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities: Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation and intangible asset amortization expense Share-based compensation Provision for doubtful accounts Provision for excess and obsolete inventory Loss on disposal of assets Amortization of operating lease ROU asset Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other Accounts payable and accrued liabilities Deferred revenue Operating lease liability, net Accrued equity compensation Net cash provided by (used in) operating activities Cash Flows From Investing Activities Purchases of property and equipment Proceeds from the sale of property and equipment Net cash provided by (used in) investing activities Cash Flows From Financing Activities Payment of dividends on series B preferred stock Redemption of series B preferred stock Net cash proceeds on sale of common stock and warrants, net of expenses Net cash provided by financing activities Net change in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental cash flow information: Interest paid Income taxes paid Non-cash investing and financing activities: Conversion of series B preferred stock Deemed dividend on series B preferred stock arising on down round Cashless exercise of prefunded warrants Options issued for accrued equity compensation liability Accounting Policies [Abstract] Nature of Operations and Significant Accounting Policies Leases Leases Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Equity [Abstract] Stockholders’ Equity Share-Based Payment Arrangement [Abstract] Equity Incentive Plans Warrants Warrants Income Tax Disclosure [Abstract] Income Taxes Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Events Description of Business Impact of the COVID-19 Pandemic on Our Business Impact of Ukrainian Conflict Inflation Financial Statement Presentation Interim Financial Statements Principles of Consolidation Use of Estimates Cash, Cash Equivalents, and Restricted Cash Income (Loss) Per Common Share Goodwill Temporary Equity Revenue Recognition Product Warranty Accounting for Share-Based Compensation Concentrations Recently Issued Accounting Pronouncements Schedule of Revenue by Source Schedule of Remaining Performance Obligations Expected to be Recognized Schedule of Share-based Compensation Costs Schedule of Lease Cost Schedule of Future Annual Minimum Lease Payments Schedule of Inventory Schedule of Property and Equipment Schedule of Accounts Payable and Accrued Liabilities Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Schedule of Stock Option Activity Summary of Non-Vested qualified Stock Option Activity Schedule of Restricted Units Activity Schedule of Outstanding Warrants to purchase Common Stock Schedule of Warrants Outstanding Schedule of Product Information [Table] Product Information [Line Items] Total revenue Remaining performance obligations related to engineering only paid contracts Remaining performance obligations related to partial equipment paid contracts Total remaining performance obligations Total share-based compensation expense included in consolidated statement of operations Federal insured amount Cash balance, amount Cash equivalent balance, amount Potentially dilutive equity instruments that are convertible into common stock Goodwill and intangible asset impairment Contract with customer liability current Revenue recognized Revenue remaining performance obligation Product warranty description Accrued warranty reserve amount Stock price volatility Expected Term Risk-free interest rate Accrued Incentive Concentration risk percentage Schedule Of Lease Cost Operating lease liability, current Operating lease liability, long-term Remaining lease term Discount rate Operating cash outflow from operating lease Schedule Of Future Annual Minimum Lease Payments 2023 (excluding the nine months ended September 30, 2023) 2024 2025 2026 Thereafter Total minimum lease payments Less imputed interest Present value of minimum lease payments Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Area of land Operating lease term description Lease rental expense Increase in rent percent Security deposit Lease renew term Operating lease liability Finished goods Work in progress Raw materials Allowance for excess & obsolete inventory Inventory, net Overhead expenses Prepaid inventory expenses Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Accumulated depreciation Property and equipment, net Depreciation expenses Accounts payable Sales commissions payable Accrued payroll liabilities Product warranty accrual Other accrued expenses Total Subsequent Event [Table] Subsequent Event [Line Items] Amount paid Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Common stock par value Number of stock options issued Exercise price Number of stock options issued Shares, vested Number of shares vested in period Management fee expense Share based compensation arrangement payment Vesting rights description Reverse stock split Reverse stock split Net proceeds from sale of common stock Number of shares sold Exercise price Stock issued during period, shares, issued for services Warrants maturity date Number of shares issued Prefunded conversion warrants Number of Options, Outstanding Beginning Weighted Average Exercise Price, Outstanding Beginning Weighted Average Remaining Contractual Term, Beginning Aggregate Intrinsic Value, Outstanding Beginning Number of Options, Granted Weighted Average Exercise Price, Granted Weighted Average Remaining Contractual Term, Granted Number of Options, Exercised Weighted Average Exercise Price, Exercised Number of Options, Forfeited/Cancelled Weighted Average Exercise Price, Forfeited/Cancelled Weighted Average Remaining Contractual Term, Forfeited Number of Options, Expired Weighted Average Exercise Price, Expired Number of Options, Outstanding Ending Weighted Average Exercise Price, Outstanding Ending Weighted Average Remaining Contractual Term, Outstanding Ending Aggregate Intrinsic Value, Outstanding Ending Number of Options, Exercisable Ending Weighted Average Exercise Price, Exercisable Ending Weighted Average Remaining Contractual Term, Exercisable Ending Aggregate Intrinsic Value, Exercisable Ending Number of Options Nonvested, Beginning Weighted Average Grant-Date Fair Value, Nonvested, Beginning Aggregated Intrinsic Value, Nonvested Beginning Grant Date Fair Value Nonvested, Beginning Number of Options Nonvested, Granted Weighted Average Grant-Date Fair Value, Nonvested, Granted Grant Date Fair Value Nonvested, Granted Number of Options Nonvested, Vested Weighted Average Grant-Date Fair Value, Nonvested, Vested Grant Date Fair Value Nonvested, Vested Number of Options Nonvested, Forfeited Weighted Average Grant-Date Fair Value, Nonvested, Forfeited Grant Date Fair Value Nonvested, Forfeited Number of Options Nonvested, Expired Weighted Average Grant-Date Fair Value, Nonvested, Expired Grant Date Fair Value Nonvested, Expired Number of Options Nonvested, Ending Weighted Average Grant-Date Fair Value, Nonvested, Beginning Aggregated Intrinsic Value, Nonvested Ending Grant Date Fair Value Nonvested, Ending Number of Units Outstanding, beginning Weighted Average Grant-Date Fair Value Outstanding, Beginning Aggregate Intrinsic Value Outstanding, Beginning Number of Units, Granted Weighted Average Grant-Date Fair Value, Granted Aggregate Intrinsic Value Outstanding, Granted Number of Units, Vested and settled with share issuance Weighted Average Grant-Date Fair Value, Vested and settled with share issuance Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance Number of Units, Forfeited/canceled Weighted Average Grant-Date Fair Value, Forfeited/Canceled Aggregate Intrinsic Value Outstanding, Forfeited/canceled Number of Units Outstanding, ending Weighted Average Grant-Date Fair Value Outstanding,ending Aggregate Intrinsic Value Outstanding, ending Number of options to purchase shares Number of option remain forfeited Number of shares authorized Number of shares issued Number of option remain outstanding Shares available for future equity awards Number of shares grant in period Shares issued during the period Number of share awards granted Exercise price per share Additional expense Number of option remain cancelled Number of shares authorized Unrecognized compensation expense Weighted Average Remaining Contractual Term Share based compensation Number of options to purchase shares Number of shares granted Schedule Of Outstanding Warrants To Purchase Common Stock Warrants Outstanding, Beginning Balance Warrants Exercisable, Beginning Balance Weighted Average Exercise Price, Beginning Balance Weighted Average Life of Outstanding Warrants in Months, Beginning Balance Aggregate Intrinsic Value, Beginning Balance Warrants Outstanding. Granted Warrants Exercisable, Granted Weighted Average Exercise Price, Granted Weighted Average Life of Outstanding Warrants in Months, Granted Aggregate Intrinsic Value, Granted Warrants Outstanding, Exercised Warrants Exercisable, Exercised Weighted Average Exercise Price, Exercised Weighted Average Remaining Life, Exercised Aggregate Intrinsic Value, Exercised Warrants Outstanding, Expired Warrants Exercisable, Expired Weighted Average Exercise Price, Expired Weighted Average Life of Outstanding Warrants in Months, Granted Aggregate Intrinsic Value, Expired Warrants Outstanding, Ending Balance Warrants Exercisable, Ending Balance Weighted Average Exercise Price, Ending Balance Weighted Average Life of Outstanding Warrants in Months, Ending Balance Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Warrants Outstanding Warrants Exercisable Weighted Average Life of Outstanding Warrants in Months Operating loss carryforward Net operating loss carry forward expected to expire amount Net operating loss expiration term NOLs usage against taxable income, percentage Percentage of ownership change NOLs carryforwards term Payments for commissions [custom:ProceedsFomDeposit] [custom:ProceedsFomSales] Revenue Payments for Deposits Outstanding receivable New Facility Lease [Member] Increase in rent percent. Convertible preferred stock converted to securities. Deemed dividend on series B preferred stock on down round. Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Fair value of vested stock options granted to employees Prepaid inventory expenses Common shares issued in settlement of restricted stock units issued to directors. Fair value of restricted stock units issued to directors Common shares issued in settlement of restricted stock units issued to directors Cashless exercise of prefunded warrants, value. Adjustments to additional paid in capital fair value of vested stock options granted to directors. Issuance of common shares to round up partial shares following reverse split Common shares and warrants issued value for cash. Dividends on series B preferred stock Common shares and warrants issued shares for cash. Stock issued during period shares cashless exercise of prefunded warrants. Inventory [Member] Non-qualified Stock Options [Member] 2021 Equity Incentive Plan [Member] January 17, 2022 [Member] January 17, 2023 [Member] Increase decrease in accrued equity compensation. Redemption of series B preferred stock Cash proceeds from sale of common stock and warrants net of issuance costs. Conversion of series B preferred stock. Two New Directors [Member] Deemed dividend on series B preferred stock arising on down round. Cashless exercise or prepaid warrants. Options issued for accrued equity compensation liability. Description Of Business [Policy Text Block] Directors [Member] 2021 Equity Plan [Member] Director And Staff [Member] Share based compensation arrangement by share based payment award value issued period. Audit Committee Chairman [Member] Committee Chairman [Member] Underwriters [Member] 2023 [Member] Booked Sales Orders From Three Customers [Member] One Customer [Member] 2017 Equity Incentive Plan [Member] 2024 [Member] Remaining performance obligations related to engineering only paid contracts. Remaining performance obligations related to partial equipment paid contracts. Non Qualified Stock Option [Member] Five Employees [Member] Employee stock ownership plan additional expense. Customer One [Member] Customer Two [Member] Share-based compensation arrangement by share-based payment award, number of shares authorized. Incentive Stock Option [Member] Employees And Consultants [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Weighted average remaining contractual term, granted. Weighted Average Remaining Contractual Term,Forfeited. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted. Number of Options, Expired. Inflation [Policy Text Block] Interim Financial Statements [Policy Text Block] Temporary Equity [Policy Text Block] Forfeited Non Refundable Customer Deposits [Member] Customer Three [Member] Customer Four [Member] Weighted Average Remaining Contractual Term, Ending. Number of Options, price per share. Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested. Warrants to purchase common stock Sharebased compensation arrangement by sharebased payment award options nonvested grant date fair values Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited. Share based compensation arrangement by sharebased payment award options nonvested grant date fair value expired. Employees, Directors and Consultants [Member] Intrinsic value of granted under share-based payment arrangement. Excludes share and unit options. Intrinsic value of forfeited under share-based payment arrangement. Excludes share and unit options. Warrants Disclosure [Text Block] Class of Warrant or Right Exercised Number of equity instruments other than options exercisable, including both vested and non-vested instruments. Net number of non-option equity instruments granted to participants. Number of non-option equity instruments exercised by participants. Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Warrants weighted average exercise price granted. Weighted average exercise price of warrants exercised. Weighted average exercise price of warrants expired. Weighted average life of outstanding warrants in months, beginning balance. Warrants weighted average remaining contractual terms. Weighted Average Remaining Life, Exercised Sharebased compensation arrangement by sharebased payment award non options expired weighted average remaining contractual terms. Weighted average life of outstanding warrants in months, ending balance. Aggregate intrinsic value of outstanding warrants. Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options. Intrinsic value of expirations award under share-based payment arrangement. Excludes share and unit options. Warrants Range [Member] Warrants Range One [Member] Warrants Range Two [Member] Warrants Range Three [Member] Net operating loss carry forward expected to expire amount. Net operating loss expiration term. Nols usage against taxable income percentage. Ownership [Member]. Nols carryforwards term description. Proceeds fom deposit. Consulting Agreement [Member] Lone Star Bioscience Inc [Member] Proceeds fom sales. Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) ConvertiblePreferredStockConvertedToSecurities Deemed dividend on series B preferred stock on down round Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expenses, Other Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability IncreaseDecreaseInAccruedEquityCompensation Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments of Ordinary Dividends, Preferred Stock and Preference Stock Redemption of series B preferred stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations CashlessExerciseOrPrepaidWarrants Lessee, Operating Leases [Text Block] Outstanding Warrants Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Inventory Valuation Reserves Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Stock Issued During Period, Shares, Stock Splits Class of Warrant or Right, Exercise Price of Warrants or Rights Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Aggregated Intrinsic Value, Nonvested Beginning Aggregated Intrinsic Value, Nonvested Beginning [Default Label] Grant Date Fair Value Nonvested, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Grant Date Fair Value Nonvested, Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Number of shares authorized [Default Label] Aggregate intrinsic value of outstanding warrants ClassOfWarrantOrRightExercised Weighted Average Exercise Price, Exercised [Default Label] Weighted Average Exercise Price, Expired [Default Label] SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms EX-101.PRE 10 cead-20230930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover - shares
9 Months Ended
Sep. 30, 2023
Nov. 14, 2023
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41266  
Entity Registrant Name CEA INDUSTRIES INC.  
Entity Central Index Key 0001482541  
Entity Tax Identification Number 27-3911608  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 385 South Pierce Avenue  
Entity Address, Address Line Two Suite C  
Entity Address, City or Town Louisville  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80027  
City Area Code (303)  
Local Phone Number 993-5271  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   8,076,372
Common Stock, $0.00001 par value    
Title of 12(b) Security Common Stock, $0.00001 par value  
Trading Symbol CEAD  
Security Exchange Name NASDAQ  
Warrants To Purchase Common Stock [Member]    
Title of 12(b) Security Warrants to purchase common stock  
Trading Symbol CEADW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 13,342,805 $ 18,637,114
Accounts receivable, net 272,547 2,649
Inventory, net 315,096 348,411
Prepaid expenses and other 323,751 1,489,921
Total Current Assets 14,254,199 20,478,095
Noncurrent Assets    
Property and equipment, net 45,737 68,513
Intangible assets, net 1,830 1,830
Deposits 14,747 14,747
Operating lease right-of-use asset 383,169 462,874
Total Noncurrent Assets 445,483 547,964
TOTAL ASSETS 14,699,682 21,026,059
Current Liabilities    
Accounts payable and accrued liabilities 571,885 1,207,258
Deferred revenue 474,888 4,338,570
Accrued equity compensation 89,970
Current portion of operating lease liability 124,319 118,235
Total Current Liabilities 1,171,092 5,754,033
Noncurrent Liabilities    
Operating lease liability, net of current portion 290,051 376,851
Total Noncurrent Liabilities 290,051 376,851
TOTAL LIABILITIES 1,461,143 6,130,884
Commitments and Contingencies (Note 6)
SHAREHOLDERS’ EQUITY    
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding
Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively 81 80
Additional paid in capital 49,441,231 49,173,836
Accumulated deficit (36,202,773) (34,278,741)
Total Shareholders’ Equity 13,238,539 14,895,175
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 14,699,682 $ 21,026,059
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par or stated value per share $ 0.00001 $ 0.00001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par or stated value per share $ 0.00001 $ 0.00001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 8,076,372 7,953,974
Common stock, shares outstanding 8,076,372 7,953,974
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue, net $ 913,571 $ 5,063,079 $ 6,659,858 $ 9,822,391
Cost of revenue 1,017,634 4,465,888 5,831,953 8,828,453
Gross profit (loss) (104,063) 597,191 827,905 993,938
Operating expenses:        
Advertising and marketing expenses 21,551 304,600 256,965 865,305
Product development costs 58,978 76,487 254,473
Selling, general and administrative expenses 681,448 1,292,746 2,452,305 3,684,617
Goodwill impairment charges 631,064
Total operating expenses 702,999 1,656,324 2,785,757 5,435,459
Operating loss (807,062) (1,059,133) (1,957,852) (4,441,521)
Other income (expense):        
Other income (expense), net 6,358 7,778 191,358
Interest income (expense), net 8,043 10,725 26,042 24,585
Total other income (expense) 8,043 17,083 33,820 215,943
Loss before provision for income taxes (799,019) (1,042,050) (1,924,032) (4,225,578)
Income taxes
Net loss (799,019) (1,042,050) (1,924,032) (4,225,578)
Convertible preferred series B stock dividends (35,984)
Deemed dividend on convertible preferred series B stock on down round (439,999)
Net loss available to common shareholders $ (799,019) $ (1,042,050) $ (1,924,032) $ (4,701,561)
Loss per common share - basic $ (0.10) $ (0.13) $ (0.24) $ (0.69)
Loss per common share - diluted $ (0.10) $ (0.13) $ (0.24) $ (0.69)
Weighted average number of common shares outstanding, basic 8,076,372 7,953,974 8,074,842 6,804,741
Weighted average number of common shares outstanding, diluted 8,076,372 7,953,974 8,074,842 6,804,741
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance value at Dec. 31, 2021 $ 16 $ 25,211,017 $ (28,781,566) $ (3,570,533)
Balance, shares at Dec. 31, 2021 1,600,835      
Fair value of vested stock options granted to employees 208,672 208,672
Net loss (4,225,578) (4,225,578)
Common shares issued in settlement of restricted stock units issued to directors 24,994 24,994
Common shares issued in settlement of restricted stock units issued to directors, shares 3,367      
Fair value of restricted stock units issued to directors 17,418 17,418
Cashless exercise of prefunded warrants 2 (2)
Fair value of vested stock options granted to directors 29,656 29,656
Issuance of common shares to round up partial shares following reverse split  
Issuance of common shares to round up partial shares following reverse split, shares 6,798      
Common shares and warrants issued for cash $ 58 21,711,073 21,711,131
Common shares and warrants issued for cash, shares 5,811,138      
Common shares and warrants issued on conversion of series B preferred stock $ 4 1,979,996 1,980,000
Common shares issued and warrants on conversion of series B preferred stock, shares 362,306      
Dividends on series B preferred stock (35,984) (35,984)
Cashless exercise of prefunded warrants, shares 169,530      
Ending balance value at Sep. 30, 2022 $ 80 49,146,840 (33,007,144) 16,139,776
Balance, shares at Sep. 30, 2022 7,953,974      
Beginning balance value at Jun. 30, 2022 $ 80 49,091,496 (31,965,094) 17,126,482
Balance, shares at Jun. 30, 2022 7,953,974      
Fair value of vested stock options granted to employees 49,099 49,099
Net loss (1,042,050) (1,042,050)
Fair value of restricted stock units issued to directors 6,245 6,245
Cashless exercise of prefunded warrants
Ending balance value at Sep. 30, 2022 $ 80 49,146,840 (33,007,144) 16,139,776
Balance, shares at Sep. 30, 2022 7,953,974      
Beginning balance value at Dec. 31, 2022 $ 80 49,173,836 (34,278,741) 14,895,175
Balance, shares at Dec. 31, 2022 7,953,974      
Fair value of vested stock options granted to employees 166,080 166,080
Net loss (1,924,032) (1,924,032)
Common shares issued in settlement of restricted stock units issued to directors $ 1 (1)
Common shares issued in settlement of restricted stock units issued to directors, shares 122,398      
Fair value of restricted stock units issued to directors 101,316 101,316
Ending balance value at Sep. 30, 2023 $ 81 49,441,231 (36,202,773) 13,238,539
Balance, shares at Sep. 30, 2023 8,076,372      
Beginning balance value at Jun. 30, 2023 $ 81 49,426,065 (35,403,754) 14,022,392
Balance, shares at Jun. 30, 2023 8,076,372      
Fair value of vested stock options granted to employees 15,166 15,166
Net loss (799,019) (799,019)
Ending balance value at Sep. 30, 2023 $ 81 $ 49,441,231 $ (36,202,773) $ 13,238,539
Balance, shares at Sep. 30, 2023 8,076,372      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows From Operating Activities:    
Net loss $ (1,924,032) $ (4,225,578)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and intangible asset amortization expense 22,476 24,731
Share-based compensation 177,427 280,739
Provision for doubtful accounts (2,056) 93,500
Provision for excess and obsolete inventory 111,123 (5,332)
Loss on disposal of assets 100 4,489
Amortization of operating lease ROU asset 79,705 76,917
Goodwill impairment charges 631,064
Changes in operating assets and liabilities:    
Accounts receivable (267,842) 8,801
Inventory (77,808) (230,966)
Prepaid expenses and other 1,166,170 171,582
Accounts payable and accrued liabilities (635,373) 910,523
Deferred revenue (3,863,683) 1,595,644
Operating lease liability, net (80,716) (65,157)
Accrued equity compensation (14,065)
Net cash provided by (used in) operating activities (5,294,509) (743,108)
Cash Flows From Investing Activities    
Purchases of property and equipment (30,348)
Proceeds from the sale of property and equipment 200 2,250
Net cash provided by (used in) investing activities 200 (28,098)
Cash Flows From Financing Activities    
Payment of dividends on series B preferred stock (35,984)
Redemption of series B preferred stock (1,980,000)
Net cash proceeds on sale of common stock and warrants, net of expenses 21,711,131
Net cash provided by financing activities 19,695,147
Net change in cash and cash equivalents (5,294,309) 18,923,941
Cash and cash equivalents, beginning of period 18,637,114 2,159,608
Cash and cash equivalents, end of period 13,342,805 21,083,549
Supplemental cash flow information:    
Interest paid
Income taxes paid
Non-cash investing and financing activities:    
Conversion of series B preferred stock 1,980,000
Deemed dividend on series B preferred stock arising on down round 439,999
Cashless exercise of prefunded warrants   2
Options issued for accrued equity compensation liability $ 89,970 $ 78,938
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Nature of Operations and Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Nature of Operations and Significant Accounting Policies

Note 1 – Nature of Operations and Significant Accounting Policies

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.

 

Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of September 30, 2023, the balance in the Company’s accounts was approximately $13,343,000, consequently approximately $13,093,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

As of September 30, 2023 and 2022, there were respectively, 7,992,829 and 7,881,160, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 related to warrants outstanding at both September 30, 2023 and 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining 369,057 and 257,388 potentially dilutive equity instruments outstanding as of September 30, 2023 and 2022, respectively, related to options and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.

 

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

 

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Revenue Recognition

 

The following table sets forth the Company’s revenue by source:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Equipment and systems sales  $647,870   $4,941,380   $5,944,445   $9,375,093 
Engineering and other services   235,301    104,434    462,943    382,559 
Shipping and handling   1,000    17,265    18,335    64,739 
Forfeited non-refundable customer deposits   29,400    -    234,135    - 
Total revenue  $913,571   $5,063,079   $6,659,858   $9,822,391 

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of September 30, 2023 and December 31, 2022, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of September 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $474,888 and $4,338,570, respectively.

 

For the three and nine months ended September 30, 2023, the Company recognized revenue of $12,461 and $3,911,083, respectively, related to the deferred revenue at January 1, 2023 For the three and nine months ended September 30, 2022, the Company recognized revenue of $125,731 and $2,318,935, respectively, related to the deferred revenue at January 1, 2022.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of September 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $548,000. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at September 30, 2023, includes booked sales orders of $353,000 from four customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $65,000 (12% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

  

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   195,000    353,000    548,000 
Total remaining performance obligations  $195,000   $353,000   $548,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of September 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $194,031 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the nine months ended September 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and September 30, 2022:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Share-based compensation expense included in:                    
Cost of revenue  $-   $3,956   $4,898   $9,851 
Advertising and marketing expenses   -    2,457    1,113    9,299 
Product development costs   -    2,481    3,570    7,442 
Selling, general and administrative expenses   15,166    69,637    167,846    240,083 
Total share-based compensation expense included in consolidated statement of operations  $15,166   $78,531   $177,427   $266,675 

 

Included in the expense for the three and nine months ended September 30, 2022, is an accrual for $23,187 and $69,561, respectively, for the 2022 Annual Employee Incentive Compensation Plan. No accrual is being recorded in 2023.

 

Concentrations

 

Four customers accounted for 29%, 19%, 16%, and 12% of the Company’s revenue for the three months ended September 30, 2023. Three customers accounted for 38%, 20% and 12% of the Company’s revenue for the nine months ended September 30, 2023. Two customers accounted for 53% and 24% of the Company’s revenue for the three months ended September 30, 2022 and three customers accounted for 28%, 25%, and 13% of the Company’s revenue for the nine months ended September 30, 2022.

 

Two customers accounted for 78%, and 12% of the Company’s accounts receivable as of September 30, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

 

Recently Issued Accounting Pronouncements

 

In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on the Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Leases
9 Months Ended
Sep. 30, 2023
Leases  
Leases

Note 2 – Leases

 

In February 2016 the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.

 

The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

The lease cost, cash flows and other information related to the New Facility Lease were as follows:

 

  

As of

September 30, 2023

 
Operating lease right-of-use asset  $383,169 
Operating lease liability, current  $124,319 
Operating lease liability, long-term  $290,051 
      
Remaining lease term   3.6 years 
Discount rate   3.63%

 

  

For the Nine

Months Ended

September 30, 2023

 
Operating cash outflow from operating lease  $93,206 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Future annual minimum lease payments on the New Facility Lease as of September 30, 2023 are as follows:

 

As of September 30, 2023    
     
Years ended December 31,    
2023 (excluding the nine months ended September 30, 2023)  $31,690 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   440,963 
Less imputed interest   (26,593)
Present value of minimum lease payments  $414,370 

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Inventory
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Inventory

Note 3 – Inventory

 

Inventory consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
Finished goods  $371,689   $270,555 
Work in progress   -    155 
Raw materials   125,437    148,608 
Allowance for excess & obsolete inventory   (182,030)   (70,907)
Inventory, net  $315,096   $348,411 

 

Overhead expenses of $15,145 and $12,770 were included in the inventory balance as of September 30, 2023, and December 31, 2022, respectively.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $36,000 and $1,176,000 in advance payments for inventory as of September 30, 2023, and December 31, 2022, respectively.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Property and Equipment
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
Furniture and equipment  $275,994   $278,389 
Vehicles   15,000    15,000 
Property and equipment, gross   290,994    293,389 
Accumulated depreciation   (245,257)   (224,876)
Property and equipment, net  $45,737   $68,513 

 

Depreciation expense was $22,476 for the nine months ended September 30, 2023. For the nine months ended September 30, 2023, $2,284 was allocated to cost of sales, $571 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts Payable and Accrued Liabilities
9 Months Ended
Sep. 30, 2023
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
Accounts payable  $164,041   $311,162 
Sales commissions payable   4,018    25,951 
Accrued payroll liabilities   146,376    465,094 
Product warranty accrual   194,031    180,457 
Other accrued expenses   63,419    224,594 
Total  $571,885   $1,207,258 

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6 – Commitments and Contingencies

 

Litigation

 

On October 20, 2023, Green Ice, LLC and Sweet Cut Grow, LLC (“Claimants”) filed an Arbitration Petition in Denver, Colorado against the Company. The Claimants allege a breach by the Company of two contracts – an Engineering Agreement with Green Ice, dated January 14, 2021 (“Engineering Agreement”), and an Equipment Agreement with Sweet Cut Grow, dated March 29, 2021 (“Equipment Agreement”).

 

The Arbitration Petition alleges causes of action for breach of the Engineering Agreement, Breach of the Equipment Agreement, Breach of the Warranties under the Equipment Agreement, and Unjust Enrichment in the amount of moneys paid by Claimant to CEA to date under the contracts, of $1,049,280.

 

Given the Arbitration Petition’s current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.

 

Regardless, we intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer.

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Stockholders’ Equity

Note 7 – Stockholders’ Equity

 

As of September 30, 2023, the Company had 200,000,000 shares of common stock and 25,000,000 shares of preferred stock authorized at a $0.00001 par value.

 

As of September 30, 2023, 8,076,372 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

 

Directors Remuneration

 

On January 3, 2022, the Company issued 3,125 non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $4.80, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.

 

On January 17, 2022, the Company issued an RSU grant of 3,367 shares of common stock under the 2021 Equity Incentive Plan to each of two new directors, 1,684 shares of common stock vested immediately on grant date and the remaining 1,683 shares of common stock vested on January 17, 2023. 1,684 shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further 1,683 shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.

 

On January 3, 2023, the Company issued an RSU grant of 29,758 shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 119,032 shares of the Company’s common stock were issued in settlement of the RSUs.

 

Revised Compensation Plan for Directors

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The plan was effective retroactively for the then current independent directors and for independent directors elected or appointed after the Effective Date.

 

The plan is divided into two phases: from the Effective Date of the plan until February 9, 2022, the day prior to the listing of the Company securities on Nasdaq. (“Pre-uplist”) and from February 10, 2022, the uplist date forward (“Post-uplist”).

 

In the Pre-uplist phase, the Company paid its independent directors an annual cash fee of $15,000, which for the Post-uplist phase was increased to $25,000. The fee is payable quarterly in advance on the first business day of each quarter, as consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of the Board, the Chairman of the Company’s Audit Committee, and the Committee Chairman).

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.

 

In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.

 

The Company pays the Audit Committee Chairman an additional annual fee of $10,000, payable quarterly in advance, for services as the Audit Committee Chairman.

 

The Company pays the Chairmen of any other committees of the Board an additional annual fee of $5,000, payable quarterly in advance, for services as a Committee Chairman.

 

Directors who are also executive officers of the Company do not receive separate compensation for their Board service.

 

Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options. Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.

 

The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.

 

All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the plan.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

An additional 6,798 shares of common stock were issued to round up partial shares following the reverse split.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from 240,125,224 to 1,600,835. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

Change in Authorized Share Capital

 

In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to 200,000,000 shares of common stock and 25,000,000 shares of preferred stock.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Equity Raise

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $22 million for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

Warrant Exercise

 

On June 21, 2022, the Company issued 169,530 shares of its common stock in connection with the cashless exercise of 170,382 prefunded conversion warrants.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Incentive Plans
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans

Note 8 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

During the nine months ended September 30, 2023, no shares or options were issued and 1,665 options were cancelled under the 2017 Plan.

 

As of September 30, 2023, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards relating to 145,512 options remain outstanding, and 24,129 shares remain available for future equity awards.

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

During the nine months ended September 30, 2023:

 

-The Company issued 122,398 shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.

 

-138,489 non-qualified stock options were issued to five employees and three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of 10 years and an exercise price of $0.8955. An expense of $89,970 in respect of this issuance had been accrued in 2022. An additional expense of $32,376 was recognized in 2023 upon management and board finalization and approval of the awards.

 

-16,631 non-qualified stock options were cancelled and 333 non-qualified stock options were forfeited that had previously been issued under the 2021 Equity Incentive Plan.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

As of September 30, 2023, of the 666,667 shares authorized under the 2021 Equity Plan, 132,568 shares have been issued in settlement of restricted stock units, awards relating to 182,728 non-qualified stock options, and 40,816 incentive stock options remain outstanding, and 310,555 shares remain available for future equity awards.

 

There was $15,586 in unrecognized compensation expense for unvested non-qualified and incentive stock options as of September 30, 2023 which will be recognized over approximately the next 18 months.

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the nine months ended September 30, 2023, are presented in the table below:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $        - 
Granted   138,489   $0.90    6.4   $- 
Exercised   -   $-    -   $- 
Forfeited   (18,629)  $2.63    9.2   $- 
Expired   -   $-    -   $- 
Outstanding, September 30, 2023   311,933   $5.74    6.6   $- 
Exercisable, September 30, 2023   286,843   $5.78    6.5   $- 

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the nine months ended September 30, 2023, are presented in the table below:

 

  Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2022   28,756   $4.73   $-   $136,016 
Granted   138,489   $0.88   $-   $121,870 
Vested   (141,822)  $0.92   $-   $(130,476)
Forfeited   (333)  $6.67   $-   $(2,222)
Expired   -   $-   $-   $- 
Nonvested, September 30, 2023   25,090   $4.98   $-   $124,948 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

For the nine months ended September 30, 2023 and September 30, 2022, the Company recorded $76,110 and $129,733 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the nine months ended September 30, 2023, are presented in the table below:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value ($000) 
                 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $        - 
Granted   -    -    -   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, September 30, 2023   57,122   $9.44    5.3   $- 
Exercisable, September 30, 2023   57,122   $9.44    5.3   $- 

 

There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the nine months ended September 30, 2023.

 

During the nine months ended September 30, 2023 and September 30, 2022, the Company incurred $0 and $29,656 respectively, as compensation expense related to 0 and 6,250 fully vested options issued to directors, respectively.

 

Restricted Stock Units

 

Effective January 3, 2023, the Company issued a total of 119,032 restricted stock units (RSUs) under the 2021 Equity Plan to its four independent directors. These RSUs vested upon grant.

 

Effective January 17, 2023, the Company settled 3,366 RSUs that had been issued on January 17, 2022 to two new directors and that vested after 12 months by the issuance of shares of common stock

 

During the nine months ended September 30, 2023 and September 30, 2022, the Company recorded $101,316 and $42,413, respectively, as compensation expense related to vested RSUs issued to directors.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

  Number of Units   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value 
            
Outstanding, December 31, 2022   3,366   $7.42   $      - 
Granted   119,032   $0.84   $- 
Vested and settled with share issuance   (122,398)  $1.02   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, September 30, 2023   -   $-   $- 

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Warrants
9 Months Ended
Sep. 30, 2023
Warrants  
Warrants

Note 9 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September 30, 2023:

 

              Weighted     
           Weighted   Average    
   Warrants  

Average

Exercise

   Remaining Life  

Aggregate

Intrinsic

 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2022   7,623,772    7,623,772   $5.14    49        - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at September 30, 2023   7,623,772    7,623,772   $5.14    40    - 

 

The following table summarizes information about warrants outstanding at September 30, 2023:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
$9.45    192,982    192,982    12 
                  
$10.40    34,737    34,737    13 
                  
$5.00    7,105,496    7,105,496    41 
                  
$5.16    290,557    290,557    41 
                  
      7,623,772    7,623,772    40 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 10 – Income Taxes

 

As of September 30, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $27,873,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of September 30, 2023 and December 31, 2022. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 11 – Related Party Transactions

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, one of our independent directors, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the nine months ended September 30, 2023 and September 30, 2022, the Company paid $18,273 and $9,884, respectively, in commissions under this agreement.

 

On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The balance due under this agreement totaled $2,500 with $1,250 received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $10,900. We entered into positive change orders in March 2023 of $3,577 increasing the total of the second sales order to $14,477. Revenue of $16,977 was recorded in the nine months ended September 30, 2023 in respect of these agreements. During the nine months ended September 30, 2023, the Company received $14,035 in cash payments for these contracts. A receivable of $1,692 remained outstanding as of September 30, 2023 which was subsequently paid in October.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 12 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No material subsequent events occurred after September 30, 2023, other than as set out below:

 

On October 20, 2023, Green Ice, LLC and Sweet Cut Grow, LLC (“Claimants”) filed an Arbitration Petition against the Company in Denver, Colorado. The Claimants allege a breach by the Company of two contracts – an Engineering Agreement with Green Ice, dated January 14, 2021 (“Engineering Agreement”), and an Equipment Agreement with Sweet Cut Grow, dated March 29, 2021 (“Equipment Agreement”).

 

The Arbitration Petition alleges causes of action for breach of the Engineering Agreement, Breach of the Equipment Agreement, Breach of the Warranties under the Equipment Agreement, and Unjust Enrichment in the amount of moneys paid by Claimant to CEA to date under the contracts, of $1,049,280.

 

Given the Arbitration Petition’s current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.

 

Regardless, we intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Nature of Operations and Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Description of Business

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.

 

Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian Conflict

Impact of Ukrainian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Inflation

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Financial Statement Presentation

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

 

Principles of Consolidation

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Cash, Cash Equivalents, and Restricted Cash

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of September 30, 2023, the balance in the Company’s accounts was approximately $13,343,000, consequently approximately $13,093,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

As of September 30, 2023 and 2022, there were respectively, 7,992,829 and 7,881,160, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 related to warrants outstanding at both September 30, 2023 and 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining 369,057 and 257,388 potentially dilutive equity instruments outstanding as of September 30, 2023 and 2022, respectively, related to options and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.

 

Goodwill

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

 

Temporary Equity

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Revenue Recognition

Revenue Recognition

 

The following table sets forth the Company’s revenue by source:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Equipment and systems sales  $647,870   $4,941,380   $5,944,445   $9,375,093 
Engineering and other services   235,301    104,434    462,943    382,559 
Shipping and handling   1,000    17,265    18,335    64,739 
Forfeited non-refundable customer deposits   29,400    -    234,135    - 
Total revenue  $913,571   $5,063,079   $6,659,858   $9,822,391 

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of September 30, 2023 and December 31, 2022, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of September 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $474,888 and $4,338,570, respectively.

 

For the three and nine months ended September 30, 2023, the Company recognized revenue of $12,461 and $3,911,083, respectively, related to the deferred revenue at January 1, 2023 For the three and nine months ended September 30, 2022, the Company recognized revenue of $125,731 and $2,318,935, respectively, related to the deferred revenue at January 1, 2022.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of September 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $548,000. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at September 30, 2023, includes booked sales orders of $353,000 from four customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $65,000 (12% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

  

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   195,000    353,000    548,000 
Total remaining performance obligations  $195,000   $353,000   $548,000 

 

Product Warranty

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of September 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $194,031 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the nine months ended September 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and September 30, 2022:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Share-based compensation expense included in:                    
Cost of revenue  $-   $3,956   $4,898   $9,851 
Advertising and marketing expenses   -    2,457    1,113    9,299 
Product development costs   -    2,481    3,570    7,442 
Selling, general and administrative expenses   15,166    69,637    167,846    240,083 
Total share-based compensation expense included in consolidated statement of operations  $15,166   $78,531   $177,427   $266,675 

 

Included in the expense for the three and nine months ended September 30, 2022, is an accrual for $23,187 and $69,561, respectively, for the 2022 Annual Employee Incentive Compensation Plan. No accrual is being recorded in 2023.

 

Concentrations

Concentrations

 

Four customers accounted for 29%, 19%, 16%, and 12% of the Company’s revenue for the three months ended September 30, 2023. Three customers accounted for 38%, 20% and 12% of the Company’s revenue for the nine months ended September 30, 2023. Two customers accounted for 53% and 24% of the Company’s revenue for the three months ended September 30, 2022 and three customers accounted for 28%, 25%, and 13% of the Company’s revenue for the nine months ended September 30, 2022.

 

Two customers accounted for 78%, and 12% of the Company’s accounts receivable as of September 30, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on the Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Nature of Operations and Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Revenue by Source

The following table sets forth the Company’s revenue by source:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Equipment and systems sales  $647,870   $4,941,380   $5,944,445   $9,375,093 
Engineering and other services   235,301    104,434    462,943    382,559 
Shipping and handling   1,000    17,265    18,335    64,739 
Forfeited non-refundable customer deposits   29,400    -    234,135    - 
Total revenue  $913,571   $5,063,079   $6,659,858   $9,822,391 
Schedule of Remaining Performance Obligations Expected to be Recognized

The remaining performance obligations expected to be recognized through 2024 are as follows:

  

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   195,000    353,000    548,000 
Total remaining performance obligations  $195,000   $353,000   $548,000 
Schedule of Share-based Compensation Costs

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and September 30, 2022:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Share-based compensation expense included in:                    
Cost of revenue  $-   $3,956   $4,898   $9,851 
Advertising and marketing expenses   -    2,457    1,113    9,299 
Product development costs   -    2,481    3,570    7,442 
Selling, general and administrative expenses   15,166    69,637    167,846    240,083 
Total share-based compensation expense included in consolidated statement of operations  $15,166   $78,531   $177,427   $266,675 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Leases (Tables)
9 Months Ended
Sep. 30, 2023
Leases  
Schedule of Lease Cost
  

As of

September 30, 2023

 
Operating lease right-of-use asset  $383,169 
Operating lease liability, current  $124,319 
Operating lease liability, long-term  $290,051 
      
Remaining lease term   3.6 years 
Discount rate   3.63%

 

  

For the Nine

Months Ended

September 30, 2023

 
Operating cash outflow from operating lease  $93,206 
Schedule of Future Annual Minimum Lease Payments

 

As of September 30, 2023    
     
Years ended December 31,    
2023 (excluding the nine months ended September 30, 2023)  $31,690 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   440,963 
Less imputed interest   (26,593)
Present value of minimum lease payments  $414,370 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Inventory (Tables)
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventory

 

   September 30,   December 31, 
   2023   2022 
Finished goods  $371,689   $270,555 
Work in progress   -    155 
Raw materials   125,437    148,608 
Allowance for excess & obsolete inventory   (182,030)   (70,907)
Inventory, net  $315,096   $348,411 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Property and Equipment (Tables)
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

 

   September 30,   December 31, 
   2023   2022 
Furniture and equipment  $275,994   $278,389 
Vehicles   15,000    15,000 
Property and equipment, gross   290,994    293,389 
Accumulated depreciation   (245,257)   (224,876)
Property and equipment, net  $45,737   $68,513 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts Payable and Accrued Liabilities (Tables)
9 Months Ended
Sep. 30, 2023
Payables and Accruals [Abstract]  
Schedule of Accounts Payable and Accrued Liabilities

 

   September 30,   December 31, 
   2023   2022 
Accounts payable  $164,041   $311,162 
Sales commissions payable   4,018    25,951 
Accrued payroll liabilities   146,376    465,094 
Product warranty accrual   194,031    180,457 
Other accrued expenses   63,419    224,594 
Total  $571,885   $1,207,258 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Incentive Plans (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $        - 
Granted   138,489   $0.90    6.4   $- 
Exercised   -   $-    -   $- 
Forfeited   (18,629)  $2.63    9.2   $- 
Expired   -   $-    -   $- 
Outstanding, September 30, 2023   311,933   $5.74    6.6   $- 
Exercisable, September 30, 2023   286,843   $5.78    6.5   $- 
Summary of Non-Vested qualified Stock Option Activity

 

  Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2022   28,756   $4.73   $-   $136,016 
Granted   138,489   $0.88   $-   $121,870 
Vested   (141,822)  $0.92   $-   $(130,476)
Forfeited   (333)  $6.67   $-   $(2,222)
Expired   -   $-   $-   $- 
Nonvested, September 30, 2023   25,090   $4.98   $-   $124,948 
Schedule of Restricted Units Activity

 

  Number of Units   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value 
            
Outstanding, December 31, 2022   3,366   $7.42   $      - 
Granted   119,032   $0.84   $- 
Vested and settled with share issuance   (122,398)  $1.02   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, September 30, 2023   -   $-   $- 
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value ($000) 
                 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $        - 
Granted   -    -    -   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, September 30, 2023   57,122   $9.44    5.3   $- 
Exercisable, September 30, 2023   57,122   $9.44    5.3   $- 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Warrants (Tables)
9 Months Ended
Sep. 30, 2023
Warrants  
Schedule of Outstanding Warrants to purchase Common Stock

 

              Weighted     
           Weighted   Average    
   Warrants  

Average

Exercise

   Remaining Life  

Aggregate

Intrinsic

 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2022   7,623,772    7,623,772   $5.14    49        - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at September 30, 2023   7,623,772    7,623,772   $5.14    40    - 
Schedule of Warrants Outstanding

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
$9.45    192,982    192,982    12 
                  
$10.40    34,737    34,737    13 
                  
$5.00    7,105,496    7,105,496    41 
                  
$5.16    290,557    290,557    41 
                  
      7,623,772    7,623,772    40 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Revenue by Source (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Product Information [Line Items]        
Total revenue $ 913,571 $ 5,063,079 $ 6,659,858 $ 9,822,391
Equipment And Systems Sales [Member]        
Product Information [Line Items]        
Total revenue 647,870 4,941,380 5,944,445 9,375,093
Engineering And Other Services [Member]        
Product Information [Line Items]        
Total revenue 235,301 104,434 462,943 382,559
Shipping and Handling [Member]        
Product Information [Line Items]        
Total revenue 1,000 17,265 18,335 64,739
Forfeited Non Refundable Customer Deposits [Member]        
Product Information [Line Items]        
Total revenue $ 29,400 $ 234,135
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Remaining Performance Obligations Expected to be Recognized (Details)
Sep. 30, 2023
USD ($)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 548,000
Total remaining performance obligations 548,000
2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 195,000
Total remaining performance obligations 195,000
2024 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 353,000
Total remaining performance obligations $ 353,000
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Share-based Compensation Costs (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Total share-based compensation expense included in consolidated statement of operations $ 15,166 $ 78,531 $ 177,427 $ 266,675
Cost of Sales [Member]        
Total share-based compensation expense included in consolidated statement of operations 3,956 4,898 9,851
Advertising And Marketing Expenses [Member]        
Total share-based compensation expense included in consolidated statement of operations 2,457 1,113 9,299
Product Development Costs [Member]        
Total share-based compensation expense included in consolidated statement of operations 2,481 3,570 7,442
Selling, General and Administrative Expenses [Member]        
Total share-based compensation expense included in consolidated statement of operations $ 15,166 $ 69,637 $ 167,846 $ 240,083
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Nature of Operations and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Product Information [Line Items]            
Federal insured amount $ 250,000     $ 250,000    
Cash balance, amount 13,343,000     13,343,000    
Cash equivalent balance, amount 13,093,000     $ 13,093,000    
Potentially dilutive equity instruments that are convertible into common stock       7,992,829 7,881,160  
Goodwill and intangible asset impairment $ 631,064 $ 631,064  
Contract with customer liability current 474,888     474,888   $ 4,338,570
Revenue recognized 12,461 125,731   3,911,083 2,318,935  
Revenue remaining performance obligation 548,000     $ 548,000    
Product warranty description       The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue    
Accrued warranty reserve amount $ 194,031     $ 194,031   $ 180,457
Stock price volatility       152.23%    
Expected Term       10 years    
Risk-free interest rate       3.48%    
Accrued Incentive   $ 23,187   $ 0 $ 69,561  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage 29.00% 53.00%   38.00% 28.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage 19.00% 24.00%   20.00% 25.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]            
Product Information [Line Items]            
Concentration risk percentage 16.00%     12.00% 13.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Four [Member]            
Product Information [Line Items]            
Concentration risk percentage 12.00%          
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage       78.00%   57.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage       12.00%   43.00%
2023 [Member]            
Product Information [Line Items]            
Revenue remaining performance obligation $ 195,000     $ 195,000    
2023 [Member] | Booked Sales Orders From Three Customers [Member]            
Product Information [Line Items]            
Revenue remaining performance obligation 353,000     $ 353,000    
Director And Staff [Member]            
Product Information [Line Items]            
Potentially dilutive equity instruments that are convertible into common stock       369,057 257,388  
One Customer [Member]            
Product Information [Line Items]            
Revenue remaining performance obligation $ 65,000     $ 65,000    
Series B Preferred Stock [Member]            
Product Information [Line Items]            
Potentially dilutive equity instruments that are convertible into common stock       7,623,772 7,623,772  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Lease Cost (Details) - USD ($)
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Leases    
Operating lease right-of-use asset $ 383,169 $ 462,874
Operating lease liability, current 124,319 118,235
Operating lease liability, long-term $ 290,051 $ 376,851
Remaining lease term 3 years 7 months 6 days  
Discount rate 3.63%  
Operating cash outflow from operating lease $ 93,206  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Future Annual Minimum Lease Payments (Details)
Sep. 30, 2023
USD ($)
Leases  
2023 (excluding the nine months ended September 30, 2023) $ 31,690
2024 128,643
2025 132,503
2026 136,473
Thereafter 11,654
Total minimum lease payments 440,963
Less imputed interest (26,593)
Present value of minimum lease payments $ 414,370
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Leases (Details Narrative)
Jul. 28, 2021
USD ($)
ft²
Sep. 30, 2023
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Lease renew term 5 years  
Operating lease liability   $ 414,370
New Facility Lease [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Area of land | ft² 11,491  
Operating lease term description The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027  
Lease rental expense $ 10,055  
Increase in rent percent 3.00%  
Security deposit $ 14,747  
Operating lease liability $ 582,838  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Inventory (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Finished goods $ 371,689 $ 270,555
Work in progress 155
Raw materials 125,437 148,608
Allowance for excess & obsolete inventory (182,030) (70,907)
Inventory, net $ 315,096 $ 348,411
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Inventory (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Overhead expenses $ 15,145 $ 12,770
Prepaid inventory expenses $ 36,000 $ 1,176,000
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Property and Equipment (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 290,994 $ 293,389
Accumulated depreciation (245,257) (224,876)
Property and equipment, net 45,737 68,513
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 275,994 278,389
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 15,000 $ 15,000
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Property and Equipment (Details Narrative)
9 Months Ended
Sep. 30, 2023
USD ($)
Property, Plant and Equipment [Line Items]  
Depreciation expenses $ 22,476
Property, Plant and Equipment [Member] | Cost of Sales [Member]  
Property, Plant and Equipment [Line Items]  
Depreciation expenses 2,284
Property, Plant and Equipment [Member] | Inventory [Member]  
Property, Plant and Equipment [Line Items]  
Depreciation expenses $ 571
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accounts payable $ 164,041 $ 311,162
Sales commissions payable 4,018 25,951
Accrued payroll liabilities 146,376 465,094
Product warranty accrual 194,031 180,457
Other accrued expenses 63,419 224,594
Total $ 571,885 $ 1,207,258
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies (Details Narrative) - USD ($)
Oct. 20, 2023
Sep. 30, 2023
Dec. 31, 2022
Subsequent Event [Line Items]      
Amount paid   $ 164,041 $ 311,162
Subsequent Event [Member] | Engineering Agreement [Member]      
Subsequent Event [Line Items]      
Amount paid $ 1,049,280    
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Details Narrative) - USD ($)
9 Months Ended
Jan. 17, 2023
Jan. 03, 2023
Jun. 21, 2022
Feb. 15, 2022
Jan. 17, 2022
Jan. 03, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 30, 2021
Mar. 22, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, shares authorized             200,000,000   200,000,000      
Preferred stock, shares authorized             25,000,000   25,000,000      
Common stock par value             $ 0.00001   $ 0.00001      
Common stock, shares issued             8,076,372   7,953,974      
Common stock, shares outstanding             8,076,372   7,953,974 1,600,835 240,125,224  
Preferred stock, shares issued             0   0      
Preferred stock, shares outstanding             0   0      
Reverse stock split         one-for-one hundred and fifty              
Reverse stock split         6,798              
Net proceeds from sale of common stock       $ 22,000,000                
Exercise price             $ 5.14   $ 5.14      
Number of shares issued     169,530                  
Prefunded conversion warrants     170,382                  
Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares sold       5,811,138                
Number of shares issued               5,811,138        
Warrant [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares sold       6,572,808                
Exercise price       $ 5.00                
Director [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Management fee expense         $ 15,000   $ 25,000          
Audit Committee Chairman [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Management fee expense         10,000              
Committee Chairman [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Management fee expense         $ 5,000              
Board of Directors Chairman [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, shares authorized             200,000,000          
Preferred stock, shares authorized             25,000,000          
Underwriters [Member] | Warrant [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price       $ 5.1625                
Stock issued during period, shares, issued for services       290,557                
Warrants maturity date       Feb. 10, 2027                
2021 Equity Incentive Plan [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Exercise price           $ 4.80            
2021 Equity Plan [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of stock options issued                       666,667
Number of shares issued             122,398          
Non-Qualified Stock Options [Member] | 2021 Equity Incentive Plan [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of stock options issued           3,125            
Restricted Stock Units (RSUs) [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Vesting rights description         Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date              
Restricted Stock Units (RSUs) [Member] | Director [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation arrangement payment         $ 25,000              
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of stock options issued   29,758     3,367              
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member] | January 17, 2022 [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of stock options issued         1,684              
Shares, vested         1,684              
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member] | January 17, 2022 [Member] | Two New Directors [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Shares, vested 1,683                      
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member] | January 17, 2023 [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of stock options issued         1,683              
Restricted Stock Units (RSUs) [Member] | 2021 Equity Plan [Member] | Directors [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares vested in period   119,032                    
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Stock Option Activity (Details) - 2017 Equity Plan and 2021 Equity Plan [Member]
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Employees And Consultants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Granted 138,489
Employees And Consultants [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 192,073
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 8.94
Weighted Average Remaining Contractual Term, Beginning 7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted 138,489
Weighted Average Exercise Price, Granted | $ / shares $ 0.90
Weighted Average Remaining Contractual Term, Granted 6 years 4 months 24 days
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled (18,629)
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares $ 2.63
Weighted Average Remaining Contractual Term, Forfeited 9 years 2 months 12 days
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 311,933
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 5.74
Weighted Average Remaining Contractual Term, Outstanding Ending 6 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 286,843
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 5.78
Weighted Average Remaining Contractual Term, Exercisable Ending 6 years 6 months
Aggregate Intrinsic Value, Exercisable Ending | $
Directors [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 57,122
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Beginning 6 years
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted
Weighted Average Exercise Price, Granted | $ / shares
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 57,122
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Outstanding Ending 5 years 3 months 18 days
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 57,122
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Exercisable Ending 5 years 3 months 18 days
Aggregate Intrinsic Value, Exercisable Ending | $
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Non-Vested qualified Stock Option Activity (Details) - Employees And Consultants [Member] - 2017 Equity Plan and 2021 Equity Plan [Member]
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Nonvested, Beginning | shares 28,756
Weighted Average Grant-Date Fair Value, Nonvested, Beginning | $ / shares $ 4.73
Aggregated Intrinsic Value, Nonvested Beginning
Grant Date Fair Value Nonvested, Beginning $ 136,016
Number of Options Nonvested, Granted | shares 138,489
Weighted Average Grant-Date Fair Value, Nonvested, Granted | $ / shares $ 0.88
Grant Date Fair Value Nonvested, Granted $ 121,870
Number of Options Nonvested, Vested $ (141,822)
Weighted Average Grant-Date Fair Value, Nonvested, Vested | $ / shares $ 0.92
Grant Date Fair Value Nonvested, Vested $ (130,476)
Number of Options Nonvested, Forfeited | shares (333)
Weighted Average Grant-Date Fair Value, Nonvested, Forfeited | $ / shares $ 6.67
Grant Date Fair Value Nonvested, Forfeited $ (2,222)
Number of Options Nonvested, Expired | shares
Weighted Average Grant-Date Fair Value, Nonvested, Expired | $ / shares
Grant Date Fair Value Nonvested, Expired
Number of Options Nonvested, Ending | shares 25,090
Weighted Average Grant-Date Fair Value, Nonvested, Beginning | $ / shares $ 4.98
Aggregated Intrinsic Value, Nonvested Ending
Grant Date Fair Value Nonvested, Ending $ 124,948
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Restricted Units Activity (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Aggregate Intrinsic Value Outstanding, Granted
Aggregate Intrinsic Value Outstanding, ending
2017 Equity Incentive Plan [Member] | Employees, Directors and Consultants [Member] | Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Units Outstanding, beginning | shares 3,366
Weighted Average Grant-Date Fair Value Outstanding, Beginning | $ / shares $ 7.42
Aggregate Intrinsic Value Outstanding, Beginning
Number of Units, Granted | shares 119,032
Weighted Average Grant-Date Fair Value, Granted | $ / shares $ 0.84
Aggregate Intrinsic Value Outstanding, Granted
Number of Units, Vested and settled with share issuance | shares (122,398)
Weighted Average Grant-Date Fair Value, Vested and settled with share issuance | $ / shares $ 1.02
Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance
Number of Units, Forfeited/canceled | shares
Weighted Average Grant-Date Fair Value, Forfeited/Canceled | $ / shares
Aggregate Intrinsic Value Outstanding, Forfeited/canceled
Number of Units Outstanding, ending | shares
Weighted Average Grant-Date Fair Value Outstanding,ending | $ / shares
Aggregate Intrinsic Value Outstanding, ending
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Incentive Plans (Details Narrative) - USD ($)
9 Months Ended
Jan. 17, 2023
Jan. 03, 2023
Jun. 21, 2022
Jan. 03, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jan. 17, 2022
Mar. 22, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Shares issued during the period     169,530            
Accrued equity compensation           $ 89,970    
Additional expense         32,376        
Share based compensation         177,427 $ 280,739      
Restricted Stock Units (RSUs) [Member] | Employees, Directors and Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Share based compensation         $ 101,316 42,413      
2017 Equity Incentive Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of options to purchase shares         333,333        
Number of option remain forfeited         1,665        
Number of shares authorized         333,333        
2017 Equity Incentive Plan [Member] | Director [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Share based compensation         $ 0 $ 29,656      
Number of options to purchase shares         0 6,250      
2017 Equity Incentive Plan [Member] | Non Qualified Stock Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         145,512        
Shares available for future equity awards         24,129        
2017 Equity Incentive Plan [Member] | Restricted Stock [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares issued         163,692        
2017 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Employees, Directors and Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares vested in period         122,398        
Number of shares granted         119,032        
2021 Equity Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Shares available for future equity awards         310,555        
Number of shares grant in period                 666,667
Shares issued during the period         122,398        
Number of shares authorized         666,667        
Unrecognized compensation expense         $ 15,586        
Weighted Average Remaining Contractual Term         18 months        
2021 Equity Plan [Member] | Non Qualified Stock Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain forfeited         333        
Number of option remain outstanding         182,728        
Number of option remain cancelled         16,631        
2021 Equity Plan [Member] | Incentive Stock Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         40,816        
2021 Equity Plan [Member] | Restricted Stock [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares issued         132,568        
2021 Equity Plan [Member] | Restricted Stock Units (RSUs) [Member] | Directors [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares vested in period   119,032              
Number of shares granted 3,366                
2021 Equity Incentive Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Exercise price per share       $ 4.80          
2021 Equity Incentive Plan [Member] | Five Employees [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of share awards granted         138,489        
Exercise price per share         $ 0.8955        
2021 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares issued       3,125          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares grant in period   29,758           3,367  
2017 Equity Plan and 2021 Equity Plan [Member] | Non-Qualified Stock Options [Member] | Employees And Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Share based compensation         $ 76,110 $ 129,733      
2017 Equity Plan and 2021 Equity Plan [Member] | Non-Qualified Stock Options [Member] | Directors [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain forfeited                
Number of option remain outstanding         57,122   57,122    
Number of share awards granted                
Exercise price per share                
Number of option remain cancelled                
Weighted Average Remaining Contractual Term         6 years        
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Outstanding Warrants to purchase Common Stock (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Warrants  
Warrants Outstanding, Beginning Balance 7,623,772
Warrants Exercisable, Beginning Balance 7,623,772
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 5.14
Weighted Average Life of Outstanding Warrants in Months, Beginning Balance 49 months
Aggregate Intrinsic Value, Beginning Balance | $
Warrants Outstanding. Granted
Warrants Exercisable, Granted
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Life of Outstanding Warrants in Months, Granted
Aggregate Intrinsic Value, Granted | $
Warrants Outstanding, Exercised
Warrants Exercisable, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Remaining Life, Exercised
Aggregate Intrinsic Value, Exercised | $
Warrants Outstanding, Expired
Warrants Exercisable, Expired
Weighted Average Exercise Price, Expired | $ / shares
Weighted Average Life of Outstanding Warrants in Months, Granted
Aggregate Intrinsic Value, Expired | $
Warrants Outstanding, Ending Balance 7,623,772
Warrants Exercisable, Ending Balance 7,623,772
Weighted Average Exercise Price, Ending Balance | $ / shares $ 5.14
Weighted Average Life of Outstanding Warrants in Months, Ending Balance 40 months
Aggregate Intrinsic Value Outstanding, ending | $
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Warrants Outstanding (Details) - $ / shares
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.14 $ 5.14
Warrants Outstanding 7,623,772 7,623,772
Warrants Exercisable 7,623,772 7,623,772
Weighted Average Life of Outstanding Warrants in Months 40 months  
Warrants Range [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 9.45  
Warrants Outstanding 192,982  
Warrants Exercisable 192,982  
Weighted Average Life of Outstanding Warrants in Months 12 months  
Warrants Range One [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 10.40  
Warrants Outstanding 34,737  
Warrants Exercisable 34,737  
Weighted Average Life of Outstanding Warrants in Months 13 months  
Warrants Range Two [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.00  
Warrants Outstanding 7,105,496  
Warrants Exercisable 7,105,496  
Weighted Average Life of Outstanding Warrants in Months 41 months  
Warrants Range Three [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.16  
Warrants Outstanding 290,557  
Warrants Exercisable 290,557  
Weighted Average Life of Outstanding Warrants in Months 41 months  
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes (Details Narrative)
9 Months Ended
Sep. 30, 2023
USD ($)
Operating loss carryforward $ 27,873,000
Net operating loss carry forward expected to expire amount $ 11,196,000
Net operating loss expiration term 2034 through 2037
NOLs usage against taxable income, percentage 80.00%
NOLs carryforwards term three-year period
Ownership [Member]  
Percentage of ownership change 50.00%
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 20, 2022
Oct. 13, 2022
Mar. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Payments for commissions       $ 18,273 $ 9,884  
Payments for Deposits       14,035    
Outstanding receivable       1,692    
Consulting Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
[custom:ProceedsFomDeposit] $ 10,900          
Consulting Agreement [Member] | Lone Star Bioscience Inc [Member] | Chief Executive Officer [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
[custom:ProceedsFomDeposit]   $ 2,500 $ 3,577     $ 1,250
[custom:ProceedsFomSales]     $ 14,477      
Revenue       $ 16,977    
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events (Details Narrative) - USD ($)
Oct. 20, 2023
Sep. 30, 2023
Dec. 31, 2022
Subsequent Event [Line Items]      
Amount paid   $ 164,041 $ 311,162
Subsequent Event [Member] | Engineering Agreement [Member]      
Subsequent Event [Line Items]      
Amount paid $ 1,049,280    
XML 60 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001482541 2023-01-01 2023-09-30 0001482541 CEAD:CommonStock0.00001ParValueMember 2023-01-01 2023-09-30 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-09-30 0001482541 2023-11-14 0001482541 2023-09-30 0001482541 2022-12-31 0001482541 2023-07-01 2023-09-30 0001482541 2022-07-01 2022-09-30 0001482541 2022-01-01 2022-09-30 0001482541 us-gaap:CommonStockMember 2023-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001482541 us-gaap:RetainedEarningsMember 2023-06-30 0001482541 2023-06-30 0001482541 us-gaap:CommonStockMember 2022-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001482541 us-gaap:RetainedEarningsMember 2022-12-31 0001482541 us-gaap:CommonStockMember 2022-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001482541 us-gaap:RetainedEarningsMember 2022-06-30 0001482541 2022-06-30 0001482541 us-gaap:CommonStockMember 2021-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001482541 us-gaap:RetainedEarningsMember 2021-12-31 0001482541 2021-12-31 0001482541 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001482541 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001482541 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001482541 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001482541 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001482541 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001482541 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001482541 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001482541 us-gaap:CommonStockMember 2023-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001482541 us-gaap:RetainedEarningsMember 2023-09-30 0001482541 us-gaap:CommonStockMember 2022-09-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001482541 us-gaap:RetainedEarningsMember 2022-09-30 0001482541 2022-09-30 0001482541 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-09-30 0001482541 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-09-30 0001482541 CEAD:DirectorAndStaffMember 2023-01-01 2023-09-30 0001482541 CEAD:DirectorAndStaffMember 2022-01-01 2022-09-30 0001482541 2022-01-01 2022-06-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember CEAD:BookedSalesOrdersFromThreeCustomersMember 2023-09-30 0001482541 CEAD:OneCustomerMember 2023-09-30 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001482541 CEAD:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001482541 CEAD:CustomerFourMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001482541 CEAD:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001482541 CEAD:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-07-01 2023-09-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-07-01 2022-09-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-01-01 2023-09-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-01-01 2022-09-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-07-01 2023-09-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-07-01 2022-09-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-01-01 2023-09-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-01-01 2022-09-30 0001482541 us-gaap:ShippingAndHandlingMember 2023-07-01 2023-09-30 0001482541 us-gaap:ShippingAndHandlingMember 2022-07-01 2022-09-30 0001482541 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-09-30 0001482541 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-09-30 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2023-07-01 2023-09-30 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2022-07-01 2022-09-30 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2023-01-01 2023-09-30 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2022-01-01 2022-09-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember 2023-09-30 0001482541 CEAD:TwoThousandAndTwentyFourMember 2023-09-30 0001482541 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001482541 us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001482541 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001482541 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-07-01 2023-09-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-07-01 2022-09-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-01-01 2023-09-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-01-01 2022-09-30 0001482541 CEAD:ProductDevelopmentCostsMember 2023-07-01 2023-09-30 0001482541 CEAD:ProductDevelopmentCostsMember 2022-07-01 2022-09-30 0001482541 CEAD:ProductDevelopmentCostsMember 2023-01-01 2023-09-30 0001482541 CEAD:ProductDevelopmentCostsMember 2022-01-01 2022-09-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2022-09-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-24 2021-07-28 0001482541 2021-07-28 0001482541 2022-01-01 2022-12-31 0001482541 us-gaap:FurnitureAndFixturesMember 2023-09-30 0001482541 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001482541 us-gaap:VehiclesMember 2023-09-30 0001482541 us-gaap:VehiclesMember 2022-12-31 0001482541 us-gaap:CostOfSalesMember us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-09-30 0001482541 CEAD:InventoryMember us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-09-30 0001482541 us-gaap:SubsequentEventMember CEAD:EngineeringAgreementMember 2023-10-20 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyTwoMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyThreeMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyTwoMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-12 2022-01-17 0001482541 CEAD:TwoNewDirectorsMember CEAD:JanuarySeventeernTwoThousandTwentyTwoMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-12 2023-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-03 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-02 2023-01-03 0001482541 srt:DirectorMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember 2023-01-01 2023-09-30 0001482541 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 CEAD:AuditCommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 CEAD:CommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 2022-01-12 2022-01-17 0001482541 2021-12-30 0001482541 srt:BoardOfDirectorsChairmanMember 2023-09-30 0001482541 2022-02-14 2022-02-15 0001482541 us-gaap:CommonStockMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-15 0001482541 CEAD:UnderwritersMember us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 CEAD:UnderwritersMember us-gaap:WarrantMember 2022-02-15 0001482541 2022-06-20 2022-06-21 0001482541 2022-06-21 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-09-30 0001482541 us-gaap:RestrictedStockMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-09-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2021-03-22 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:FiveEmployeesMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-01 2023-09-30 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-09-30 0001482541 us-gaap:RestrictedStockMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-09-30 0001482541 CEAD:IncentiveStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-09-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-09-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-09-30 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-09-30 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-09-30 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-16 2023-01-17 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001482541 CEAD:DirectorsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-09-30 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-09-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-09-30 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-09-30 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-09-30 0001482541 CEAD:WarrantsRangeMember 2023-09-30 0001482541 CEAD:WarrantsRangeMember 2023-01-01 2023-09-30 0001482541 CEAD:WarrantsRangeOneMember 2023-09-30 0001482541 CEAD:WarrantsRangeOneMember 2023-01-01 2023-09-30 0001482541 CEAD:WarrantsRangeTwoMember 2023-09-30 0001482541 CEAD:WarrantsRangeTwoMember 2023-01-01 2023-09-30 0001482541 CEAD:WarrantsRangeThreeMember 2023-09-30 0001482541 CEAD:WarrantsRangeThreeMember 2023-01-01 2023-09-30 0001482541 CEAD:OwnershipMember 2023-09-30 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2022-10-12 2022-10-13 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2022-01-01 2022-12-31 0001482541 CEAD:ConsultingAgreementMember 2022-12-19 2022-12-20 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2023-01-01 2023-03-31 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2023-01-01 2023-09-30 iso4217:USD shares iso4217:USD shares pure utr:sqft CEAD:integer CEAD:Segment false --12-31 Q3 0001482541 Yes Yes 10-Q true 2023-09-30 2023 false 001-41266 CEA INDUSTRIES INC. NV 27-3911608 385 South Pierce Avenue Suite C Louisville CO 80027 80027 (303) 993-5271 Common Stock, $0.00001 par value CEAD NASDAQ Warrants to purchase common stock CEADW NASDAQ Non-accelerated Filer true false false 8076372 13342805 18637114 272547 2649 315096 348411 323751 1489921 14254199 20478095 45737 68513 1830 1830 14747 14747 383169 462874 445483 547964 14699682 21026059 571885 1207258 474888 4338570 89970 124319 118235 1171092 5754033 290051 376851 290051 376851 1461143 6130884 0.00001 0.00001 25000000 25000000 0 0 0 0 0.00001 0.00001 200000000 200000000 8076372 8076372 7953974 7953974 81 80 49441231 49173836 -36202773 -34278741 13238539 14895175 14699682 21026059 913571 5063079 6659858 9822391 1017634 4465888 5831953 8828453 -104063 597191 827905 993938 21551 304600 256965 865305 58978 76487 254473 681448 1292746 2452305 3684617 631064 702999 1656324 2785757 5435459 -807062 -1059133 -1957852 -4441521 6358 7778 191358 8043 10725 26042 24585 8043 17083 33820 215943 -799019 -1042050 -1924032 -4225578 -799019 -1042050 -1924032 -4225578 35984 439999 -799019 -1042050 -1924032 -4701561 -0.10 -0.10 -0.13 -0.13 -0.24 -0.24 -0.69 -0.69 8076372 8076372 7953974 7953974 8074842 8074842 6804741 6804741 8076372 81 49426065 -35403754 14022392 15166 15166 -799019 -799019 8076372 81 49441231 -36202773 13238539 7953974 80 49173836 -34278741 14895175 166080 166080 122398 1 -1 101316 101316 -1924032 -1924032 8076372 81 49441231 -36202773 13238539 7953974 80 49091496 -31965094 17126482 49099 49099 6245 6245 -1042050 -1042050 7953974 80 49146840 -33007144 16139776 1600835 16 25211017 -28781566 -3570533 1600835 16 25211017 -28781566 -3570533 208672 208672 29656 29656 3367 24994 24994 17418 17418 6798 5811138 58 21711073 21711131 362306 4 1979996 1980000 -35984 -35984 169530 2 -2 -4225578 -4225578 7953974 80 49146840 -33007144 16139776 7953974 80 49146840 -33007144 16139776 -1924032 -4225578 22476 24731 177427 280739 -2056 93500 111123 -5332 -100 -4489 79705 76917 631064 267842 -8801 77808 230966 -1166170 -171582 -635373 910523 -3863683 1595644 -80716 -65157 -14065 -5294509 -743108 30348 200 2250 200 -28098 35984 1980000 21711131 19695147 -5294309 18923941 18637114 2159608 13342805 21083549 1980000 439999 2 89970 78938 <p id="xdx_800_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zlCmA0l8UhX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_82B_zrKakLQugLTe">Nature of Operations and Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--DescriptionOfBusinessPolicyTextBlock_zamHGs59aAH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zPMP9GuPrvo9">Description of Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zsi8M5CxOUv5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zU6QSJXhI6J4">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--ImpactofUkrainianConflictPolicyTextBlock_zPvZGbp3BFcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z97I3BT6F1ke">Impact of Ukrainian Conflict</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_843_ecustom--InflationPolicyTextBlock_zs8KVzvCS8D2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z00hoOvffKKb">Inflation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzEfzitqymFb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zPqkC2iKUAp2">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--InterimFinancialStatementsPolicyTextBlock_zikvwLVBWwm9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zUwCztaISTxk">Interim Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zjWeyS6eGAoa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zkY7J0ICdw54">Principles of Consolidation</span> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_z5p8Ez2TbBsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z0nbJIT7LhYi">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zVtcgChDRjq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zF2emqMU4JBa">Cash, Cash Equivalents, and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20230930_znIz1iSVKCp7" title="Federal insured amount">250,000</span>. As of September 30, 2023, the balance in the Company’s accounts was approximately $<span id="xdx_90F_eus-gaap--Cash_iI_c20230930_zPPplbbYcEe" title="Cash balance, amount">13,343,000</span>, consequently approximately $<span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_c20230930_zDuVS7568Fgl" title="Cash equivalent balance, amount">13,093,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zd2ySSqoxI57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zBAXYVdBEdRc">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023 and 2022, there were respectively, <span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230930_zgmflJwe8wD6" title="Potentially dilutive equity instruments that are convertible into common stock">7,992,829</span> and <span id="xdx_908_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220930_zggNuOTCakv7" title="Potentially dilutive equity instruments that are convertible into common stock">7,881,160</span>, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, <span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zNnQvbx1ujFc" title="Potentially dilutive equity instruments that are convertible into common stock"><span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zL07BCCQyk9e" title="Potentially dilutive equity instruments that are convertible into common stock">7,623,772</span></span> related to warrants outstanding at both September 30, 2023 and 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining <span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zH2QHYNNKjCl" title="Potentially dilutive equity instruments that are convertible into common stock">369,057</span> and <span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220930__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zWqxMS5phA7f" title="Potentially dilutive equity instruments that are convertible into common stock">257,388</span> potentially dilutive equity instruments outstanding as of September 30, 2023 and 2022, respectively, related to options and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zisWqbe8Tnf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_z84EO3EtoMzj">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $<span id="xdx_903_eus-gaap--GoodwillAndIntangibleAssetImpairment_c20220101__20220630_zOh7RXOPIX8g" title="Goodwill and intangible asset impairment">631,064</span> at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--TemporaryEquityPolicyTextBlock_z8nexd9Ig4li" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zQ7gM6FroKj7">Temporary Equity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_845_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoS7Rs2zEKBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_znYeMAPpM6g">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_z8HrhD33xZ7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_z8yv3LNFUsC7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230701__20230930_zxjzkPM2jfEl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220701__20220930_zg3zJ4HtpjLl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930_zTImAHSoD5Ml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220930_zy5XU3FzWo5j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKTVaKg6mMyk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Equipment and systems sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">647,870</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,941,380</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,944,445</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,375,093</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zkf9QdYQ5LN8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Engineering and other services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">235,301</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">104,434</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">462,943</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">382,559</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z3PkRLfLBY9h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping and handling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,265</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,335</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,739</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ForfeitedNonRefundableCustomerDepositsMember_zDmLi7B40XMd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited non-refundable customer deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">29,400</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0677">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">234,135</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0679">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zf5ED4QwBWm3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">913,571</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,063,079</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,659,858</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,822,391</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zLh11eq45oll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Judgments and Assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of September 30, 2023 and December 31, 2022, the Company had no contract assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of September 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230930_zggy9VUsDAm4" title="Contract with customer liability current">474,888</span> and $<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20221231_zzVNY3vhNXae" title="Contract with customer liability current">4,338,570</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three and nine months ended September 30, 2023, the Company recognized revenue of $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230701__20230930_zymhcrrqPhha" title="Revenue recognized">12,461</span> and $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20230930_zwenEumPRpQ4" title="Revenue recognized">3,911,083</span>, respectively, related to the deferred revenue at January 1, 2023 For the three and nine months ended September 30, 2022, the Company recognized revenue of $<span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220701__20220930_zG9C7nePDPpf">125,731</span> and $<span id="xdx_901_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220101__20220930_z9In9rPox1Rg">2,318,935</span>, respectively, related to the deferred revenue at January 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $<span id="xdx_901_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230930_zmvjH8heqXLi" title="Revenue remaining performance obligation">548,000</span>. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at September 30, 2023, includes booked sales orders of $<span id="xdx_908_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember__us-gaap--TypeOfArrangementAxis__custom--BookedSalesOrdersFromThreeCustomersMember_zeKXEVsc2zjg">353,000</span> from four customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $<span id="xdx_90B_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230930__srt--TitleOfIndividualAxis__custom--OneCustomerMember_zO8X3ZBsNGJa">65,000</span> (12% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zbcIOAZIuu5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zylsv26EzbW2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zmv6nWa9bXMc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_zHkV7bh2V9f4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230930_zj5AVfW22CA5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_z63kBa3469sd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0702">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0703">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0704">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_zhYsiAqkdzy6" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">195,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">353,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">548,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_zTDk7jqfZCBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">195,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">353,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">548,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zNthDbZVAQba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--StandardProductWarrantyPolicy_z1Mcjc8SGE29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zLoSxZ4etkb1">Product Warranty</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--StandardProductWarrantyDescription_c20230101__20230930_zduQFfLTJmz8" title="Product warranty description">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue</span>. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of September 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $<span id="xdx_90F_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20230930_zRmMHsPoH283" title="Accrued warranty reserve amount">194,031</span> and $<span id="xdx_90C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20221231_zmH3ygK5njxf" title="Accrued warranty reserve amount">180,457</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zv7HyqbQCrS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zGxdGu5oX6v3">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the nine months ended September 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230930_z0ZY3cinDFE2" title="Stock price volatility">152.23</span>%; expected term in years of <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930_ztWsEg2DQDRf" title="Expected Term">10</span> and risk-free interest rate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230930_zGxsD7VoU57f" title="Risk-free interest rate">3.48</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zEdMVDVBWQCb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and September 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zYNcxKBMrgYg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230701__20230930_z4HY8hAfI27l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220701__20220930_zamjZ2kFZF35" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930_zolvzG3FZlwg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220930_zC7fHSnt2eBl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zndTYz3rbg3k" style="vertical-align: bottom; background-color: White"> <td style="width: 36%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0732">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,956</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,898</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,851</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zkOE4NBfR0ja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0737">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,299</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_z1n8yyrJz9Oj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,570</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,442</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhIBrqKnR1yj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,166</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,637</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">167,846</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">240,083</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zKsSaYXi5Kd1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">78,531</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">177,427</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">266,675</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zJxvbXjSeqd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the expense for the three and nine months ended September 30, 2022, is an accrual for $<span id="xdx_903_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20220701__20220930_zDSp647ZNMW1" title="Accrued Incentive">23,187</span> and $<span id="xdx_90B_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20220101__20220930_z3kuC5BvuKTc" title="Accrued Incentive">69,561</span>, respectively, for the 2022 Annual Employee Incentive Compensation Plan. <span id="xdx_903_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_do_c20230101__20230930_zRzD7Ml58djb" title="Accrued Incentive">No</span> accrual is being recorded in 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zmuErVsug2i6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zwczAdw1Nek4">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Four customers accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zfhLN3umGLYe" title="Concentration risk percentage">29</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zqRCvFUdNiH7" title="Concentration risk percentage">19</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zuBFihkx9z74" title="Concentration risk percentage">16</span>%, and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zxf1uqXmeI04" title="Concentration risk percentage">12</span>% of the Company’s revenue for the three months ended September 30, 2023. Three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zzcRri84h8c" title="Concentration risk percentage">38</span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z69w8lHthSic" title="Concentration risk percentage">20</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zSrUhcyE0ROj" title="Concentration risk percentage">12</span>% of the Company’s revenue for the nine months ended September 30, 2023. Two customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z4DIUTB3Cd65" title="Concentration risk percentage">53</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zCm2tVQ5MNpc" title="Concentration risk percentage">24</span>% of the Company’s revenue for the three months ended September 30, 2022 and three customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z3lPtCdajOTi" title="Concentration risk percentage">28</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zszU3VUS5l91" title="Concentration risk percentage">25</span>%, and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z6jM4yq3c1S3" title="Concentration risk percentage">13</span>% of the Company’s revenue for the nine months ended September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two customers accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z2HoBDOOu3Cd" title="Concentration risk percentage">78</span>%, and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zMkui1rsTkJi" title="Concentration risk percentage">12</span>% of the Company’s accounts receivable as of September 30, 2023. Two customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zoxgiw4sEqp9" title="Concentration risk percentage">57</span>% and<span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zN5VWX04z1d3" title="Concentration risk percentage"> 43</span>% of the Company’s accounts receivable as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zVRVTBYxXx9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z1RwwfBvLLwk">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of <i>Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i> (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the FASB issued ASU 2021-08, “<i>Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”</i>, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on the Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FAS issued ASU No. 2020-04 “<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p id="xdx_852_zHMb5U2SLe0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--DescriptionOfBusinessPolicyTextBlock_zamHGs59aAH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zPMP9GuPrvo9">Description of Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zsi8M5CxOUv5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zU6QSJXhI6J4">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--ImpactofUkrainianConflictPolicyTextBlock_zPvZGbp3BFcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z97I3BT6F1ke">Impact of Ukrainian Conflict</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_843_ecustom--InflationPolicyTextBlock_zs8KVzvCS8D2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z00hoOvffKKb">Inflation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzEfzitqymFb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zPqkC2iKUAp2">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--InterimFinancialStatementsPolicyTextBlock_zikvwLVBWwm9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zUwCztaISTxk">Interim Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zjWeyS6eGAoa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zkY7J0ICdw54">Principles of Consolidation</span> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_z5p8Ez2TbBsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z0nbJIT7LhYi">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zVtcgChDRjq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zF2emqMU4JBa">Cash, Cash Equivalents, and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20230930_znIz1iSVKCp7" title="Federal insured amount">250,000</span>. As of September 30, 2023, the balance in the Company’s accounts was approximately $<span id="xdx_90F_eus-gaap--Cash_iI_c20230930_zPPplbbYcEe" title="Cash balance, amount">13,343,000</span>, consequently approximately $<span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_c20230930_zDuVS7568Fgl" title="Cash equivalent balance, amount">13,093,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 250000 13343000 13093000 <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zd2ySSqoxI57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zBAXYVdBEdRc">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023 and 2022, there were respectively, <span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230930_zgmflJwe8wD6" title="Potentially dilutive equity instruments that are convertible into common stock">7,992,829</span> and <span id="xdx_908_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220930_zggNuOTCakv7" title="Potentially dilutive equity instruments that are convertible into common stock">7,881,160</span>, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, <span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zNnQvbx1ujFc" title="Potentially dilutive equity instruments that are convertible into common stock"><span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zL07BCCQyk9e" title="Potentially dilutive equity instruments that are convertible into common stock">7,623,772</span></span> related to warrants outstanding at both September 30, 2023 and 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining <span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zH2QHYNNKjCl" title="Potentially dilutive equity instruments that are convertible into common stock">369,057</span> and <span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220930__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zWqxMS5phA7f" title="Potentially dilutive equity instruments that are convertible into common stock">257,388</span> potentially dilutive equity instruments outstanding as of September 30, 2023 and 2022, respectively, related to options and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 7992829 7881160 7623772 7623772 369057 257388 <p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zisWqbe8Tnf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_z84EO3EtoMzj">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $<span id="xdx_903_eus-gaap--GoodwillAndIntangibleAssetImpairment_c20220101__20220630_zOh7RXOPIX8g" title="Goodwill and intangible asset impairment">631,064</span> at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 631064 <p id="xdx_84E_ecustom--TemporaryEquityPolicyTextBlock_z8nexd9Ig4li" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zQ7gM6FroKj7">Temporary Equity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_845_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoS7Rs2zEKBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_znYeMAPpM6g">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_z8HrhD33xZ7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_z8yv3LNFUsC7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230701__20230930_zxjzkPM2jfEl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220701__20220930_zg3zJ4HtpjLl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930_zTImAHSoD5Ml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220930_zy5XU3FzWo5j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKTVaKg6mMyk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Equipment and systems sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">647,870</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,941,380</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,944,445</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,375,093</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zkf9QdYQ5LN8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Engineering and other services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">235,301</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">104,434</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">462,943</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">382,559</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z3PkRLfLBY9h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping and handling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,265</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,335</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,739</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ForfeitedNonRefundableCustomerDepositsMember_zDmLi7B40XMd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited non-refundable customer deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">29,400</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0677">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">234,135</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0679">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zf5ED4QwBWm3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">913,571</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,063,079</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,659,858</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,822,391</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zLh11eq45oll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Judgments and Assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of September 30, 2023 and December 31, 2022, the Company had no contract assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of September 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230930_zggy9VUsDAm4" title="Contract with customer liability current">474,888</span> and $<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20221231_zzVNY3vhNXae" title="Contract with customer liability current">4,338,570</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three and nine months ended September 30, 2023, the Company recognized revenue of $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230701__20230930_zymhcrrqPhha" title="Revenue recognized">12,461</span> and $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20230930_zwenEumPRpQ4" title="Revenue recognized">3,911,083</span>, respectively, related to the deferred revenue at January 1, 2023 For the three and nine months ended September 30, 2022, the Company recognized revenue of $<span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220701__20220930_zG9C7nePDPpf">125,731</span> and $<span id="xdx_901_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220101__20220930_z9In9rPox1Rg">2,318,935</span>, respectively, related to the deferred revenue at January 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $<span id="xdx_901_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230930_zmvjH8heqXLi" title="Revenue remaining performance obligation">548,000</span>. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at September 30, 2023, includes booked sales orders of $<span id="xdx_908_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember__us-gaap--TypeOfArrangementAxis__custom--BookedSalesOrdersFromThreeCustomersMember_zeKXEVsc2zjg">353,000</span> from four customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $<span id="xdx_90B_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230930__srt--TitleOfIndividualAxis__custom--OneCustomerMember_zO8X3ZBsNGJa">65,000</span> (12% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zbcIOAZIuu5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zylsv26EzbW2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zmv6nWa9bXMc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_zHkV7bh2V9f4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230930_zj5AVfW22CA5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_z63kBa3469sd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0702">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0703">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0704">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_zhYsiAqkdzy6" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">195,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">353,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">548,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_zTDk7jqfZCBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">195,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">353,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">548,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zNthDbZVAQba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_z8HrhD33xZ7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_z8yv3LNFUsC7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230701__20230930_zxjzkPM2jfEl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220701__20220930_zg3zJ4HtpjLl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930_zTImAHSoD5Ml" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220930_zy5XU3FzWo5j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zKTVaKg6mMyk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Equipment and systems sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">647,870</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,941,380</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,944,445</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,375,093</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zkf9QdYQ5LN8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Engineering and other services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">235,301</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">104,434</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">462,943</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">382,559</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z3PkRLfLBY9h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping and handling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,265</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,335</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,739</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ForfeitedNonRefundableCustomerDepositsMember_zDmLi7B40XMd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited non-refundable customer deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">29,400</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0677">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">234,135</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0679">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zf5ED4QwBWm3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">913,571</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,063,079</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,659,858</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,822,391</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 647870 4941380 5944445 9375093 235301 104434 462943 382559 1000 17265 18335 64739 29400 234135 913571 5063079 6659858 9822391 474888 4338570 12461 3911083 125731 2318935 548000 353000 65000 <p id="xdx_898_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zbcIOAZIuu5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zylsv26EzbW2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zmv6nWa9bXMc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_zHkV7bh2V9f4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230930_zj5AVfW22CA5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_z63kBa3469sd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0702">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0703">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0704">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_zhYsiAqkdzy6" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">195,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">353,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">548,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_zTDk7jqfZCBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">195,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">353,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">548,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 195000 353000 548000 195000 353000 548000 <p id="xdx_84F_eus-gaap--StandardProductWarrantyPolicy_z1Mcjc8SGE29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zLoSxZ4etkb1">Product Warranty</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--StandardProductWarrantyDescription_c20230101__20230930_zduQFfLTJmz8" title="Product warranty description">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue</span>. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of September 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $<span id="xdx_90F_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20230930_zRmMHsPoH283" title="Accrued warranty reserve amount">194,031</span> and $<span id="xdx_90C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20221231_zmH3ygK5njxf" title="Accrued warranty reserve amount">180,457</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue 194031 180457 <p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zv7HyqbQCrS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zGxdGu5oX6v3">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the nine months ended September 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230930_z0ZY3cinDFE2" title="Stock price volatility">152.23</span>%; expected term in years of <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930_ztWsEg2DQDRf" title="Expected Term">10</span> and risk-free interest rate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230930_zGxsD7VoU57f" title="Risk-free interest rate">3.48</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zEdMVDVBWQCb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and September 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zYNcxKBMrgYg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230701__20230930_z4HY8hAfI27l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220701__20220930_zamjZ2kFZF35" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930_zolvzG3FZlwg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220930_zC7fHSnt2eBl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zndTYz3rbg3k" style="vertical-align: bottom; background-color: White"> <td style="width: 36%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0732">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,956</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,898</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,851</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zkOE4NBfR0ja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0737">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,299</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_z1n8yyrJz9Oj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,570</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,442</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhIBrqKnR1yj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,166</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,637</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">167,846</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">240,083</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zKsSaYXi5Kd1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">78,531</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">177,427</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">266,675</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zJxvbXjSeqd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the expense for the three and nine months ended September 30, 2022, is an accrual for $<span id="xdx_903_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20220701__20220930_zDSp647ZNMW1" title="Accrued Incentive">23,187</span> and $<span id="xdx_90B_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20220101__20220930_z3kuC5BvuKTc" title="Accrued Incentive">69,561</span>, respectively, for the 2022 Annual Employee Incentive Compensation Plan. <span id="xdx_903_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_do_c20230101__20230930_zRzD7Ml58djb" title="Accrued Incentive">No</span> accrual is being recorded in 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1.5223 P10Y 0.0348 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zEdMVDVBWQCb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and September 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zYNcxKBMrgYg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230701__20230930_z4HY8hAfI27l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220701__20220930_zamjZ2kFZF35" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230101__20230930_zolvzG3FZlwg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220930_zC7fHSnt2eBl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zndTYz3rbg3k" style="vertical-align: bottom; background-color: White"> <td style="width: 36%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0732">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,956</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,898</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,851</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zkOE4NBfR0ja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0737">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,299</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_z1n8yyrJz9Oj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,570</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,442</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zhIBrqKnR1yj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,166</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,637</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">167,846</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">240,083</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zKsSaYXi5Kd1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">78,531</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">177,427</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">266,675</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3956 4898 9851 2457 1113 9299 2481 3570 7442 15166 69637 167846 240083 15166 78531 177427 266675 23187 69561 0 <p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zmuErVsug2i6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zwczAdw1Nek4">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Four customers accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zfhLN3umGLYe" title="Concentration risk percentage">29</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zqRCvFUdNiH7" title="Concentration risk percentage">19</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zuBFihkx9z74" title="Concentration risk percentage">16</span>%, and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zxf1uqXmeI04" title="Concentration risk percentage">12</span>% of the Company’s revenue for the three months ended September 30, 2023. Three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zzcRri84h8c" title="Concentration risk percentage">38</span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z69w8lHthSic" title="Concentration risk percentage">20</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zSrUhcyE0ROj" title="Concentration risk percentage">12</span>% of the Company’s revenue for the nine months ended September 30, 2023. Two customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z4DIUTB3Cd65" title="Concentration risk percentage">53</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zCm2tVQ5MNpc" title="Concentration risk percentage">24</span>% of the Company’s revenue for the three months ended September 30, 2022 and three customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z3lPtCdajOTi" title="Concentration risk percentage">28</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zszU3VUS5l91" title="Concentration risk percentage">25</span>%, and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z6jM4yq3c1S3" title="Concentration risk percentage">13</span>% of the Company’s revenue for the nine months ended September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two customers accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z2HoBDOOu3Cd" title="Concentration risk percentage">78</span>%, and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zMkui1rsTkJi" title="Concentration risk percentage">12</span>% of the Company’s accounts receivable as of September 30, 2023. Two customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zoxgiw4sEqp9" title="Concentration risk percentage">57</span>% and<span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zN5VWX04z1d3" title="Concentration risk percentage"> 43</span>% of the Company’s accounts receivable as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.29 0.19 0.16 0.12 0.38 0.20 0.12 0.53 0.24 0.28 0.25 0.13 0.78 0.12 0.57 0.43 <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zVRVTBYxXx9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z1RwwfBvLLwk">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of <i>Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i> (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the FASB issued ASU 2021-08, “<i>Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”</i>, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on the Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FAS issued ASU No. 2020-04 “<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p id="xdx_80C_eus-gaap--LesseeOperatingLeasesTextBlock_zbFPxHlbRcoe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – <span id="xdx_823_z6wlDE7cqNce">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016 the FASB issued ASU 2016-02, <i>Leases (Topic 842) </i>(“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2021, the Company entered into an agreement to lease <span id="xdx_905_eus-gaap--AreaOfLand_iI_uSquareFoot_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zVRmdIe72agj" title="Area of land">11,491</span> square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. <span id="xdx_90B_eus-gaap--LesseeOperatingLeaseDescription_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zjQE2JdjR6Kh" title="Operating lease term description">The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027</span>. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $<span id="xdx_902_eus-gaap--PaymentsForRent_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zfU5653QoRuk" title="Lease rental expense">10,055</span> and will increase by <span id="xdx_905_ecustom--IncreaseInRentPercent_pid_dp_uPure_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zYtfp4x7nvk1" title="Increase in rent percent">3</span>% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $<span id="xdx_90A_eus-gaap--SecurityDeposit_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zslxX8IFSLEh" title="Security deposit">14,747</span>. The Company has the option to renew the New Facility Lease for an additional <span id="xdx_906_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210728_zQVvalHLGeMl" title="Lease renew term">five years</span>. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $<span id="xdx_90E_eus-gaap--OperatingLeaseLiability_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zFvVhbC7XNb7" title="Operating lease liability">582,838</span>. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease cost, cash flows and other information related to the New Facility Lease were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--LeaseCostTableTextBlock_zoIzc6nPOTyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zGAdgYTDnGzd">Schedule of Lease Cost</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230930_zNgS587MCVgb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">September 30, 2023</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zOIsgxU7pr09" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating lease right-of-use asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">383,169</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zWTUH5f18YSh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating lease liability, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">124,319</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zOq5PXXXyra1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, long-term</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">290,051</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230930_zQXc7IHhLuRe" title="Remaining lease term">3.6</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230930_zZ6wbaPXGgsa" title="Discount rate">3.63</span></td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine</p> <p style="margin-top: 0; margin-bottom: 0">Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30, 2023</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating cash outflow from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeasePayments_c20230101__20230930_zt5WhHPkj2fd" style="width: 20%; text-align: right" title="Operating cash outflow from operating lease">93,206</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zgs3QFtAGcD6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future annual minimum lease payments on the New Facility Lease as of September 30, 2023 are as follows:</span></p> <p id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z828lrMhu5zj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zANHXZ1Yh4Uh" style="display: none">Schedule of Future Annual Minimum Lease Payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left">As of September 30, 2023</td><td> </td> <td colspan="2" id="xdx_495_20230930_zzFRqUHNN9M8"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzNo0_zQnHp1PNcvK8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 80%">2023 (excluding the nine months ended September 30, 2023)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">31,690</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzNo0_ztHoGcJ2AMra" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,643</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzNo0_zi1avZc6rJM2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,503</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzNo0_zyaIBTgqWgJa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">136,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree_iI_pp0p0_maLOLLPzNo0_z589UPkeSrxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzNo0_zy2nfNuspxy" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">440,963</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zlfdUDt4kPQf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(26,593</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Present value of minimum lease payments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">414,370</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zY8NcvQWPEfd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 11491 The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027 10055 0.03 14747 P5Y 582838 <p id="xdx_892_eus-gaap--LeaseCostTableTextBlock_zoIzc6nPOTyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zGAdgYTDnGzd">Schedule of Lease Cost</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230930_zNgS587MCVgb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">September 30, 2023</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zOIsgxU7pr09" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating lease right-of-use asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">383,169</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zWTUH5f18YSh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating lease liability, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">124,319</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zOq5PXXXyra1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, long-term</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">290,051</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230930_zQXc7IHhLuRe" title="Remaining lease term">3.6</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230930_zZ6wbaPXGgsa" title="Discount rate">3.63</span></td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine</p> <p style="margin-top: 0; margin-bottom: 0">Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30, 2023</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating cash outflow from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeasePayments_c20230101__20230930_zt5WhHPkj2fd" style="width: 20%; text-align: right" title="Operating cash outflow from operating lease">93,206</td><td style="width: 1%; text-align: left"> </td></tr> </table> 383169 124319 290051 P3Y7M6D 0.0363 93206 <p id="xdx_891_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z828lrMhu5zj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zANHXZ1Yh4Uh" style="display: none">Schedule of Future Annual Minimum Lease Payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left">As of September 30, 2023</td><td> </td> <td colspan="2" id="xdx_495_20230930_zzFRqUHNN9M8"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzNo0_zQnHp1PNcvK8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 80%">2023 (excluding the nine months ended September 30, 2023)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">31,690</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzNo0_ztHoGcJ2AMra" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,643</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzNo0_zi1avZc6rJM2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,503</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzNo0_zyaIBTgqWgJa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">136,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree_iI_pp0p0_maLOLLPzNo0_z589UPkeSrxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzNo0_zy2nfNuspxy" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">440,963</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zlfdUDt4kPQf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(26,593</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Present value of minimum lease payments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">414,370</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 31690 128643 132503 136473 11654 440963 26593 414370 <p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zXpchfQW2Pc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 – <span id="xdx_828_zR4QE4ZbHcGa">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p id="xdx_894_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zmTw5PGeY7Zi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zuQmIur0hmYl" style="display: none">Schedule of Inventory</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20230930_zpbHHeaq76oh" style="font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20221231_zVS5SplLJKlb" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINztRx_zohkfoOLo2rb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished goods</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">371,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">270,555</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_maINztRx_z9PFXZG3goKe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">155</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maINztRx_zta7EJ6WoKri" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125,437</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">148,608</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryValuationReserves_iNI_di_msINztRx_zscnddkxEhW9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(182,030</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(70,907</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--InventoryNet_iTI_mtINztRx_z96PTyviBuy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">315,096</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">348,411</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zArfJja6yUs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overhead expenses of $<span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20230101__20230930_zkRWzSMTaI97" title="Overhead expenses">15,145</span> and $<span id="xdx_90E_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20220101__20221231_zzt1KMxA7Nnj" title="Overhead expenses">12,770</span> were included in the inventory balance as of September 30, 2023, and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $<span id="xdx_907_ecustom--PrepaidInventoryExpenses_iI_c20230930_zaFnxJwAqhv8" title="Prepaid inventory expenses">36,000</span> and $<span id="xdx_90C_ecustom--PrepaidInventoryExpenses_iI_c20221231_zV5VYZ9mMQqa" title="Prepaid inventory expenses">1,176,000</span> in advance payments for inventory as of September 30, 2023, and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_894_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zmTw5PGeY7Zi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zuQmIur0hmYl" style="display: none">Schedule of Inventory</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20230930_zpbHHeaq76oh" style="font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20221231_zVS5SplLJKlb" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINztRx_zohkfoOLo2rb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished goods</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">371,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">270,555</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_maINztRx_z9PFXZG3goKe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">155</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maINztRx_zta7EJ6WoKri" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125,437</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">148,608</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryValuationReserves_iNI_di_msINztRx_zscnddkxEhW9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(182,030</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(70,907</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--InventoryNet_iTI_mtINztRx_z96PTyviBuy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">315,096</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">348,411</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 371689 270555 155 125437 148608 182030 70907 315096 348411 15145 12770 36000 1176000 <p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z71kmJ8iEw3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – <span id="xdx_822_zlCZQ7PFeF17">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p id="xdx_898_eus-gaap--PropertyPlantAndEquipmentTextBlock_z6l3LkTdugah" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B9_zVJiO8RH92Oj" style="display: none">Schedule of Property and Equipment</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20230930_zrx8jvTfIsP2" style="font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20221231_zFaYpZ69oV4h" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zSoGXOINqpei" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">275,994</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">278,389</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zQWV1Djn4o83" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Vehicles</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_zkhaxEQqfzwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">290,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">293,389</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_zM88fq7RCJkd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(245,257</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(224,876</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_zUm1nYrNxJbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">45,737</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68,513</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z4q7QmE84PKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense was $<span id="xdx_903_eus-gaap--Depreciation_c20230101__20230930_zEhrMuOGbB53" title="Depreciation expenses">22,476</span> for the nine months ended September 30, 2023. For the nine months ended September 30, 2023, $<span id="xdx_904_eus-gaap--Depreciation_c20230101__20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zJcKEh5lZnUc" title="Depreciation expenses">2,284</span> was allocated to cost of sales, $<span id="xdx_90B_eus-gaap--Depreciation_pp0p0_c20230101__20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_znFQQDDCZ072" title="Depreciation expenses">571</span> was allocated to inventory with the remainder recorded as selling, general, and administrative expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--PropertyPlantAndEquipmentTextBlock_z6l3LkTdugah" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B9_zVJiO8RH92Oj" style="display: none">Schedule of Property and Equipment</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20230930_zrx8jvTfIsP2" style="font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20221231_zFaYpZ69oV4h" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zSoGXOINqpei" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">275,994</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">278,389</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zQWV1Djn4o83" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Vehicles</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_zkhaxEQqfzwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">290,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">293,389</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_zM88fq7RCJkd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(245,257</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(224,876</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_zUm1nYrNxJbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">45,737</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68,513</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 275994 278389 15000 15000 290994 293389 245257 224876 45737 68513 22476 2284 571 <p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zRgxicw5OKK9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_82D_zw1KWMIYln1c">Accounts Payable and Accrued Liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities consisted of the following:</span></p> <p id="xdx_890_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zrpRUVjxRIhg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zx2AWcTiu4M" style="display: none">Schedule of Accounts Payable and Accrued Liabilities</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20230930_zU7SANdN4gK9" style="font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20221231_zgGDsPufyrP5" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_maAPAALztwN_zN0Qeuia3O27" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">164,041</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">311,162</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedSalesCommissionCurrent_iI_maAPAALztwN_zeQ4j4HJokTj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales commissions payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,018</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,951</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maAPAALztwN_zRIOKvF5axzk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">146,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465,094</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maAPAALztwN_zzQ0RMqaGpd6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product warranty accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">194,031</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,457</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maAPAALztwN_zMZCwnLhAF77" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,419</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">224,594</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALztwN_zp33dhJRtiT" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">571,885</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,207,258</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zc3bJuOyh7ch" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zrpRUVjxRIhg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zx2AWcTiu4M" style="display: none">Schedule of Accounts Payable and Accrued Liabilities</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20230930_zU7SANdN4gK9" style="font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20221231_zgGDsPufyrP5" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_maAPAALztwN_zN0Qeuia3O27" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">164,041</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">311,162</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedSalesCommissionCurrent_iI_maAPAALztwN_zeQ4j4HJokTj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales commissions payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,018</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,951</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maAPAALztwN_zRIOKvF5axzk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">146,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465,094</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maAPAALztwN_zzQ0RMqaGpd6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product warranty accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">194,031</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,457</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maAPAALztwN_zMZCwnLhAF77" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,419</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">224,594</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALztwN_zp33dhJRtiT" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">571,885</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,207,258</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 164041 311162 4018 25951 146376 465094 194031 180457 63419 224594 571885 1207258 <p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z5LIMV0Gxzge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 – <span id="xdx_825_zQXvdLv61NJh">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On October 20, 2023, Green Ice, LLC and Sweet Cut Grow, LLC (“Claimants”) filed an Arbitration Petition in Denver, Colorado against the Company. The Claimants allege a breach by the Company of two contracts – an Engineering Agreement with Green Ice, dated January 14, 2021 (“Engineering Agreement”), and an Equipment Agreement with Sweet Cut Grow, dated March 29, 2021 (“Equipment Agreement”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Arbitration Petition alleges causes of action for breach of the Engineering Agreement, Breach of the Equipment Agreement, Breach of the Warranties under the Equipment Agreement, and Unjust Enrichment in the amount of moneys paid by Claimant to CEA to date under the contracts, of $<span id="xdx_901_eus-gaap--AccountsPayableCurrent_iI_c20231020__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--EngineeringAgreementMember_zOZ5e3FAAEJ2" title="Amount paid">1,049,280</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Given the Arbitration Petition’s current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Regardless, we intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a lease agreement for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other Commitments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1049280 <p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zhyGvmvzsqq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_825_z5qdU6idxHX2">Stockholders’ Equity</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the Company had <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20230930_zqKcab9EljIi" title="Common stock, shares authorized">200,000,000</span> shares of common stock and <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20230930_z2cCo9DdLsf4" title="Preferred stock, shares authorized">25,000,000</span> shares of preferred stock authorized at a $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230930_z4tZRLgwEfZ" title="Common stock par value">0.00001</span> par value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20230930_zbg9OdXzmV77" title="Common stock, shares issued"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20230930_z3fqsgmWRsT9" title="Common stock, shares outstanding">8,076,372</span></span> shares of common stock were issued and outstanding and <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20230930_zn43EqrwT869" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20230930_zbjekvS6cws5" title="Preferred stock, shares outstanding">no</span></span> shares of preferred stock were issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Directors Remuneration</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, the Company issued <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220101__20220103__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zklJ7l6dRS7d" title="Number of stock options issued">3,125</span> non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220103__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zIY0hyAp9fW9" title="Exercise price">4.80</span>, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Company issued an RSU grant of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zg6KZTFvs80l" title="Shares, granted">3,367</span> shares of common stock under the 2021 Equity Incentive Plan to each of two new directors, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyTwoMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zQMQPAXBOOOc" title="Shares, granted">1,684</span> shares of common stock vested immediately on grant date and the remaining <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyThreeMember_zjEvvaWDXsij" title="Shares, granted">1,683</span> shares of common stock vested on January 17, 2023. <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyTwoMember_zhNjJb9ZutZ9" title="Shares, vested">1,684</span> shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20230112__20230117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyTwoMember__srt--TitleOfIndividualAxis__custom--TwoNewDirectorsMember_zQOXuXqZXjXg" title="Shares, vested">1,683</span> shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2023, the Company issued an RSU grant of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230103__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z52RsMgGh20g" title="Number of stock options issued">29,758</span> shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230102__20230103__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0OyahxCeTM3" title="Number of shares vested in period">119,032</span> shares of the Company’s common stock were issued in settlement of the RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revised Compensation Plan for Directors</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The plan was effective retroactively for the then current independent directors and for independent directors elected or appointed after the Effective Date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The plan is divided into two phases: from the Effective Date of the plan until February 9, 2022, the day prior to the listing of the Company securities on Nasdaq. (“Pre-uplist”) and from February 10, 2022, the uplist date forward (“Post-uplist”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the Pre-uplist phase, the Company paid its independent directors an annual cash fee of $<span id="xdx_903_eus-gaap--ManagementFeeExpense_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember_zFk7Tt5DZzS3" title="Annual cash fee">15,000</span>, which for the Post-uplist phase was increased to $<span id="xdx_90B_eus-gaap--ManagementFeeExpense_c20230101__20230930__srt--TitleOfIndividualAxis__srt--DirectorMember_zczI2CtK4oUj" title="Management fee expense">25,000</span>. The fee is payable quarterly in advance on the first business day of each quarter, as consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of the Board, the Chairman of the Company’s Audit Committee, and the Committee Chairman).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $<span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRrMy2dnamv1" title="Share based compensation arrangement payment">25,000</span>, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zbNErGvtytKh" title="Vesting rights description">Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $<span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znhZ1YFUCvm7" title="Share based compensation arrangement payment">25,000</span>, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company pays the Audit Committee Chairman an additional annual fee of $<span id="xdx_909_eus-gaap--ManagementFeeExpense_c20220112__20220117__srt--TitleOfIndividualAxis__custom--AuditCommitteeChairmanMember_zcF5XjecpNb4" title="Management fee expense">10,000</span>, payable quarterly in advance, for services as the Audit Committee Chairman.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company pays the Chairmen of any other committees of the Board an additional annual fee of $<span id="xdx_904_eus-gaap--ManagementFeeExpense_c20220112__20220117__srt--TitleOfIndividualAxis__custom--CommitteeChairmanMember_zdIoK2hajp12" title="Management fee expense">5,000</span>, payable quarterly in advance, for services as a Committee Chairman.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors who are also executive officers of the Company do not receive separate compensation for their Board service.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options. Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse Stock Split</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of <span id="xdx_909_eus-gaap--StockholdersEquityReverseStockSplit_c20220112__20220117_zQyhx0S2pSSh" title="Reverse stock split">one-for-one hundred and fifty</span>. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An additional <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_c20220112__20220117_zAc4heJgJI65" title="Reverse stock split">6,798</span> shares of common stock were issued to round up partial shares following the reverse split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from <span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211230_zurr7dnWR4Ge" title="Common stock, shares outstanding">240,125,224</span> to <span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zpX1Wc2vvMgc" title="Common stock, shares outstanding">1,600,835</span>. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change in Authorized Share Capital</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20230930__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zdl3Cede6FM" title="Common stock, shares authorized">200,000,000</span> shares of common stock and <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_c20230930__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zPNA3xAtdvw3" title="Preferred stock, shares authorized">25,000,000</span> shares of preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity Raise</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20220214__20220215_zUweq0DumEgc" title="Net proceeds from sale of common stock">22</span> million for the sale of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z11T834TdHPg" title="Net proceeds from sale of common stock">5,811,138</span> shares of common stock and <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUi7u750DPaa" title="Number of shares sold">6,572,808</span> warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zML1LYaeU1H8" title="Exercise price, per share">5.00</span>. The Company also issued to the representative of the underwriters <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zqyUSjmTTchk" title="Stock issued during period, shares, issued for services">290,557</span> warrants, each warrant to purchase one share of common stock at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zfrWVF8uPQHa" title="Exercise price">5.1625</span>, during the period commencing August 9, 2022, and expiring on <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zM4mPb1Y1eh4" title="Warrants maturity date">February 10, 2027</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrant Exercise</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 21, 2022, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220620__20220621_zgYgAjJY5EBh" title="Number of shares issued">169,530</span> shares of its common stock in connection with the cashless exercise of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220621_zZSt67Tcxsph" title="Prefunded conversion warrants">170,382</span> prefunded conversion warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 200000000 25000000 0.00001 8076372 8076372 0 0 3125 4.80 3367 1684 1683 1684 1683 29758 119032 15000 25000 25000 Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date 25000 10000 5000 one-for-one hundred and fifty 6798 240125224 1600835 200000000 25000000 22000000 5811138 6572808 5.00 290557 5.1625 2027-02-10 169530 170382 <p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z4HvBfbFo89d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 – <span id="xdx_82D_zfBBMizrmzPi">Equity Incentive Plans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2017 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zVo5QpINev54" title="Number of options to purchase shares">333,333</span> shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2023, no shares or options were issued and <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zsE33Q7AY718" title="Number of shares option cancelled">1,665</span> options were cancelled under the 2017 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, of the <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z51fw8kbxfj3" title="Number of shares authorized">333,333</span> shares authorized under the 2017 Plan for equity awards, <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z3lR1o1mEUk6" title="Number of shares issued">163,692</span> shares have been issued, awards relating to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_z5eyQnmZfpT8" title="Number of option remain outstanding">145,512</span> options remain outstanding, and <span id="xdx_90A_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zJCTvU3lXIfl" title="Shares available for future equity awards">24,129</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210322__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zP7gQkOmSD74" title="Number of shares grant in period">666,667</span> shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zJBYynYMexV8" title="Shares issued during the period">122,398</span> shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--FiveEmployeesMember_zp3eUK5VtAuc" title="Number of share awards granted">138,489</span> non-qualified stock options were issued to five employees and three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of 10 years and an exercise price of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--FiveEmployeesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zUCyFsFOuFR4" title="Exercise price per share">0.8955</span>. An expense of $<span id="xdx_90B_eus-gaap--DeferredCompensationLiabilityCurrent_iI_c20221231_za3T5n5JuGfh" title="Accrued equity compensation">89,970</span> in respect of this issuance had been accrued in 2022. An additional expense of $<span id="xdx_902_ecustom--EmployeeStockOwnershipPlanAdditionalExpense_c20230101__20230930_ztIr8DBOvRzk" title="Additional expense">32,376</span> was recognized in 2023 upon management and board finalization and approval of the awards.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zSAQWW3nyOk1" title="Number of option remain cancelled">16,631</span> non-qualified stock options were cancelled and <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zi6SHJlPiol" title="Number of option remain forfeited">333</span> non-qualified stock options were forfeited that had previously been issued under the 2021 Equity Incentive Plan.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, of the <span id="xdx_902_ecustom--ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zxR71tYiPd01" title="Number of shares authorized">666,667</span> shares authorized under the 2021 Equity Plan, <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqMYq9wXi3Y9" title="Number of shares issued">132,568</span> shares have been issued in settlement of restricted stock units, awards relating to <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zfAyf18knnR1" title="Number of option remain outstanding">182,728</span> non-qualified stock options, and <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--IncentiveStockOptionMember_zmFlZdnFTN41" title="Number of option remain outstanding">40,816</span> incentive stock options remain outstanding, and <span id="xdx_904_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zNEdgSIvM6lj" title="Shares available for future equity awards">310,555</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There was $<span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_z4eBW92LA8nf" title="Unrecognized compensation expense">15,586</span> in unrecognized compensation expense for unvested non-qualified and incentive stock options as of September 30, 2023 which will be recognized over approximately the next <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtM_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zlBn2NqOb9gf" title="Weighted Average Remaining Contractual Term">18</span> months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-Qualified and Incentive Stock Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the nine months ended September 30, 2023, are presented in the table below:</span></p> <p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zANY0YheGRQ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zQIpKFpXzvcc" style="display: none">Schedule of Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Term</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2iUwkNNKhmh" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning">192,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTEdfi1PeiC1" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">8.94</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zXbiUxlc3iHl" title="Weighted Average Remaining Contractual Term, Beginning">7.6</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zaHuC5GHANpd" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">        <span style="-sec-ix-hidden: xdx2ixbrl1055">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zwoqlgf8s9Ae" style="text-align: right" title="Number of Options, Granted">138,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVSLD1K0xWdd" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQETw5xo7oii" title="Weighted Average Remaining Contractual Term, Granted">6.4</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zO6KR8bi4Duh" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPduEkig1MV9" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1065">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxhImqD9Ysi6" style="text-align: right" title="Number of Options, Forfeited">(18,629</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zuvSadVhMFEb" style="text-align: right" title="Weighted Average Exercise Price, Forfeited">2.63</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7IrMDA8CGma" title="Weighted Average Remaining Contractual Term, Forfeited">9.2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqglk5a7BETd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1073">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z5XGWuwUiqNl" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1075">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQsUeEpnF42f" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">311,933</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zSmBfV2ymVQ3" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">5.74</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zImC8nnJ19A1" title="Weighted Average Remaining Contractual Term, Outstanding Ending">6.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zp6woDQrnes8" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkNtNi0pRF8l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">286,843</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zA0esyQdVQla" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">5.78</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZNq6I1cYy4l" title="Weighted Average Remaining Contractual Term, Exercisable Ending">6.5</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHfXeZntYCFb" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zhfq0kRaxnHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the nine months ended September 30, 2023, are presented in the table below:</span></p> <p id="xdx_89D_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zmVHTXhbJrM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B9_zVTXyBH2EtFe" style="display: none">Summary of Non-Vested qualified Stock Option Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Grant-Date Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Grant-Date Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Nonvested, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdjvGIH8gOnk" style="width: 12%; text-align: right" title="Number of Options Nonvested, Beginning">28,756</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z87cpCzsr9Ch" style="width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning">4.73</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdCvD5zqT5gd" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1099">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zU6DM36horbc" style="width: 12%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">136,016</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zw3G6jfCtLX1" style="text-align: right" title="Number of Options Nonvested, Granted">138,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z3USaqB40yGi" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Granted">0.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zaQ08lNsFm0e" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted">121,870</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zG9ywCVz20Cl" style="text-align: right" title="Number of Options Nonvested, Vested">(141,822</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zNYPuwdSLBG3" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Vested">0.92</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_iN_pp0p0_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zwT2TtiwC4Oa" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(130,476</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zm66Tjd396ak" style="text-align: right" title="Number of Options Nonvested, Forfeited">(333</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z2EBjukY8a6" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Forfeited">6.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_iN_pp0p0_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zG1GpYaMnred" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited">(2,222</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxN72hBMKeL" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1121">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zson4HPph4eh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired_iN_pp0p0_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zO1mA386jgrk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1125">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpc5SSd6XD48" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending">25,090</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2S4MdCdKfj2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning">4.98</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZ4iA1tAkwMf" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl1131">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKSdaLZixzvh" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending">124,948</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zTT8K7iwGt18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the nine months ended September 30, 2023 and September 30, 2022, the Company recorded $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20230101__20230930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zHGtfvrp6sh1" title="Compensation expense">76,110</span> and $<span id="xdx_901_eus-gaap--ShareBasedCompensation_c20220101__20220930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zXqsGq5Y40lj" title="Compensation expense">129,733</span> as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the nine months ended September 30, 2023, are presented in the table below:</span></p> <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zDq8RZUNyyS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B8_zxX1Ew7zAZMb" style="display: none">Schedule of Stock Option Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Term</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value ($000)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z5TDardxbh5d" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning">57,122</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqZaJbfuti6d" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">9.44</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zV0Lr4nYhmh9" title="Weighted Average Remaining Contractual Term, Beginning">6.0</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrgioHWzvmul" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">        <span style="-sec-ix-hidden: xdx2ixbrl1147">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zYBTcMkMM9Ug" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1149">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z10PVGgaTMZa" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1151">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zgOSGd4tkd85" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1153">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zld3Ct8zJTS8" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1155">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvMORLcOVjT7" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1157">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyhiGXUbKP78" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1159">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrJMM922lZh2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1161">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFgfQUd0dIWl" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1163">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zcAMRPg01Ctk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zw4QBIfyJDYk" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqAXNCmVW9h7" title="Weighted Average Remaining Contractual Term, Outstanding Ending">5.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zCuS8IpFiso6" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zv4VveK3UECf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGGElhjeZjSb" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrPzIDnd8mjf" title="Weighted Average Remaining Contractual Term, Exercisable Ending">5.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zq2HLWKYYlub" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zR1cGttJiXPd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the nine months ended September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2023 and September 30, 2022, the Company incurred $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20230101__20230930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zOkVvoDRCCF7" title="Share based compensation">0</span> and $<span id="xdx_901_eus-gaap--ShareBasedCompensation_c20220101__20220930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zL1qJKUKuUt3" title="Share based compensation">29,656</span> respectively, as compensation expense related to <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20230101__20230930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zGkPelxJn8jd" title="Number of options to purchase shares">0</span> and <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20220930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z9tcgP4iw5oa" title="Number of options to purchase shares">6,250</span> fully vested options issued to directors, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Restricted Stock Units</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 3, 2023, the Company issued a total of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230102__20230103__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zL4jGZvhhLc3" title="Number of shares vested in period">119,032</span> restricted stock units (RSUs) under the 2021 Equity Plan to its four independent directors. These RSUs vested upon grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 17, 2023, the Company settled <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230116__20230117__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWIOY8lCnJW2" title="Number of shares granted">3,366</span> RSUs that had been issued on January 17, 2022 to two new directors and that vested after 12 months by the issuance of shares of common stock</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2023 and September 30, 2022, the Company recorded $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zwtG2dHVXXA9">101,316</span> and $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20220101__20220930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zdr7p9RCKN7f">42,413</span>, respectively, as compensation expense related to vested RSUs issued to directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z880rbP9JkW7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z1Ll3lG0klv8" style="display: none">Schedule of Restricted Units Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Grant-Date Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqoYLHX7tXYk" style="width: 14%; text-align: right" title="Number of Units Outstanding, beginning">3,366</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6vtmsPEjk41" style="width: 14%; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding, Beginning">7.42</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSYZCOCCBm4h" style="width: 14%; text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning">      <span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUZaDUHFziO8" style="text-align: right" title="Number of Units, Granted">119,032</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zNWScHluGZI4" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">0.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTTT8XuIVZ7c" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Vested and settled with share issuance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRwEViI75hH7" style="text-align: right" title="Number of Units, Vested and settled with share issuance">(122,398</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zghWaFzmtWfc" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested and settled with share issuance">1.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9mKpC6qnQNi" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Forfeited/canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLOwiKRrbTk6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1215">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zz6fe3MPXni3" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDxfAQ6cDukd" style="padding-bottom: 1.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zh5igDdvma3h" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units Outstanding, ending"><span style="-sec-ix-hidden: xdx2ixbrl1221">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLJZ5FBNFS46" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding,ending"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zsafkzIWLA2d" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, ending"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zTM6vfqPGiIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 333333 1665 333333 163692 145512 24129 666667 122398 138489 0.8955 89970 32376 16631 333 666667 132568 182728 40816 310555 15586 P18M <p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zANY0YheGRQ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zQIpKFpXzvcc" style="display: none">Schedule of Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Term</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2iUwkNNKhmh" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning">192,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTEdfi1PeiC1" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">8.94</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zXbiUxlc3iHl" title="Weighted Average Remaining Contractual Term, Beginning">7.6</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zaHuC5GHANpd" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">        <span style="-sec-ix-hidden: xdx2ixbrl1055">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zwoqlgf8s9Ae" style="text-align: right" title="Number of Options, Granted">138,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVSLD1K0xWdd" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQETw5xo7oii" title="Weighted Average Remaining Contractual Term, Granted">6.4</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zO6KR8bi4Duh" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPduEkig1MV9" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1065">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxhImqD9Ysi6" style="text-align: right" title="Number of Options, Forfeited">(18,629</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zuvSadVhMFEb" style="text-align: right" title="Weighted Average Exercise Price, Forfeited">2.63</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7IrMDA8CGma" title="Weighted Average Remaining Contractual Term, Forfeited">9.2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqglk5a7BETd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1073">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z5XGWuwUiqNl" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1075">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQsUeEpnF42f" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">311,933</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zSmBfV2ymVQ3" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">5.74</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zImC8nnJ19A1" title="Weighted Average Remaining Contractual Term, Outstanding Ending">6.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zp6woDQrnes8" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkNtNi0pRF8l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">286,843</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zA0esyQdVQla" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">5.78</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZNq6I1cYy4l" title="Weighted Average Remaining Contractual Term, Exercisable Ending">6.5</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHfXeZntYCFb" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 192073 8.94 P7Y7M6D 138489 0.90 P6Y4M24D 18629 2.63 P9Y2M12D 311933 5.74 P6Y7M6D 286843 5.78 P6Y6M <p id="xdx_89D_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zmVHTXhbJrM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B9_zVTXyBH2EtFe" style="display: none">Summary of Non-Vested qualified Stock Option Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Grant-Date Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Grant-Date Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Nonvested, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdjvGIH8gOnk" style="width: 12%; text-align: right" title="Number of Options Nonvested, Beginning">28,756</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z87cpCzsr9Ch" style="width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning">4.73</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdCvD5zqT5gd" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1099">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zU6DM36horbc" style="width: 12%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">136,016</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zw3G6jfCtLX1" style="text-align: right" title="Number of Options Nonvested, Granted">138,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z3USaqB40yGi" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Granted">0.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zaQ08lNsFm0e" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted">121,870</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zG9ywCVz20Cl" style="text-align: right" title="Number of Options Nonvested, Vested">(141,822</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zNYPuwdSLBG3" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Vested">0.92</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_iN_pp0p0_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zwT2TtiwC4Oa" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(130,476</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zm66Tjd396ak" style="text-align: right" title="Number of Options Nonvested, Forfeited">(333</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z2EBjukY8a6" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Forfeited">6.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_iN_pp0p0_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zG1GpYaMnred" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited">(2,222</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxN72hBMKeL" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1121">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zson4HPph4eh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired_iN_pp0p0_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zO1mA386jgrk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1125">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpc5SSd6XD48" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending">25,090</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2S4MdCdKfj2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning">4.98</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZ4iA1tAkwMf" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl1131">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKSdaLZixzvh" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending">124,948</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 28756 4.73 136016 138489 0.88 121870 -141822 0.92 130476 333 6.67 2222 25090 4.98 124948 76110 129733 <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zDq8RZUNyyS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B8_zxX1Ew7zAZMb" style="display: none">Schedule of Stock Option Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Term</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value ($000)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z5TDardxbh5d" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning">57,122</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqZaJbfuti6d" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">9.44</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zV0Lr4nYhmh9" title="Weighted Average Remaining Contractual Term, Beginning">6.0</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrgioHWzvmul" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">        <span style="-sec-ix-hidden: xdx2ixbrl1147">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zYBTcMkMM9Ug" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1149">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z10PVGgaTMZa" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1151">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zgOSGd4tkd85" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1153">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zld3Ct8zJTS8" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1155">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvMORLcOVjT7" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1157">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyhiGXUbKP78" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1159">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrJMM922lZh2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1161">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFgfQUd0dIWl" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1163">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zcAMRPg01Ctk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zw4QBIfyJDYk" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqAXNCmVW9h7" title="Weighted Average Remaining Contractual Term, Outstanding Ending">5.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zCuS8IpFiso6" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zv4VveK3UECf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGGElhjeZjSb" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrPzIDnd8mjf" title="Weighted Average Remaining Contractual Term, Exercisable Ending">5.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zq2HLWKYYlub" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 57122 9.44 P6Y 57122 9.44 P5Y3M18D 57122 9.44 P5Y3M18D 0 29656 0 6250 119032 3366 101316 42413 <p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_z880rbP9JkW7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z1Ll3lG0klv8" style="display: none">Schedule of Restricted Units Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Grant-Date Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqoYLHX7tXYk" style="width: 14%; text-align: right" title="Number of Units Outstanding, beginning">3,366</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6vtmsPEjk41" style="width: 14%; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding, Beginning">7.42</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSYZCOCCBm4h" style="width: 14%; text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning">      <span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUZaDUHFziO8" style="text-align: right" title="Number of Units, Granted">119,032</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zNWScHluGZI4" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">0.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTTT8XuIVZ7c" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Vested and settled with share issuance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRwEViI75hH7" style="text-align: right" title="Number of Units, Vested and settled with share issuance">(122,398</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zghWaFzmtWfc" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested and settled with share issuance">1.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9mKpC6qnQNi" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Forfeited/canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLOwiKRrbTk6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1215">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zz6fe3MPXni3" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDxfAQ6cDukd" style="padding-bottom: 1.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zh5igDdvma3h" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units Outstanding, ending"><span style="-sec-ix-hidden: xdx2ixbrl1221">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLJZ5FBNFS46" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding,ending"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zsafkzIWLA2d" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, ending"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3366 7.42 119032 0.84 122398 1.02 <p id="xdx_80D_ecustom--WarrantsDisclosureTextBlock_zT95W3hEWtmg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 - <span id="xdx_821_zM2k7l9sCCqb">Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September 30, 2023:</span></p> <p id="xdx_89C_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zmHIjJuiJTv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zRvHBBfStZKa" style="display: none">Schedule of Outstanding Warrants to purchase Common Stock</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-weight: bold"></td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Remaining Life</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">In Months</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230930_z1FBFscZUZNj" style="width: 9%; text-align: right" title="Warrants Outstanding, Beginning Balance">7,623,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iS_c20230101__20230930_zb5W0JaijGck" style="width: 9%; text-align: right" title="Warrants Exercisable, Beginning Balance">7,623,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20230930_zhvpFaokxcPi" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">5.14</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930_zYHgIKpf0ORf" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">49</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20230101__20230930_zu1ytCznsxN1" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">    <span style="-sec-ix-hidden: xdx2ixbrl1239">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20230930_zb2VkNjZWui3" style="text-align: right" title="Warrants Outstanding. Granted"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted_c20230101__20230930_zBPXcJCF6j77" style="text-align: right" title="Warrants Exercisable, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceGranted_c20230101__20230930_z2EbpspyYatd" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dt_c20230101__20230930_fKg_____zmHJ7rIikWcb" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1247">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230930_zik5zQ4nFdy3" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercised_iN_di_c20230101__20230930_zJ32fzPvPkuh" style="text-align: right" title="Warrants Outstanding, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised_c20230101__20230930_zRzaWMl5jFm2" style="text-align: right" title="Warrants Exercisable, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1253">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20230101__20230930_zIQtvYWQKjof" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1255">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dt_c20230101__20230930_fKg_____zP8P1zRKE2Rh"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_pp0p0_c20230101__20230930_zsD0cibefp65" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1258">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pp0p0_c20230101__20230930_zv3ZVbrEjLw5" style="text-align: right" title="Warrants Outstanding, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations_pp0p0_c20230101__20230930_zET9TFHrH5Vh" style="text-align: right" title="Warrants Exercisable, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20230101__20230930_zprzzVebfVP1" style="text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms_dt_c20230101__20230930_fKg_____zl4yknKvJbC4" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations_pp0p0_c20230101__20230930_zG0DRqkiN7kd" style="text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230930_zdYWVlQS2hI4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20230101__20230930_zld0BStfaapb" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable, Ending Balance">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20230930_zegSMQQ99Y89" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance">5.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20230101__20230930_zO5qHzBHPrE8" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">40</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230930_znIh5m4Jtrlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl1278">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zt9JHZKUwCO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants outstanding at September 30, 2023:</span></p> <p id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zT2UfA1eRNpl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zd5mH4uK9yi2" style="display: none">Schedule of Warrants Outstanding</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Weighted Average</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold">Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Months Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z3JXG0SMZst6" style="width: 20%; text-align: right" title="Exercise price">9.45</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z5OmoNfKitf" style="width: 22%; text-align: right" title="Warrants Outstanding">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zpLIgx8iLmEl" style="width: 22%; text-align: right" title="Warrants Exercisable">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zYFY2nFihZci" title="Weighted average remaining contractual terms (in Months)">12</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z9fDLciPemQd" style="text-align: right" title="Exercise price">10.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zcETXVBU1Ark" style="text-align: right" title="Warrants Outstanding">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zi1dzp9xf1n9" style="text-align: right" title="Warrants Exercisable">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zWguHYxvBI74" title="Weighted average remaining contractual terms (in Months)">13</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_z1h530CI5YAh" style="text-align: right" title="Exercise price">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zMe8ZN5vaB5a" style="text-align: right" title="Warrants Outstanding">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zGDZvZGhMQEl" style="text-align: right" title="Warrants Exercisable">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zx18CX2qXgYg" title="Weighted average remaining contractual terms (in Months)">41</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zl7M4aQ9IR4j" style="text-align: right" title="Exercise price">5.16</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zVnGRLYtnNHg" style="text-align: right" title="Warrants Outstanding">290,557</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_ztEhZp60XaO6" style="text-align: right" title="Warrants Exercisable">290,557</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zafsIgZ7VuB" title="Weighted average remaining contractual terms (in Months)">41</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930_zFodHRJVCsTc" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930_zOmaIZqk6zSa" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930_zPoYb7fyAVci" title="Weighted Average Life of Outstanding Warrants in Months">40</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zNsz1wsl53b9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_89C_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zmHIjJuiJTv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zRvHBBfStZKa" style="display: none">Schedule of Outstanding Warrants to purchase Common Stock</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-weight: bold"></td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Remaining Life</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">In Months</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230930_z1FBFscZUZNj" style="width: 9%; text-align: right" title="Warrants Outstanding, Beginning Balance">7,623,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iS_c20230101__20230930_zb5W0JaijGck" style="width: 9%; text-align: right" title="Warrants Exercisable, Beginning Balance">7,623,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20230930_zhvpFaokxcPi" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">5.14</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930_zYHgIKpf0ORf" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">49</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20230101__20230930_zu1ytCznsxN1" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">    <span style="-sec-ix-hidden: xdx2ixbrl1239">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20230930_zb2VkNjZWui3" style="text-align: right" title="Warrants Outstanding. Granted"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted_c20230101__20230930_zBPXcJCF6j77" style="text-align: right" title="Warrants Exercisable, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceGranted_c20230101__20230930_z2EbpspyYatd" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dt_c20230101__20230930_fKg_____zmHJ7rIikWcb" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1247">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230930_zik5zQ4nFdy3" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercised_iN_di_c20230101__20230930_zJ32fzPvPkuh" style="text-align: right" title="Warrants Outstanding, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised_c20230101__20230930_zRzaWMl5jFm2" style="text-align: right" title="Warrants Exercisable, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1253">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20230101__20230930_zIQtvYWQKjof" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1255">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dt_c20230101__20230930_fKg_____zP8P1zRKE2Rh"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_pp0p0_c20230101__20230930_zsD0cibefp65" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1258">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pp0p0_c20230101__20230930_zv3ZVbrEjLw5" style="text-align: right" title="Warrants Outstanding, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1260">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations_pp0p0_c20230101__20230930_zET9TFHrH5Vh" style="text-align: right" title="Warrants Exercisable, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20230101__20230930_zprzzVebfVP1" style="text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1264">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms_dt_c20230101__20230930_fKg_____zl4yknKvJbC4" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations_pp0p0_c20230101__20230930_zG0DRqkiN7kd" style="text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230930_zdYWVlQS2hI4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20230101__20230930_zld0BStfaapb" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable, Ending Balance">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20230930_zegSMQQ99Y89" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance">5.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20230101__20230930_zO5qHzBHPrE8" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">40</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230930_znIh5m4Jtrlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl1278">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 7623772 7623772 5.14 P49M 7623772 7623772 5.14 P40M <p id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zT2UfA1eRNpl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zd5mH4uK9yi2" style="display: none">Schedule of Warrants Outstanding</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Weighted Average</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold">Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Months Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z3JXG0SMZst6" style="width: 20%; text-align: right" title="Exercise price">9.45</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z5OmoNfKitf" style="width: 22%; text-align: right" title="Warrants Outstanding">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zpLIgx8iLmEl" style="width: 22%; text-align: right" title="Warrants Exercisable">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zYFY2nFihZci" title="Weighted average remaining contractual terms (in Months)">12</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z9fDLciPemQd" style="text-align: right" title="Exercise price">10.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zcETXVBU1Ark" style="text-align: right" title="Warrants Outstanding">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zi1dzp9xf1n9" style="text-align: right" title="Warrants Exercisable">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zWguHYxvBI74" title="Weighted average remaining contractual terms (in Months)">13</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_z1h530CI5YAh" style="text-align: right" title="Exercise price">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zMe8ZN5vaB5a" style="text-align: right" title="Warrants Outstanding">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zGDZvZGhMQEl" style="text-align: right" title="Warrants Exercisable">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zx18CX2qXgYg" title="Weighted average remaining contractual terms (in Months)">41</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zl7M4aQ9IR4j" style="text-align: right" title="Exercise price">5.16</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zVnGRLYtnNHg" style="text-align: right" title="Warrants Outstanding">290,557</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_ztEhZp60XaO6" style="text-align: right" title="Warrants Exercisable">290,557</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zafsIgZ7VuB" title="Weighted average remaining contractual terms (in Months)">41</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230930_zFodHRJVCsTc" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230930_zOmaIZqk6zSa" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230930_zPoYb7fyAVci" title="Weighted Average Life of Outstanding Warrants in Months">40</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 9.45 192982 192982 P12M 10.40 34737 34737 P13M 5.00 7105496 7105496 P41M 5.16 290557 290557 P41M 7623772 7623772 P40M <p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zDhnjWaKPVyf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10 – <span id="xdx_821_ztTN9aUKvE82">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20230930_zXAuMNysMkd4" title="Operating loss carryforward">27,873,000</span>, of which $<span id="xdx_90F_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_iI_c20230930_zQElen9jEwjg" title="Net operating loss carry forward expected to expire amount">11,196,000</span> will expire, if not utilized, in the years <span id="xdx_901_ecustom--NetOperatingLossExpirationTerm_c20230101__20230930_zI8yGo6e0KRa" title="Net operating loss expiration term">2034 through 2037</span>, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to <span id="xdx_900_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20230930_z0UiWdZYapli" title="NOLs usage against taxable income, percentage">80</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OwnershipMember_zqxV4UOhYhI6" title="Percentage of ownership change">50</span>% within a <span id="xdx_90C_ecustom--NolsCarryforwardsTermDescription_c20230101__20230930_zswO8I4zPuQ" title="NOLs carryforwards term">three-year period</span>. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OwnershipMember_z7Tts1S2Nxx3" title="Percentage of ownership change">50</span>% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of September 30, 2023 and December 31, 2022. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 27873000 11196000 2034 through 2037 0.80 0.50 three-year period 0.50 <p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zDUtNo9VuEFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11 – <span id="xdx_828_z6PkZrBSTcjd">Related Party Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, one of our independent directors, has a significant ownership interest in RSX.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the nine months ended September 30, 2023 and September 30, 2022, the Company paid $<span id="xdx_90C_eus-gaap--PaymentsForCommissions_c20230101__20230930_zDsmky1XnKL2" title="Payments for commissions">18,273</span> and $<span id="xdx_900_eus-gaap--PaymentsForCommissions_c20220101__20220930_zpjp2vxo3Pr4" title="Payments for commissions">9,884</span>, respectively, in commissions under this agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The balance due under this agreement totaled $<span id="xdx_904_ecustom--ProceedsFomDeposit_c20221012__20221013__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zvHhYSiA4aZd">2,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with $<span id="xdx_905_ecustom--ProceedsFomDeposit_c20220101__20221231__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zpZ40qf1TiX2">1,250 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $<span id="xdx_901_ecustom--ProceedsFomDeposit_c20221219__20221220__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zexOSAqr5DTg">10,900</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. We entered into positive change orders in March 2023 of $<span id="xdx_903_ecustom--ProceedsFomDeposit_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zdIkCzxgkrI2">3,577 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increasing the total of the second sales order to $<span id="xdx_905_ecustom--ProceedsFomSales_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zq1ml2JZBwWj">14,477</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Revenue of $<span id="xdx_905_eus-gaap--Revenues_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zyVSP2OlO1V8" title="Revenue">16,977</span> was recorded in the nine months ended September 30, 2023 in respect of these agreements. During the nine months ended September 30, 2023, the Company received $<span id="xdx_908_eus-gaap--PaymentsForDeposits_c20230101__20230930_zqgWHoTgfAdk">14,035 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in cash payments for these contracts. A receivable of $<span id="xdx_90C_eus-gaap--AccountsReceivableNet_iI_c20230930_z6krWcif6rT1" title="Outstanding receivable">1,692</span> remained outstanding as of September 30, 2023 which was subsequently paid in October.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 18273 9884 2500 1250 10900 3577 14477 16977 14035 1692 <p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_z8sxwq9lG3Tl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12 – <span id="xdx_82D_z8ch5V0kBjh4">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No material subsequent events occurred after September 30, 2023, other than as set out below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On October 20, 2023, Green Ice, LLC and Sweet Cut Grow, LLC (“Claimants”) filed an Arbitration Petition against the Company in Denver, Colorado. The Claimants allege a breach by the Company of two contracts – an Engineering Agreement with Green Ice, dated January 14, 2021 (“Engineering Agreement”), and an Equipment Agreement with Sweet Cut Grow, dated March 29, 2021 (“Equipment Agreement”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Arbitration Petition alleges causes of action for breach of the Engineering Agreement, Breach of the Equipment Agreement, Breach of the Warranties under the Equipment Agreement, and Unjust Enrichment in the amount of moneys paid by Claimant to CEA to date under the contracts, of $<span id="xdx_90C_eus-gaap--AccountsPayableCurrent_iI_c20231020__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--EngineeringAgreementMember_zye4DG1J0ldb" title="Amount paid">1,049,280</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Given the Arbitration Petition’s current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Regardless, we intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> 1049280 EXCEL 61 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 62 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 63 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 64 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 182 316 1 false 64 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://ceaindustries.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://ceaindustries.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://ceaindustries.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Nature of Operations and Significant Accounting Policies Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies Nature of Operations and Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Leases Sheet http://ceaindustries.com/role/Leases Leases Notes 8 false false R9.htm 00000009 - Disclosure - Inventory Sheet http://ceaindustries.com/role/Inventory Inventory Notes 9 false false R10.htm 00000010 - Disclosure - Property and Equipment Sheet http://ceaindustries.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 11 false false R12.htm 00000012 - Disclosure - Commitments and Contingencies Sheet http://ceaindustries.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders??? Equity Sheet http://ceaindustries.com/role/StockholdersEquity Stockholders??? Equity Notes 13 false false R14.htm 00000014 - Disclosure - Equity Incentive Plans Sheet http://ceaindustries.com/role/EquityIncentivePlans Equity Incentive Plans Notes 14 false false R15.htm 00000015 - Disclosure - Warrants Sheet http://ceaindustries.com/role/Warrants Warrants Notes 15 false false R16.htm 00000016 - Disclosure - Income Taxes Sheet http://ceaindustries.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 00000017 - Disclosure - Related Party Transactions Sheet http://ceaindustries.com/role/RelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 00000018 - Disclosure - Subsequent Events Sheet http://ceaindustries.com/role/SubsequentEvents Subsequent Events Notes 18 false false R19.htm 00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies) Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies Nature of Operations and Significant Accounting Policies (Policies) Policies http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables) Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables Nature of Operations and Significant Accounting Policies (Tables) Tables http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Leases (Tables) Sheet http://ceaindustries.com/role/LeasesTables Leases (Tables) Tables http://ceaindustries.com/role/Leases 21 false false R22.htm 00000022 - Disclosure - Inventory (Tables) Sheet http://ceaindustries.com/role/InventoryTables Inventory (Tables) Tables http://ceaindustries.com/role/Inventory 22 false false R23.htm 00000023 - Disclosure - Property and Equipment (Tables) Sheet http://ceaindustries.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://ceaindustries.com/role/PropertyAndEquipment 23 false false R24.htm 00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities 24 false false R25.htm 00000025 - Disclosure - Equity Incentive Plans (Tables) Sheet http://ceaindustries.com/role/EquityIncentivePlansTables Equity Incentive Plans (Tables) Tables http://ceaindustries.com/role/EquityIncentivePlans 25 false false R26.htm 00000026 - Disclosure - Warrants (Tables) Sheet http://ceaindustries.com/role/WarrantsTables Warrants (Tables) Tables http://ceaindustries.com/role/Warrants 26 false false R27.htm 00000027 - Disclosure - Schedule of Revenue by Source (Details) Sheet http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails Schedule of Revenue by Source (Details) Details 27 false false R28.htm 00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Sheet http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Details 28 false false R29.htm 00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details) Sheet http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails Schedule of Share-based Compensation Costs (Details) Details 29 false false R30.htm 00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative) Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative Nature of Operations and Significant Accounting Policies (Details Narrative) Details http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables 30 false false R31.htm 00000031 - Disclosure - Schedule of Lease Cost (Details) Sheet http://ceaindustries.com/role/ScheduleOfLeaseCostDetails Schedule of Lease Cost (Details) Details 31 false false R32.htm 00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) Sheet http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails Schedule of Future Annual Minimum Lease Payments (Details) Details 32 false false R33.htm 00000033 - Disclosure - Leases (Details Narrative) Sheet http://ceaindustries.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://ceaindustries.com/role/LeasesTables 33 false false R34.htm 00000034 - Disclosure - Schedule of Inventory (Details) Sheet http://ceaindustries.com/role/ScheduleOfInventoryDetails Schedule of Inventory (Details) Details 34 false false R35.htm 00000035 - Disclosure - Inventory (Details Narrative) Sheet http://ceaindustries.com/role/InventoryDetailsNarrative Inventory (Details Narrative) Details http://ceaindustries.com/role/InventoryTables 35 false false R36.htm 00000036 - Disclosure - Schedule of Property and Equipment (Details) Sheet http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails Schedule of Property and Equipment (Details) Details 36 false false R37.htm 00000037 - Disclosure - Property and Equipment (Details Narrative) Sheet http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://ceaindustries.com/role/PropertyAndEquipmentTables 37 false false R38.htm 00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Schedule of Accounts Payable and Accrued Liabilities (Details) Details 38 false false R39.htm 00000039 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://ceaindustries.com/role/CommitmentsAndContingencies 39 false false R40.htm 00000040 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://ceaindustries.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://ceaindustries.com/role/StockholdersEquity 40 false false R41.htm 00000041 - Disclosure - Schedule of Stock Option Activity (Details) Sheet http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails Schedule of Stock Option Activity (Details) Details 41 false false R42.htm 00000042 - Disclosure - Summary of Non-Vested qualified Stock Option Activity (Details) Sheet http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails Summary of Non-Vested qualified Stock Option Activity (Details) Details 42 false false R43.htm 00000043 - Disclosure - Schedule of Restricted Units Activity (Details) Sheet http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails Schedule of Restricted Units Activity (Details) Details 43 false false R44.htm 00000044 - Disclosure - Equity Incentive Plans (Details Narrative) Sheet http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative Equity Incentive Plans (Details Narrative) Details http://ceaindustries.com/role/EquityIncentivePlansTables 44 false false R45.htm 00000045 - Disclosure - Schedule of Outstanding Warrants to purchase Common Stock (Details) Sheet http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails Schedule of Outstanding Warrants to purchase Common Stock (Details) Details 45 false false R46.htm 00000046 - Disclosure - Schedule of Warrants Outstanding (Details) Sheet http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails Schedule of Warrants Outstanding (Details) Details 46 false false R47.htm 00000047 - Disclosure - Income Taxes (Details Narrative) Sheet http://ceaindustries.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://ceaindustries.com/role/IncomeTaxes 47 false false R48.htm 00000048 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://ceaindustries.com/role/RelatedPartyTransactions 48 false false R49.htm 00000049 - Disclosure - Subsequent Events (Details Narrative) Sheet http://ceaindustries.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://ceaindustries.com/role/SubsequentEvents 49 false false All Reports Book All Reports cead-20230930.xsd cead-20230930_cal.xml cead-20230930_def.xml cead-20230930_lab.xml cead-20230930_pre.xml form10-q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 66 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "CEAD", "nsuri": "http://ceaindustries.com/20230930", "dts": { "schema": { "local": [ "cead-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "cead-20230930_cal.xml" ] }, "definitionLink": { "local": [ "cead-20230930_def.xml" ] }, "labelLink": { "local": [ "cead-20230930_lab.xml" ] }, "presentationLink": { "local": [ "cead-20230930_pre.xml" ] }, "inline": { "local": [ "form10-q.htm" ] } }, "keyStandard": 252, "keyCustom": 64, "axisStandard": 19, "axisCustom": 0, "memberStandard": 20, "memberCustom": 43, "hidden": { "total": 138, "http://ceaindustries.com/20230930": 44, "http://fasb.org/us-gaap/2023": 88, "http://xbrl.sec.gov/dei/2023": 6 }, "contextCount": 182, "entityCount": 1, "segmentCount": 64, "elementCount": 495, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 655, "http://xbrl.sec.gov/dei/2023": 34 }, "report": { "R1": { "role": "http://ceaindustries.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://ceaindustries.com/role/BalanceSheets", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R3": { "role": "http://ceaindustries.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R4": { "role": "http://ceaindustries.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:CostOfRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R5": { "role": "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)", "shortName": "Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R6": { "role": "http://ceaindustries.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R7": { "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies", "longName": "00000007 - Disclosure - Nature of Operations and Significant Accounting Policies", "shortName": "Nature of Operations and Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R8": { "role": "http://ceaindustries.com/role/Leases", "longName": "00000008 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://ceaindustries.com/role/Inventory", "longName": "00000009 - Disclosure - Inventory", "shortName": "Inventory", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://ceaindustries.com/role/PropertyAndEquipment", "longName": "00000010 - Disclosure - Property and Equipment", "shortName": "Property and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities", "longName": "00000011 - Disclosure - Accounts Payable and Accrued Liabilities", "shortName": "Accounts Payable and Accrued Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://ceaindustries.com/role/CommitmentsAndContingencies", "longName": "00000012 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://ceaindustries.com/role/StockholdersEquity", "longName": "00000013 - Disclosure - Stockholders\u2019 Equity", "shortName": "Stockholders\u2019 Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://ceaindustries.com/role/EquityIncentivePlans", "longName": "00000014 - Disclosure - Equity Incentive Plans", "shortName": "Equity Incentive Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://ceaindustries.com/role/Warrants", "longName": "00000015 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CEAD:WarrantsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CEAD:WarrantsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://ceaindustries.com/role/IncomeTaxes", "longName": "00000016 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://ceaindustries.com/role/RelatedPartyTransactions", "longName": "00000017 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://ceaindustries.com/role/SubsequentEvents", "longName": "00000018 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R19": { "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies", "longName": "00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies)", "shortName": "Nature of Operations and Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables", "longName": "00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables)", "shortName": "Nature of Operations and Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R21": { "role": "http://ceaindustries.com/role/LeasesTables", "longName": "00000021 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R22": { "role": "http://ceaindustries.com/role/InventoryTables", "longName": "00000022 - Disclosure - Inventory (Tables)", "shortName": "Inventory (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R23": { "role": "http://ceaindustries.com/role/PropertyAndEquipmentTables", "longName": "00000023 - Disclosure - Property and Equipment (Tables)", "shortName": "Property and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R24": { "role": "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables", "longName": "00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R25": { "role": "http://ceaindustries.com/role/EquityIncentivePlansTables", "longName": "00000025 - Disclosure - Equity Incentive Plans (Tables)", "shortName": "Equity Incentive Plans (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R26": { "role": "http://ceaindustries.com/role/WarrantsTables", "longName": "00000026 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R27": { "role": "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "longName": "00000027 - Disclosure - Schedule of Revenue by Source (Details)", "shortName": "Schedule of Revenue by Source (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30_custom_EquipmentAndSystemsSalesMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R28": { "role": "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "longName": "00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "shortName": "Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "CEAD:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "CEAD:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R29": { "role": "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "longName": "00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)", "shortName": "Schedule of Share-based Compensation Costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R30": { "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "longName": "00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative)", "shortName": "Nature of Operations and Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R31": { "role": "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails", "longName": "00000031 - Disclosure - Schedule of Lease Cost (Details)", "shortName": "Schedule of Lease Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R32": { "role": "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails", "longName": "00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)", "shortName": "Schedule of Future Annual Minimum Lease Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R33": { "role": "http://ceaindustries.com/role/LeasesDetailsNarrative", "longName": "00000033 - Disclosure - Leases (Details Narrative)", "shortName": "Leases (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2021-07-28", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-07-28", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R34": { "role": "http://ceaindustries.com/role/ScheduleOfInventoryDetails", "longName": "00000034 - Disclosure - Schedule of Inventory (Details)", "shortName": "Schedule of Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryFinishedGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryFinishedGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R35": { "role": "http://ceaindustries.com/role/InventoryDetailsNarrative", "longName": "00000035 - Disclosure - Inventory (Details Narrative)", "shortName": "Inventory (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R36": { "role": "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails", "longName": "00000036 - Disclosure - Schedule of Property and Equipment (Details)", "shortName": "Schedule of Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R37": { "role": "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "longName": "00000037 - Disclosure - Property and Equipment (Details Narrative)", "shortName": "Property and Equipment (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R38": { "role": "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails", "longName": "00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)", "shortName": "Schedule of Accounts Payable and Accrued Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccruedSalesCommissionCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R39": { "role": "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "00000039 - Disclosure - Commitments and Contingencies (Details Narrative)", "shortName": "Commitments and Contingencies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R40": { "role": "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "longName": "00000040 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R41": { "role": "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "longName": "00000041 - Disclosure - Schedule of Stock Option Activity (Details)", "shortName": "Schedule of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "From2023-01-012023-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_EmployeesAndConsultantsMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R42": { "role": "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails", "longName": "00000042 - Disclosure - Summary of Non-Vested qualified Stock Option Activity (Details)", "shortName": "Summary of Non-Vested qualified Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R43": { "role": "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "longName": "00000043 - Disclosure - Schedule of Restricted Units Activity (Details)", "shortName": "Schedule of Restricted Units Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R44": { "role": "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "longName": "00000044 - Disclosure - Equity Incentive Plans (Details Narrative)", "shortName": "Equity Incentive Plans (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "From2022-06-202022-06-21", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CEAD:EmployeeStockOwnershipPlanAdditionalExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R45": { "role": "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "longName": "00000045 - Disclosure - Schedule of Outstanding Warrants to purchase Common Stock (Details)", "shortName": "Schedule of Outstanding Warrants to purchase Common Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "CEAD:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R46": { "role": "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "longName": "00000046 - Disclosure - Schedule of Warrants Outstanding (Details)", "shortName": "Schedule of Warrants Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R47": { "role": "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "longName": "00000047 - Disclosure - Income Taxes (Details Narrative)", "shortName": "Income Taxes (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R48": { "role": "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "00000048 - Disclosure - Related Party Transactions (Details Narrative)", "shortName": "Related Party Transactions (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PaymentsForCommissions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PaymentsForCommissions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R49": { "role": "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative", "longName": "00000049 - Disclosure - Subsequent Events (Details Narrative)", "shortName": "Subsequent Events (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Forfeited/Canceled", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r277" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r140", "r141", "r330", "r331", "r332", "r333", "r334", "r335" ] }, "CEAD_WarrantsRangeThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "WarrantsRangeThreeMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Range Three [Member]", "documentation": "Warrants Range Three [Member]" } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "auth_ref": [ "r202", "r203", "r204" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r73", "r100", "r378", "r395", "r396", "r403", "r432", "r509" ] }, "CEAD_InflationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "InflationPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inflation", "documentation": "Inflation [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r344", "r508" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss per common share - basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r144", "r160", "r161", "r162", "r163", "r164", "r168", "r171", "r177", "r178", "r179", "r180", "r327", "r328", "r370", "r384", "r502" ] }, "CEAD_DescriptionOfBusinessPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "DescriptionOfBusinessPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of Business", "documentation": "Description Of Business [Policy Text Block]" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r199", "r506", "r581", "r624", "r625" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r22", "r128", "r153", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r316", "r317", "r318", "r329", "r509", "r578", "r619", "r620" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of stock options issued", "verboseLabel": "Number of shares issued", "documentation": "Number of shares issued under share-based payment arrangement." } } }, "auth_ref": [ "r48" ] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest income (expense), net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r110" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r81", "r91", "r109", "r126", "r138", "r139", "r142", "r153", "r158", "r160", "r161", "r162", "r163", "r166", "r167", "r175", "r184", "r190", "r194", "r196", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r328", "r329", "r383", "r453", "r472", "r473", "r504", "r519", "r578" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options to purchase shares", "documentation": "Number of shares purchased for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r610" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss available to common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r146", "r160", "r161", "r162", "r163", "r168", "r169", "r176", "r179", "r184", "r190", "r194", "r196", "r504" ] }, "us-gaap_ManagementFeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ManagementFeeExpense", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Management fee expense", "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment." } } }, "auth_ref": [ "r62", "r456", "r519", "r629" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total minimum lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r345" ] }, "CEAD_ImpactofUkrainianConflictPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ImpactofUkrainianConflictPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impact of Ukrainian Conflict" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r345" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r199", "r506", "r581", "r624", "r625" ] }, "CEAD_OwnershipMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "OwnershipMember", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Member]", "documentation": "Ownership [Member]." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r345" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Federal insured amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r345" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total Shareholders\u2019 Equity", "periodStartLabel": "Beginning balance value", "periodEndLabel": "Ending balance value", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r71", "r74", "r75", "r95", "r433", "r451", "r475", "r476", "r509", "r521", "r563", "r569", "r613", "r630" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "2023 (excluding the nine months ended September 30, 2023)", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r616" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://ceaindustries.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Future Annual Minimum Lease Payments", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r616" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r147", "r149", "r150" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r197", "r357", "r386", "r387", "r388", "r389", "r390", "r391", "r496", "r505", "r510", "r547", "r573", "r574", "r581", "r624" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r97", "r130", "r381" ] }, "CEAD_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impact of the COVID-19 Pandemic on Our Business" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information:" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 }, "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "totalLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r6", "r372", "r381", "r509" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "auth_ref": [ "r197", "r357", "r386", "r387", "r388", "r389", "r390", "r391", "r496", "r505", "r510", "r547", "r573", "r574", "r581", "r624" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prefunded conversion warrants", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r33", "r35", "r60", "r61", "r199", "r493" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized compensation expense", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r609" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r33", "r35", "r60", "r61", "r199", "r397", "r493" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common shares and warrants issued for cash", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r8", "r70", "r71", "r100", "r408", "r474", "r487", "r520" ] }, "us-gaap_ShippingAndHandlingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShippingAndHandlingMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Shipping and Handling [Member]", "documentation": "Packing and transport of product." } } }, "auth_ref": [ "r582" ] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r550", "r551", "r580" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for doubtful accounts", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r145", "r208" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r140", "r141", "r330", "r331", "r332", "r333", "r334", "r335" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "verboseLabel": "Amount paid", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17", "r509" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options, Expired", "verboseLabel": "Number of option remain cancelled", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r271" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Nonvested, Granted", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r278" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Options, Forfeited/Cancelled", "label": "Number of option remain forfeited", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r270" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities", "totalLabel": "Total", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r19" ] }, "us-gaap_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VehiclesMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [Member]", "documentation": "Equipment used primarily for road transportation." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning", "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Options, Outstanding Beginning", "periodEndLabel": "Number of Options, Outstanding Ending", "label": "Number of option remain outstanding", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r264", "r265" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Outstanding Beginning", "periodEndLabel": "Weighted Average Exercise Price, Outstanding Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r264", "r265" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r511", "r512", "r515", "r516", "r517", "r518" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of Options, Exercisable Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r266" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted Average Exercise Price, Exercisable Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r266" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price", "verboseLabel": "Weighted Average Exercise Price, Granted", "terseLabel": "Exercise price per share", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r268" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r356", "r560" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock price volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r285" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r269" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Expired", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired." } } }, "auth_ref": [ "r271" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r287" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r18" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://ceaindustries.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r99", "r152", "r225", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r240", "r325", "r477", "r479", "r491" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Forfeited/Cancelled", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r270" ] }, "us-gaap_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Member]", "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r260", "r261", "r262", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r284", "r285", "r286", "r287", "r288" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r257", "r258", "r260", "r261", "r262", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r284", "r285", "r286", "r287", "r288" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r257", "r258", "r260", "r261", "r262", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r284", "r285", "r286", "r287", "r288" ] }, "us-gaap_StockholdersEquityReverseStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityReverseStockSplit", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reverse stock split", "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements." } } }, "auth_ref": [ "r101" ] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Units, Forfeited/canceled", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r277" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss before provision for income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r80", "r108", "r184", "r190", "r194", "r196", "r371", "r382", "r504" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Units, Granted", "verboseLabel": "Number of shares granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r275" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r275" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Units Outstanding, beginning", "periodEndLabel": "Number of Units Outstanding, ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r272", "r273" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Grant-Date Fair Value Outstanding, Beginning", "periodEndLabel": "Weighted Average Grant-Date Fair Value Outstanding,ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r272", "r273" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r493" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Remaining Performance Obligations Expected to be Recognized", "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation." } } }, "auth_ref": [ "r543" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r556" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares vested in period", "negatedLabel": "Number of Units, Vested and settled with share issuance", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r276" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Vested and settled with share issuance", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r276" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r111", "r122", "r166", "r167", "r188", "r303", "r310", "r385" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation expenses", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r5", "r41" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vesting rights description", "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r49" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r33", "r35", "r60", "r61", "r199", "r493", "r545" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term, Beginning", "verboseLabel": "Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r103" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r53" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term, Exercisable Ending", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Axis]", "documentation": "Information by range of option prices pertaining to options granted." } } }, "auth_ref": [ "r52" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r284" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of stock options issued", "label": "Number of shares grant in period", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]", "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r48" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r6" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNet", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Outstanding receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r440", "r492", "r514", "r623" ] }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation Costs", "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value." } } }, "auth_ref": [ "r13", "r14", "r51" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r523" ] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued Incentive", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [] }, "CEAD_ConvertiblePreferredStockConvertedToSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ConvertiblePreferredStockConvertedToSecurities", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Convertible preferred series B stock dividends", "documentation": "Convertible preferred stock converted to securities.", "label": "ConvertiblePreferredStockConvertedToSecurities" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationLiabilityCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued equity compensation", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date." } } }, "auth_ref": [ "r46", "r102" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://ceaindustries.com/role/Leases" ], "lang": { "en-us": { "role": { "verboseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r337" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "CEAD_StockIssuedDuringPeriodSharesCashlessExerciseOfPrefundedWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "StockIssuedDuringPeriodSharesCashlessExerciseOfPrefundedWarrants", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Cashless exercise of prefunded warrants, shares", "documentation": "Stock issued during period shares cashless exercise of prefunded warrants." } } }, "auth_ref": [] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r70", "r376", "r509" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://ceaindustries.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r154", "r302", "r304", "r305", "r306", "r309", "r311", "r312", "r313", "r404" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r526" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r527" ] }, "CEAD_NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deemed dividend on series B preferred stock arising on down round", "documentation": "Deemed dividend on series B preferred stock arising on down round." } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Total share-based compensation expense included in consolidated statement of operations", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r289", "r300" ] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares available for future equity awards", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r24" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r336", "r354" ] }, "CEAD_PaymentsForRedemptionOfPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "PaymentsForRedemptionOfPreferredStock", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Redemption of series B preferred stock", "documentation": "Redemption of series B preferred stock", "label": "Redemption of series B preferred stock" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r31" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r531" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://ceaindustries.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r353", "r355" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r314" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-based compensation", "verboseLabel": "Share based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r56", "r57", "r58", "r59", "r421", "r422", "r436", "r437", "r438", "r441", "r442", "r443", "r444", "r446", "r447", "r448", "r449", "r462", "r463", "r464", "r465", "r468", "r469", "r470", "r471", "r482", "r483", "r484", "r485", "r500", "r511", "r513" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r336", "r354" ] }, "CEAD_WarrantsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "WarrantsDisclosureTextBlock", "presentation": [ "http://ceaindustries.com/role/Warrants" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants", "documentation": "Warrants Disclosure [Text Block]", "label": "Outstanding Warrants" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r336", "r354" ] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r314" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r511", "r512", "r513", "r515", "r516", "r517", "r518", "r564", "r565", "r611", "r626", "r630" ] }, "CEAD_NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of series B preferred stock", "documentation": "Conversion of series B preferred stock." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r524" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r314" ] }, "CEAD_OptionsIssuedForAccruedEquityCompensationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "OptionsIssuedForAccruedEquityCompensationLiability", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Options issued for accrued equity compensation liability", "documentation": "Options issued for accrued equity compensation liability." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r336", "r354" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Property and Equipment", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r6" ] }, "CEAD_StockIssuedDuringPeriodValueReverseStockSplits": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "StockIssuedDuringPeriodValueReverseStockSplits", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common shares to round up partial shares following reverse split", "documentation": "Issuance of common shares to round up partial shares following reverse split" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r28", "r129", "r497" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r540" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r541" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from the sale of property and equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r87" ] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Potentially dilutive equity instruments that are convertible into common stock", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method." } } }, "auth_ref": [ "r173", "r174", "r179" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r293", "r294", "r295", "r408", "r564", "r565", "r566", "r611", "r630" ] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash balance, amount", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r112", "r375", "r419", "r439", "r509", "r521", "r548" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding, diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r170", "r179" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r421", "r422", "r436", "r437", "r438", "r441", "r442", "r443", "r444", "r446", "r447", "r448", "r449", "r462", "r463", "r464", "r465", "r468", "r469", "r470", "r471", "r482", "r483", "r484", "r485", "r511", "r513" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r524" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of operating lease ROU asset", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r561" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding, basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r168", "r179" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://ceaindustries.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Lease Cost", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r615" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r255", "r350", "r351", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r424", "r425", "r426", "r427", "r428", "r450", "r452", "r481", "r618" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value Outstanding, Beginning", "periodEndLabel": "Aggregate Intrinsic Value Outstanding, ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance", "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://ceaindustries.com/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Inventory", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r16", "r77", "r78", "r79" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Fair value of vested stock options granted to directors", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlans" ], "lang": { "en-us": { "role": { "label": "Equity Incentive Plans", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r256", "r259", "r290", "r291", "r292", "r507" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r539" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Fair value of vested stock options granted to employees", "documentation": "Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r71" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Fair value of restricted stock units issued to directors", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r148" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flows From Financing Activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r148" ] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r155", "r156", "r157", "r181", "r357", "r398", "r420", "r423", "r424", "r425", "r426", "r427", "r428", "r431", "r434", "r435", "r436", "r437", "r438", "r441", "r442", "r443", "r444", "r446", "r447", "r448", "r449", "r450", "r452", "r455", "r456", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r474", "r514" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flows From Investing Activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r89", "r90", "r91" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r26", "r125", "r140", "r141", "r142", "r155", "r156", "r157", "r159", "r165", "r167", "r181", "r206", "r207", "r240", "r293", "r294", "r295", "r307", "r308", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r330", "r331", "r332", "r333", "r334", "r335", "r346", "r392", "r393", "r394", "r408", "r474" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r71", "r377", "r509" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flows From Operating Activities:" } } }, "auth_ref": [] }, "CEAD_CashlessExerciseOrPrepaidWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "CashlessExerciseOrPrepaidWarrants", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Cashless exercise of prefunded warrants", "documentation": "Cashless exercise or prepaid warrants.", "label": "CashlessExerciseOrPrepaidWarrants" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r98", "r213", "r214", "r494", "r572" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r125", "r155", "r156", "r157", "r159", "r165", "r167", "r206", "r207", "r293", "r294", "r295", "r307", "r308", "r319", "r321", "r322", "r324", "r326", "r392", "r394", "r408", "r630" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r106", "r132", "r153", "r184", "r191", "r195", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r315", "r317", "r329", "r373", "r445", "r509", "r521", "r578", "r579", "r619" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants Outstanding, Beginning Balance", "periodEndLabel": "Warrants Outstanding, Ending Balance", "label": "Warrants Outstanding", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r9", "r10" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r71", "r431" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r71", "r431", "r451", "r630", "r631" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Outstanding. Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r11" ] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease liability, net", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r546", "r560" ] }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetIncludingGoodwill", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance." } } }, "auth_ref": [] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued during period, shares, issued for services", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r125", "r140", "r141", "r142", "r155", "r156", "r157", "r159", "r165", "r167", "r181", "r206", "r207", "r240", "r293", "r294", "r295", "r307", "r308", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r330", "r331", "r332", "r333", "r334", "r335", "r346", "r392", "r393", "r394", "r408", "r474" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Restricted Units Activity", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r50" ] }, "CEAD_DisclosureWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "DisclosureWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Warrants", "verboseLabel": "Schedule Of Outstanding Warrants To Purchase Common Stock" } } }, "auth_ref": [] }, "us-gaap_PaymentsForCommissions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForCommissions", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for commissions", "documentation": "The amount of cash paid for commissions during the current period." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Outstanding, Expired", "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r33", "r35", "r60", "r61", "r199", "r493" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts Payable and Accrued Liabilities", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r314" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r202", "r203", "r204" ] }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingMaturityDate", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants maturity date", "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format." } } }, "auth_ref": [ "r612" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise price", "periodStartLabel": "Weighted Average Exercise Price, Beginning Balance", "periodEndLabel": "Weighted Average Exercise Price, Ending Balance", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r239" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r36", "r37", "r38", "r113", "r114", "r117", "r118" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock Option Activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r13", "r14", "r50" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and intangible asset amortization expense", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r5", "r187" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r538" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common shares issued in settlement of restricted stock units issued to directors", "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period." } } }, "auth_ref": [ "r8", "r70", "r71", "r100" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "lang": { "en-us": { "role": { "label": "Summary of Non-Vested qualified Stock Option Activity", "documentation": "Tabular disclosure of the changes in outstanding nonvested shares." } } }, "auth_ref": [ "r51" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r535" ] }, "CEAD_IncreaseDecreaseInAccruedEquityCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "IncreaseDecreaseInAccruedEquityCompensation", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued equity compensation", "documentation": "Increase decrease in accrued equity compensation.", "label": "IncreaseDecreaseInAccruedEquityCompensation" } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r522" ] }, "CEAD_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "2017 Equity Plan and 2021 Equity Plan [Member]", "documentation": "2017 Equity Plan and 2021 Equity Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r72", "r509", "r628" ] }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of dividends on series B preferred stock", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity." } } }, "auth_ref": [ "r27" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common shares and warrants issued on conversion of series B preferred stock", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r26", "r100" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration risk percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r33", "r35", "r60", "r61", "r199" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Grant Date Fair Value Nonvested, Granted", "documentation": "Sharebased compensation arrangement by sharebased payment award options nonvested grant date fair values" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options Nonvested, Vested", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted." } } }, "auth_ref": [] }, "CEAD_DeemedDividendPreferredStockOnDownRound": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "DeemedDividendPreferredStockOnDownRound", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Deemed dividend on convertible preferred series B stock on down round", "documentation": "Deemed dividend on series B preferred stock on down round.", "label": "Deemed dividend on series B preferred stock on down round" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Grant Date Fair Value Nonvested, Vested", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.", "label": "Grant Date Fair Value Nonvested, Vested" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common shares and warrants issued for cash, shares", "verboseLabel": "Number of shares issued", "terseLabel": "Shares issued during the period", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r8", "r70", "r71", "r100", "r399", "r474", "r487" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Grant Date Fair Value Nonvested, Forfeited", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.", "label": "Grant Date Fair Value Nonvested, Forfeited" } } }, "auth_ref": [] }, "CEAD_EmployeesAndConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "EmployeesAndConsultantsMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Employees And Consultants [Member]", "documentation": "Employees And Consultants [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired": { "xbrltype": "sharesItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options Nonvested, Expired", "documentation": "Number of Options, Expired." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit (loss)", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r82", "r153", "r184", "r190", "r194", "r196", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r329", "r504", "r578" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Nonvested, Expired", "documentation": "Number of Options, price per share." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Grant Date Fair Value Nonvested, Expired", "documentation": "Share based compensation arrangement by sharebased payment award options nonvested grant date fair value expired.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value Outstanding, Granted", "verboseLabel": "Aggregate Intrinsic Value, Granted", "documentation": "Intrinsic value of granted under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value Outstanding, Forfeited/canceled", "documentation": "Intrinsic value of forfeited under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r524" ] }, "CEAD_EmployeeStockOwnershipPlanAdditionalExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "EmployeeStockOwnershipPlanAdditionalExpense", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Additional expense", "documentation": "Employee stock ownership plan additional expense." } } }, "auth_ref": [] }, "CEAD_ConsultingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ConsultingAgreementMember", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consulting Agreement [Member]", "documentation": "Consulting Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetImpairment", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 }, "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/StatementsOfCashFlows", "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Goodwill impairment charges", "verboseLabel": "Goodwill and intangible asset impairment", "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months", "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r103" ] }, "CEAD_ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of shares authorized", "documentation": "Share-based compensation arrangement by share-based payment award, number of shares authorized.", "label": "Number of shares authorized [Default Label]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r42", "r131", "r380" ] }, "CEAD_EmployeesDirectorsandConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "EmployeesDirectorsandConsultantsMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Employees, Directors and Consultants [Member]", "documentation": "Employees, Directors and Consultants [Member]" } } }, "auth_ref": [] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants Exercisable, Beginning Balance", "periodEndLabel": "Warrants Exercisable, Ending Balance", "label": "Warrants Exercisable", "documentation": "Number of equity instruments other than options exercisable, including both vested and non-vested instruments." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "srt_BoardOfDirectorsChairmanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "BoardOfDirectorsChairmanMember", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]" } } }, "auth_ref": [ "r568" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r7", "r40" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months, Beginning Balance", "documentation": "Weighted average life of outstanding warrants in months, beginning balance." } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "CEAD_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value, Beginning Balance", "documentation": "Aggregate intrinsic value of outstanding warrants.", "label": "Aggregate intrinsic value of outstanding warrants" } } }, "auth_ref": [] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted": { "xbrltype": "sharesItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common shares issued in settlement of restricted stock units issued to directors, shares", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r8", "r100" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceGranted": { "xbrltype": "perShareItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceGranted", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Granted", "documentation": "Warrants weighted average exercise price granted." } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "DirectorMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "auth_ref": [ "r568", "r627" ] }, "CEAD_WarrantsRangeMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "WarrantsRangeMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Range [Member]", "documentation": "Warrants Range [Member]" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months, Granted", "documentation": "Warrants weighted average remaining contractual terms." } } }, "auth_ref": [] }, "CEAD_DisclosureLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "DisclosureLeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases", "verboseLabel": "Schedule Of Lease Cost", "terseLabel": "Schedule Of Future Annual Minimum Lease Payments" } } }, "auth_ref": [] }, "CEAD_ClassOfWarrantOrRightExercised": { "xbrltype": "sharesItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ClassOfWarrantOrRightExercised", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrants Outstanding, Exercised", "documentation": "Class of Warrant or Right Exercised", "label": "ClassOfWarrantOrRightExercised" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://ceaindustries.com/role/Inventory" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r209" ] }, "CEAD_LoneStarBioscienceIncMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "LoneStarBioscienceIncMember", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lone Star Bioscience Inc [Member]", "documentation": "Lone Star Bioscience Inc [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r70", "r226" ] }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised": { "xbrltype": "perShareItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercised", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted Average Exercise Price, Exercised", "documentation": "Weighted average exercise price of warrants exercised.", "label": "Weighted Average Exercise Price, Exercised [Default Label]" } } }, "auth_ref": [] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised": { "xbrltype": "sharesItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r568" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r536" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options, Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r8", "r70", "r71", "r100", "r269" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Life, Exercised", "documentation": "Weighted Average Remaining Life, Exercised" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r524" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common shares issued and warrants on conversion of series B preferred stock, shares", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r25", "r45", "r100", "r224" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Exercised", "documentation": "Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r533", "r535", "r536" ] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable, Expired", "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed." } } }, "auth_ref": [] }, "CEAD_StockIssuedDuringPeriodValueCashlessExerciseOfPrefundedWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "StockIssuedDuringPeriodValueCashlessExerciseOfPrefundedWarrants", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Cashless exercise of prefunded warrants", "documentation": "Cashless exercise of prefunded warrants, value." } } }, "auth_ref": [] }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired": { "xbrltype": "perShareItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExpired", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted Average Exercise Price, Expired", "documentation": "Weighted average exercise price of warrants expired.", "label": "Weighted Average Exercise Price, Expired [Default Label]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockSplits", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Reverse stock split", "label": "Stock Issued During Period, Shares, Stock Splits", "documentation": "Number of shares issued during the period as a result of a stock split." } } }, "auth_ref": [ "r8", "r70", "r71", "r100" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r534" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r536" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted Average Life of Outstanding Warrants in Months, Granted", "documentation": "Sharebased compensation arrangement by sharebased payment award non options expired weighted average remaining contractual terms.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r70", "r431" ] }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common shares to round up partial shares following reverse split, shares", "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split." } } }, "auth_ref": [ "r8" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Expired", "documentation": "Intrinsic value of expirations award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r70", "r431", "r451", "r630", "r631" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months, Ending Balance", "documentation": "Weighted average life of outstanding warrants in months, ending balance." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r535" ] }, "us-gaap_AreaOfLand": { "xbrltype": "areaItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AreaOfLand", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Area of land", "documentation": "Area of land held." } } }, "auth_ref": [] }, "CEAD_NetOperatingLossCarryForwardExpectedToExpireAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "NetOperatingLossCarryForwardExpectedToExpireAmount", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss carry forward expected to expire amount", "documentation": "Net operating loss carry forward expected to expire amount." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options, Granted", "verboseLabel": "Number of Options Nonvested, Granted", "terseLabel": "Number of share awards granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r268" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Dividends on series B preferred stock", "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance." } } }, "auth_ref": [ "r8", "r100" ] }, "CEAD_NetOperatingLossExpirationTerm": { "xbrltype": "stringItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "NetOperatingLossExpirationTerm", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss expiration term", "documentation": "Net operating loss expiration term." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r535" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r537" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r536" ] }, "CEAD_CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net cash proceeds on sale of common stock and warrants, net of expenses", "documentation": "Cash proceeds from sale of common stock and warrants net of issuance costs." } } }, "auth_ref": [] }, "CEAD_NolsCarryforwardsTermDescription": { "xbrltype": "stringItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "NolsCarryforwardsTermDescription", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "NOLs carryforwards term", "documentation": "Nols carryforwards term description." } } }, "auth_ref": [] }, "CEAD_NolsUsageAgainstTaxableIncomePercentage": { "xbrltype": "percentItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "NolsUsageAgainstTaxableIncomePercentage", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "NOLs usage against taxable income, percentage", "documentation": "Nols usage against taxable income percentage." } } }, "auth_ref": [] }, "CEAD_CommonStock0.00001ParValueMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "CommonStock0.00001ParValueMember", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, $0.00001 par value" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSoldOverhead": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSoldOverhead", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/InventoryDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Overhead expenses", "documentation": "Indirect cost incurred related to good produced and service rendered." } } }, "auth_ref": [ "r557" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "CEAD_ProceedsFomDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ProceedsFomDeposit", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:ProceedsFomDeposit]", "documentation": "Proceeds fom deposit." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r524" ] }, "CEAD_ProceedsFomSales": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ProceedsFomSales", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:ProceedsFomSales]", "documentation": "Proceeds fom sales." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r535" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWriteDown", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for excess and obsolete inventory", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r210" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par or stated value per share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r70", "r226" ] }, "CEAD_TwoThousandAndTwentyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "TwoThousandAndTwentyThreeMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "label": "2023 [Member]", "documentation": "2023 [Member]" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "auth_ref": [] }, "CEAD_DirectorAndStaffMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "DirectorAndStaffMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Director And Staff [Member]", "documentation": "Director And Staff [Member]" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense)", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r85" ] }, "CEAD_WarrantsToPurchaseCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "WarrantsToPurchaseCommonStockMember", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants To Purchase Common Stock [Member]", "documentation": "Warrants to purchase common stock" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r6" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Options Nonvested, Beginning", "periodEndLabel": "Number of Options Nonvested, Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited": { "xbrltype": "durationItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term, Forfeited", "documentation": "Weighted Average Remaining Contractual Term,Forfeited." } } }, "auth_ref": [] }, "CEAD_JanuarySeventeernTwoThousandTwentyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "JanuarySeventeernTwoThousandTwentyTwoMember", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "January 17, 2022 [Member]", "documentation": "January 17, 2022 [Member]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Grant-Date Fair Value, Nonvested, Beginning", "periodEndLabel": "Weighted Average Grant-Date Fair Value, Nonvested, Beginning", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "documentation": "Weighted average grant-date fair value of non-vested options outstanding." } } }, "auth_ref": [] }, "CEAD_TwoThousandTwentyOneEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2021 Equity Incentive Plan [Member]", "documentation": "2021 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "CEAD_TwoNewDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "TwoNewDirectorsMember", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two New Directors [Member]", "documentation": "Two New Directors [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income taxes paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r30" ] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Noncurrent Assets", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r153", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r315", "r317", "r329", "r578", "r579", "r619" ] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryValuationReserves", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for excess & obsolete inventory", "label": "Inventory Valuation Reserves", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r39", "r555" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares, vested", "verboseLabel": "Number of options to purchase shares", "documentation": "Number of options vested." } } }, "auth_ref": [] }, "CEAD_JanuarySeventeernTwoThousandTwentyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "JanuarySeventeernTwoThousandTwentyThreeMember", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "January 17, 2023 [Member]", "documentation": "January 17, 2023 [Member]" } } }, "auth_ref": [] }, "us-gaap_SecurityDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecurityDeposit", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Security deposit", "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease." } } }, "auth_ref": [ "r549" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r127", "r137", "r153", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r315", "r317", "r329", "r509", "r578", "r579", "r619" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Options Nonvested, Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "documentation": "Number of non-vested options forfeited." } } }, "auth_ref": [] }, "CEAD_WarrantsRangeOneMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "WarrantsRangeOneMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Range One [Member]", "documentation": "Warrants Range One [Member]" } } }, "auth_ref": [] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcess", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Work in progress", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r553" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r568", "r617" ] }, "CEAD_OneCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "OneCustomerMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "One Customer [Member]", "documentation": "One Customer [Member]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Nonvested, Vested", "documentation": "Weighted average grant-date fair value of options vested." } } }, "auth_ref": [] }, "CEAD_BookedSalesOrdersFromThreeCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "BookedSalesOrdersFromThreeCustomersMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Booked Sales Orders From Three Customers [Member]", "documentation": "Booked Sales Orders From Three Customers [Member]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Nonvested, Forfeited", "documentation": "Weighted average grant-date fair value of non-vested options forfeited." } } }, "auth_ref": [] }, "CEAD_TwoThousandTwentyOneEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "TwoThousandTwentyOneEquityPlanMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2021 Equity Plan [Member]", "documentation": "2021 Equity Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares authorized", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "CEAD_DirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "DirectorsMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Directors [Member]", "documentation": "Directors [Member]" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r34", "r199" ] }, "CEAD_CustomerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "CustomerOneMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer One [Member]", "documentation": "Customer One [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r525" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r345" ] }, "CEAD_AuditCommitteeChairmanMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "AuditCommitteeChairmanMember", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Audit Committee Chairman [Member]", "documentation": "Audit Committee Chairman [Member]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Noncurrent Liabilities" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Nature of Operations and Significant Accounting Policies", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r92", "r93", "r94", "r104" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred revenue", "verboseLabel": "Contract with customer liability current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r241", "r242", "r253" ] }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRenewalTerm", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease renew term", "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r614" ] }, "CEAD_CommitteeChairmanMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "CommitteeChairmanMember", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Committee Chairman [Member]", "documentation": "Committee Chairman [Member]" } } }, "auth_ref": [] }, "CEAD_CustomerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "CustomerTwoMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Two [Member]", "documentation": "Customer Two [Member]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss per common share - diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r144", "r160", "r161", "r162", "r163", "r164", "r171", "r177", "r178", "r179", "r180", "r327", "r328", "r370", "r384", "r502" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Remaining lease term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r343", "r508" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Noncurrent Assets" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Present value of minimum lease payments", "verboseLabel": "Operating lease liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r339" ] }, "CEAD_UnderwritersMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "UnderwritersMember", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriters [Member]", "documentation": "Underwriters [Member]" } } }, "auth_ref": [] }, "CEAD_CustomerThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "CustomerThreeMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Three [Member]", "documentation": "Customer Three [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating loss carryforward", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r54" ] }, "CEAD_WarrantsRangeTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "WarrantsRangeTwoMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Range Two [Member]", "documentation": "Warrants Range Two [Member]" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r20", "r153", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r316", "r317", "r318", "r329", "r429", "r503", "r521", "r578", "r619", "r620" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r143", "r153", "r185", "r186", "r189", "r192", "r193", "r197", "r198", "r199", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r329", "r371", "r578" ] }, "CEAD_NonQualifiedStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "NonQualifiedStockOptionMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non Qualified Stock Option [Member]", "documentation": "Non Qualified Stock Option [Member]" } } }, "auth_ref": [] }, "CEAD_TwoThousandAndSeventeenEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "TwoThousandAndSeventeenEquityPlanMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "2017 Equity Incentive Plan [Member]", "documentation": "2017 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "CEAD_CustomerFourMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "CustomerFourMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Four [Member]", "documentation": "Customer Four [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Operating loss", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r184", "r190", "r194", "r196", "r504" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Current portion of operating lease liability", "verboseLabel": "Operating lease liability, current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r339" ] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Noncurrent Liabilities", "label": "Liabilities, Noncurrent", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r15", "r66", "r67", "r68", "r69", "r153", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r316", "r317", "r318", "r329", "r578", "r619", "r620" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net proceeds from sale of common stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpensesOther", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other", "label": "Increase (Decrease) in Prepaid Expenses, Other", "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods." } } }, "auth_ref": [ "r4" ] }, "CEAD_EquipmentAndSystemsSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "EquipmentAndSystemsSalesMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Equipment And Systems Sales [Member]" } } }, "auth_ref": [] }, "CEAD_FiveEmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "FiveEmployeesMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Five Employees [Member]", "documentation": "Five Employees [Member]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term, Outstanding Ending", "documentation": "Weighted Average Remaining Contractual Term, Ending." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://ceaindustries.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Warrants Outstanding", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r47" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Grant Date Fair Value Nonvested, Beginning", "periodEndLabel": "Grant Date Fair Value Nonvested, Ending", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.", "label": "Aggregated Intrinsic Value, Nonvested Beginning [Default Label]" } } }, "auth_ref": [] }, "CEAD_ForfeitedNonRefundableCustomerDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ForfeitedNonRefundableCustomerDepositsMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Forfeited Non Refundable Customer Deposits [Member]", "documentation": "Forfeited Non Refundable Customer Deposits [Member]" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregated Intrinsic Value, Nonvested Beginning", "periodEndLabel": "Aggregated Intrinsic Value, Nonvested Ending", "documentation": "Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Aggregated Intrinsic Value, Nonvested Beginning" } } }, "auth_ref": [] }, "CEAD_EngineeringAndOtherServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "EngineeringAndOtherServicesMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Engineering And Other Services [Member]" } } }, "auth_ref": [] }, "CEAD_IncentiveStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "IncentiveStockOptionMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Incentive Stock Option [Member]", "documentation": "Incentive Stock Option [Member]" } } }, "auth_ref": [] }, "CEAD_TwoThousandAndTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "TwoThousandAndTwentyFourMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "label": "2024 [Member]", "documentation": "2024 [Member]" } } }, "auth_ref": [] }, "CEAD_TemporaryEquityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "TemporaryEquityPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Temporary Equity", "documentation": "Temporary Equity [Policy Text Block]" } } }, "auth_ref": [] }, "CEAD_InterimFinancialStatementsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "InterimFinancialStatementsPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Interim Financial Statements", "documentation": "Interim Financial Statements [Policy Text Block]" } } }, "auth_ref": [] }, "CEAD_ProductDevelopmentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ProductDevelopmentCostsMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Product Development Costs [Member]" } } }, "auth_ref": [] }, "CEAD_AdvertisingAndMarketingExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "AdvertisingAndMarketingExpensesMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Advertising And Marketing Expenses [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liability, net of current portion", "verboseLabel": "Operating lease liability, long-term", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r339" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r76", "r107", "r379", "r509", "r563", "r569", "r613" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "auth_ref": [] }, "CEAD_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "label": "Remaining performance obligations related to engineering only paid contracts", "documentation": "Remaining performance obligations related to engineering only paid contracts." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "CEAD_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "presentation": [ "http://ceaindustries.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Outstanding Warrants to purchase Common Stock" } } }, "auth_ref": [] }, "CEAD_NewFacilityLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "NewFacilityLeaseMember", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "New Facility Lease [Member]", "documentation": "New Facility Lease [Member]" } } }, "auth_ref": [] }, "CEAD_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "label": "Remaining performance obligations related to partial equipment paid contracts", "documentation": "Remaining performance obligations related to partial equipment paid contracts." } } }, "auth_ref": [] }, "CEAD_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "CEAD_EngineeringAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "EngineeringAgreementMember", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Engineering Agreement [Member]" } } }, "auth_ref": [] }, "CEAD_IncreaseInRentPercent": { "xbrltype": "percentItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "IncreaseInRentPercent", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase in rent percent", "documentation": "Increase in rent percent." } } }, "auth_ref": [] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r55", "r501" ] }, "CEAD_InventoryMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "InventoryMember", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory [Member]", "documentation": "Inventory [Member]" } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expenses", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r84" ] }, "us-gaap_MarketingAndAdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketingAndAdvertisingExpense", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Advertising and marketing expenses", "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising." } } }, "auth_ref": [ "r84" ] }, "CEAD_PrepaidInventoryExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "PrepaidInventoryExpenses", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/InventoryDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prepaid inventory expenses", "documentation": "Prepaid inventory expenses" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted": { "xbrltype": "durationItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term, Granted", "documentation": "Weighted average remaining contractual term, granted." } } }, "auth_ref": [] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation arrangement payment", "documentation": "Share based compensation arrangement by share based payment award value issued period." } } }, "auth_ref": [] }, "CEAD_NonQualifiedStockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://ceaindustries.com/20230930", "localname": "NonQualifiedStockOptionsMember", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-Qualified Stock Options [Member]", "documentation": "Non-qualified Stock Options [Member]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r123", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r495" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other accrued expenses", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r21" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r199", "r544" ] }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualClassifiedCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued warranty reserve amount", "verboseLabel": "Product warranty accrual", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r21", "r576", "r577" ] }, "us-gaap_StandardProductWarrantyDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StandardProductWarrantyDescription", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product warranty description", "documentation": "Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty." } } }, "auth_ref": [ "r43", "r44" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r89" ] }, "us-gaap_StandardProductWarrantyPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StandardProductWarrantyPolicy", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Product Warranty", "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability." } } }, "auth_ref": [ "r575" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedQualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of period", "periodEndLabel": "Cash and cash equivalents, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r28", "r89", "r151" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r260", "r261", "r262", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r284", "r285", "r286", "r287", "r288" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r254" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r124", "r133", "r134", "r135", "r153", "r171", "r172", "r177", "r179", "r182", "r183", "r205", "r215", "r217", "r218", "r219", "r222", "r223", "r226", "r227", "r229", "r232", "r238", "r329", "r399", "r400", "r401", "r402", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r420", "r431", "r454", "r474", "r486", "r487", "r488", "r489", "r490", "r542", "r562", "r567" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Aggregate Intrinsic Value, Exercisable Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r48" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r4" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expense), net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r86" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r4" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Note 6)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r23", "r63", "r374", "r430" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r211", "r212", "r459" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r83", "r153", "r205", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r329", "r578" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "auth_ref": [ "r212", "r459" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r336", "r354" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Financial Statement Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Operating cash outflow from operating lease", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r340", "r342" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounting for Share-Based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r256", "r263", "r282", "r283", "r284", "r285", "r288", "r296", "r297", "r298", "r299" ] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r552" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r532" ] }, "us-gaap_AccruedSalesCommissionCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedSalesCommissionCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Sales commissions payable", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r21", "r499" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r96", "r116", "r120", "r121" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r88" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash equivalent balance, amount", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r548", "r622" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, and Restricted Cash", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r29", "r105" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r338" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r530" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income (Loss) Per Common Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r31", "r32" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Issued Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r529" ] }, "us-gaap_DepositsAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositsAssetsNoncurrent", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r549" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r528" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r97" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r155", "r156", "r157", "r181", "r357", "r398", "r420", "r423", "r424", "r425", "r426", "r427", "r428", "r431", "r434", "r435", "r436", "r437", "r438", "r441", "r442", "r443", "r444", "r446", "r447", "r448", "r449", "r450", "r452", "r455", "r456", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r474", "r514" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseDescription", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease term description", "documentation": "Description of lessee's operating lease." } } }, "auth_ref": [ "r341" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued payroll liabilities", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r21" ] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares sold", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenue by Source", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r581" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r347", "r348", "r349", "r351", "r352", "r405", "r406", "r407", "r457", "r458", "r459", "r478", "r480" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue, net", "verboseLabel": "Total revenue", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r185", "r186", "r189", "r192", "r193", "r197", "r198", "r199", "r251", "r252", "r357" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par or stated value per share", "verboseLabel": "Common stock par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r71" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r200", "r201" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r255", "r350", "r351", "r424", "r425", "r426", "r427", "r428", "r450", "r452", "r481" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Inventory, net", "totalLabel": "Inventory, net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r136", "r498", "r509" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r524" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r124", "r133", "r134", "r135", "r153", "r171", "r172", "r177", "r179", "r182", "r183", "r205", "r215", "r217", "r218", "r219", "r222", "r223", "r226", "r227", "r229", "r232", "r238", "r329", "r399", "r400", "r401", "r402", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r420", "r431", "r454", "r474", "r486", "r487", "r488", "r489", "r490", "r542", "r562", "r567" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterials", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r554" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of ownership change", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r202" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product development costs", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r65", "r301", "r621" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentrations", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r64", "r115" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r524" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_PaymentsForDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForDeposits", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for Deposits", "documentation": "The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities." } } }, "auth_ref": [ "r558", "r559" ] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "label": "Total remaining performance obligations", "verboseLabel": "Revenue remaining performance obligation", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r119" ] }, "us-gaap_PaymentsForRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRent", "crdr": "credit", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease rental expense", "documentation": "Cash payments to lessor's for use of assets under operating leases." } } }, "auth_ref": [ "r3" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfAssets", "crdr": "credit", "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on disposal of assets", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property." } } }, "auth_ref": [ "r561", "r570", "r571" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(4)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-9" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r496": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r497": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r500": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r501": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r502": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r503": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r504": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r505": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r506": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r507": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r509": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r510": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r513": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r518": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r519": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r520": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r521": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r522": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r523": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r524": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r526": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r528": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r529": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r530": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r531": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r532": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r533": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r534": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r535": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r536": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r537": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r539": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r540": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r541": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r542": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r543": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r544": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r545": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r546": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r547": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r548": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r549": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r550": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r551": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r552": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r553": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r554": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r555": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r556": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r557": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r558": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r578": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r579": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r580": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r581": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r582": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r583": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r584": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 67 0001493152-23-041025-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-041025-xbrl.zip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